






































This! thesis! describes! research! conducted! in! the! Department! of! Pharmacology,! UCL!
School! of! Pharmacy! between! October! 2009! and! September! 2012! under! the!
supervision! of! Professor! Robert! J.! Harvey.! I! certify! that! the! research! described! is!
original!and!that!any!parts!of!the!work!that!have!been!conducted!by!collaboration!are!









This! study! describes! an! inNdepth! investigation! into! the! pathogenic! mechanisms! of!
inherited! mutations! that! lead! to! disorders! of! inhibitory! glycinergic! transmission,!
primarily! the! rare! human! disorder! known! as! startle! disease/hyperekplexia.! I! also!
investigated!mutations!causing!a!similar!startle!phenotype!in!cows,!mice!and!zebrafish.!
Using!molecular! genetics! techniques,! I! identified! pathogenic!mutations! in! the! genes!
that! encode! for! proteins! involved! in! glycinergic! neurotransmission,! specifically! the!
postsynaptic!glycine!receptor! (GlyR)!subunits!and!the!presynaptic!glycine!transporter!
GlyT2.! Using! homology! modelling! and! other! computational! biology! methods,! I!
examined! the! structural! and! functional! impacts! of! mutations! on! protein! function,!
revealing! key! motifs! and! amino! acids! crucial! for! receptor! and! transporter! activity.!
Using! cDNA! cloning! and! siteNdirected! mutagenesis,! I! also! generated! expression!
constructs! for! wildNtype! and! mutant! proteins! that! were! used! in! functional! tests! to!
measure! the! impact! of! pathogenic! mutations! on! glycine! receptor! and! transporter!
function.! For! certain! animal! models! of! startle! disease,! I! was! also! able! to! develop!
diagnostic!PCR!tests!for!pathogenic!mutations,!which!can!be!used!to!alleviate!further!
animal!suffering!by!preventing!'at!risk!matings'!of!carrier!animals.!Taken!together,!my!
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Table!4.1! Data! from! diagnostic! DNA! sequencing! of! SLC6A5! exon! 4! in!
fourteen!cases!
93!




Table!5.2! Properties! of!α1β,!α1βL285R,! α1βW310C! and!α1βM177R!GlyRs!using!
wholeNcell!patchNclamp!electrophysiology!
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inhibitory!synaptic! transmission! in! the!spinal!cord,!brainstem,!cerebellum!and!retina.!
They!are!members!of!the!CysNloop! ligandNgated! ion!channel!superfamily,!of!which!all!
share!a!common!structure!and!topology.!Each!receptor!is!made!up!of!five!subunits!that!
create! a! membrane! spanning! ionNchannel! pore.! Each! subunit! consists! of! four!
transmembrane!(TM)!domains!connected!by!innerN!and!outerNmembrane!loops,!and!a!
large! extracellular! domain! (ECD)! that! is! made! up! of! βNsheets! and! loops.! The!major!
adult! GlyR! isoform,! consists! of! α1! and! β!GlyR! subunits,! and! has! a!major! role! in! the!
control!of!spinal!motor!reflex!circuits! (Fig.!1.1).!Mutations! in!the!genes!encoding!this!




under! investigation.! The! embryonic/neonatal! GlyR! α2! subtype! has! previously! been!
linked! to! roles! in! synaptogenesis! (Kirsch!&!Betz! 1998;! Lévi!et) al! 1998),! cell! fate! and!
paracrine!transmitter!release!(Mangin!et)al!2003)!in!the!developing!cortex!(Flint!et)al!
1998)!and!spinal!cord!(Scain!et)al!2010)!as!well!as!retinal!photoreceptor!development!
(Young!&!Cepko!2010).! It!was! therefore! surprising! that!Glra2! knockout!mice!did!not!
show!a!clear!behavioural!phenotype!(YoungNPearse!et)al!2006).!However,!this!was!also!
true!for! initial!studies!on!GlyR!α3!subunit!knockout!mice,!where!detailed!phenotypic!
characterisation! was! required! to! reveal! subtle! defects! in! central! inflammatory! pain!
sensitisation! (Harvey! et) al! 2004;! Hösl! et) al! 2006;! Harvey! et) al! 2009)! and! rhythmic!
breathing! (Manzke! et) al! 2010).! The! GlyR! α4! subunit! has! been! linked! to!





due! to! a! stop! codon! in! GLRA4! exon! 9,! causing! a! protein! truncation! between!
membraneNspanning!domains!TM3!and!TM4.!However,!this!finding!may!need!revisiting!
in! the! light! of! recent! reNsequencing! studies! showing! that! certain! genes! on! the! X!
chromosome! are! apparently! functional! in! some! individuals! but! contain! nonsense!






Figure! 1.1.! The! glycinergic! inhibitory! synapse.! Human!GlyRs! are! each! composed! of!
two! α1! subunits! and! three! β! subunits! and! are! clustered! on! the! membrane! of! the!
postsynaptic! neurone! opposite! the! presynaptic! terminals! that! release! glycine.! GlyRs!
are!clustered!at!the!membrane!by!gephyrin.!GlyT1!is!located!on!neighbouring!glial!cell!
membranes,!and!is!responsible!for!transporting!glycine!away!from!the!synapse.!GlyT2!




Glycine! transporters! 1! and! 2! (GlyT1! and! GlyT2)! belong! to! the! Na+/ClGNdependent!
neurotransmitter! transporter! family! that! includes! transporters! for! dopamine,!
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norepinephrine,! epinephrine,! serotonin! and! γNaminobutyric! acid! (GABA)! (Nelson!
1998).!These!membrane!proteins!share!a!similar!topology,!having!12!transmembrane!
(TM)! domains! connected! by! a! series! of! extracellular! and! intracellular! loops,! and!
intracellular!NN! and!CNtermini.!GlyT1! and!GlyT2! are! encoded!by! two!different! genes,!
SLC6A9!and!SLC6A5,!and!although!the!proteins!share!around!50%!amino!acid!sequence!
identity,!they!differ!in!function,!localisation!and!uptake!capacity.!As!illustrated!in!figure!
1.1,! GlyT1! terminates! glycinergic! neurotransmission! via! uptake! of! glycine! from! the!
synapse! into!surrounding!glial! cells,!whilst!GlyT2!mediates! the!uptake!of!glycine! into!
the! presynaptic! terminal,! providing! glycine! for! vesicular! inhibitory! amino! acid!
transporter! (VIAAT)Nmediated! refilling! of! synaptic! vesicles! (Eulenburg! et) al! 2005).!
These! roles! were! revealed! by! the! generation! of! GlyT1! and! GlyT2! knockout! mice!
(Gomeza!et)al!2003a,b),!which!show!normal!histology!and!synaptic!protein!expression,!
but!show!differing!neuromotor!defects!that!ultimately!lead!to!their!premature!death.!
GlyT1! knockout! mice! display! severe! motor! and! respiration! deficits! at! birth! with!
lethargy,!hypotonia!and!hyporesponsivity! resulting! from!overinhibition.!The!pups!die!
on! the! first! postnatal! day,! indicating! that! GlyT1! is! not! essential! for! embryonic!
development! but! is! vital! for! postnatal! CNS! functions.! The! reduction! of! overall!
motosensory! functions! in! the! GlyT1Ndeficient! mice! is! similar! to! some! symptoms!
characteristic! of! a! group! of! human! inherited! disorders! known! as! glycine!
encephalopathy! or! nonketotic! hyperglycinemia! (NKH)! (Gomeza! et) al! 2003a).! By!
contrast,!GlyT2!knockout!mice!are!normal!at!birth,!but! in!the!second!postnatal!week!
develop! a! severe! neuromotor! phenotype! characterised! by! spasticity,! a! rigid! muscle!
tone,!strong!tremor!and!a!severely! impaired!righting!response.!They!die!prematurely!
by! the! end! of! the! second! postnatal! week! as! a! result! of! being! unable! to! feed! and!
continued! convulsions.! The! symptoms! observed! in! these! mice! are! similar! to! those!
associated!with!the!hereditary!human!motor!disease!hyperekplexia.!Cultured!neurons!
from!GlyT2!knockout!mice!have!a!significant!reduction! in!the!amplitude!of!miniature!








the! shoulders! and! flexion! of! the! elbows,! trunk! and! knees! causing! falling! without! a!
protective! reaction! (Praveen! et) al! 2001;! Sharma! et) al! 2006).! Startle! disease,! also!
known! as! hyperekplexia,! is! a! rare! neurological! disorder! that! causes! an! exaggerated!






2008).! Clonazepam,! a! benzodiazepine! that! potentiates! the! action! of! GABA! at! the!
GABAA! receptor! can! be! used! to! treat! the! hypertonia! and! apnoea! associated! with!
hyperekplexia.! In!addition,! the!Vigevano!manoeuvre,!which!entails! the! flexing!of! the!
head!and! limbs! towards! the! trunk,!has!also!proved! to!be!effective!particularly!when!
prolonged! stiffness! affects! respiration! (Vigevano! et) al! 1989;! Praveen! et) al! 2001).!




The! primary! cause! of! hyperekplexia! in! humans! is! missense,! nonsense,! deletion! and!
frameshift! mutations! in! the! GlyR!α1! subunit! gene! (GLRA1)! on! chromosome! 5q33.1!
(Shiang! et) al! 1993;! 1995).! The! most! common! mutations! in! GLRA1! to! date! are!
autosomal! dominant! missense! mutations! (depicted! as! red! circles! in! Fig.! 1.2),! and!
typically!affect!residues!in!the!second!transmembrane!domain,!which!lines!the!ClN!ion!
channel! that! is! essential! for! the! GlyR! function,! or! the! extracellular! TM2NTM3! loop!
nearby.! These! mutations! typically! lead! to! a! decrease! in! agonist! affinity! by! causing!
disruptions!in!the!signal!transduction!pathway!that!links!glycine!binding!to!the!gating!
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of! the! integral! chloride! channel.! A! number! of! recessive!GLRA1! mutations! have! also!
been! identified,!which! are! thought! to! either! be! a! result! of! the! inheritance! of! single!
alleles!in!consanguineous!families!or!compound!heterozygosity!of!different!mutations!
(blue!circles! in!Fig.!1.2;!Harvey!et)al! 2008a).! In! fact,! it!has! recently!been!shown! that!
recessive!hyperekplexia!caused!by!GLRA1!mutations! is!more!common!than!dominant!
hyperekplexia! on! a! population! basis! (Chung! et) al! 2010).! Mutations! in! the! GlyR! α1!









the!mutant!mouse!oscillator! results! in!a! lethal!phenotype!whereby! the!mutant!mice!
will! die! by! three! weeks! of! age.! In! this! case,! a! microdeletion! in! exon! 8! results! in! a!
complete! loss! of! GlyR! function! (Buckwalter! et) al) 1994).! The! cincinnati! mutant!
phenotype! closely! resembles! that! of! oscillator,! and! is! the! result! of! a! duplication! of!
exon! 5! in! Glra1,! ultimately! leading! to! a! frameshift! mutation! and! loss! of! function!
(Holland!et)al)2006).!Nmf11!is!the!result!of!an!NNethylNNNnitrosoureaNinduced!missense!
mutation!(N46K;!Traka!et)al)2006).!The!substitution!results!in!a!significant!reduction!in!
agonist! sensitivity! (Harvey! and! Smart,! personal! communication),! which! results! in! a!
lethal!phenotype!resembling!that!of!oscillator)and)cincinnati.!In!Poll!Hereford!cattle,!a!
hyperekplexiaNlike! disorder! known! as! inherited! congenital!myoclonus! (ICM)! has! also!
been! characterised! (Pierce!et)al)2001).! ICM! is! an!autosomal! recessive!disease!and! is!
reported! to! be! characterized! by! hyperesthesia! and! myoclonic! jerks! of! the! skeletal!







startle! disease! mutations.! A! representation! of! GlyR!α1! (A)! and! GlyR! β! (B)! subunit!
topology! annotated!with! the! positions! of! dominant! (red! circles)! and! recessive! (blue!




have! been! reported! in! hyperekplexia.! However,! mutations! in! other! postsynaptic!
proteins! involved! in!glycinergic!transmission!have!been!identified.!Mutations! in!GLRB!
that!encodes!the!GlyR!β!subunit!have!been!reported!in!two!families!(Rees!et)al)2002;!
AlNOwain! et) al) 2011)! (blue! circles! in! Fig.! 1.2).! A!missense! (G229D)! and! a! splice! site!
(IVS5+5→GA)!mutation! occurred! together! in! a! compound! heterozygote! leading! to! a!
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Mutations! in!mouse!Glrb! (Kingsmore! et) al! 1994)! and! zebrafish! glrbb! (Granato! et) al!
1996;!Hirata!et)al! 2005;!Masino!&!Fetcho!2005)! (purple! circles! in! Fig.! 1.2)!have!also!
been! reported.! The! spontaneous! mouse! mutant! spastic) is! characterised! by! an!
exaggerated! startle! reflex! in! response! to! auditory! and! tactile! stimuli,! with! severe!
rigidity! and! tremor,! and! impaired! righting! reflex! (Mulhardt! et) al! 1994)! N! a! similar!
phenotype! to! the!Glra1)mouse!mutants! spasmodic,!oscillator,! cincinnati! and!Nmf11.!
The!mutation!responsible!for!the!phenotype!is!an!intronic!long!interspersed!element!1!
(LINEN1)! retrotransposon! that! lies!between!exons!6!and!7.! This! insertion! causes!misN
splicing! of! GlyR! β! subunit! RNAs! and! impairs! expression! of! normal! GlyR! complexes!
(Kingsmore!et)al)1994;!Mulhardt!et)al!1994).!Zebrafish!bandoneon! (beo)!mutants!are!
defective! in! glycinergic! neurotransmission! due! to! mutations! in! glrbb! encoding! the!
zebrafish!GlyR!βb!subunit.!24N28!hour!wildNtype!embryos!exhibit!characteristic!coiling!
movements! in!response!to!tactile!stimuli,!whereas!beo)mutants! instead!demonstrate!











Initial! genetics! studies! established! that!many! individuals!with! startle! disease! do! not!
carry!mutations!in!GLRA1)or)GLRB.!For!this!reason,!several!additional!candidate!genes!
were! examined! based! on! biological! plausibility,! including! the! clustering! proteins!
gephyrin! (Rees! et) al! 2003)! and! collybistin! (Harvey! et) al! 2004).! However,! neither! of!
these!genes!are!now!thought!to!play!a!major!role!in!hyperekplexia!(Harvey!et)al!2006),!
having! been! implicated! in! molybdenum! coNfactor! (MOCO)! deficiency! (Reiss! &!
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Hahnewald!2011)!and!XNlinked!intellectual!disability!(Harvey!et)al!2004;!Kalscheuer!et)
al! 2009),! respectively.!However,!SLC6A5,! encoding! the!glycine! transporter!GlyT2!was!
considered! to! be! an! excellent! candidate! gene! based! on! biological! function.! In! 2006,!
Rees! and! coNworkers! identified!missense,! nonsense! and! frameshift!mutations! in! the!
GlyT2! gene! in! individuals! presenting! with! typical! hyperekplexia! symptoms:!
exaggerated! startle! response! to! tactile! or! acoustic! stimuli,! hypertonia! and! neonatal!
apnoea!episodes.!The!mutations!resulted!in!defective! localisation!of!GlyT2,!abolished!
[3H]glycine! uptake,! or! both.! Based! on! the! structural! similarity! of! human! GlyT2! to! a!
bacterial! leucine! transporter! (LeuT;! Yamashita! et) al) 2005),! certain! mutations! were!
predicted! to! affect! Na+! or! glycine! binding! residues.! This! was! the! first! example! of! a!
human! disorder! directly! related! to! genetic! defects! in! a! gene! encoding! a! Na+/ClNN
dependent! neurotransmitter! transporter,! and! suggested! that! neurological! disorders!






to! suckle.! They! have! a! severe! phenotype! whereby! the! pups! show! very! weak!
spontaneous! motor! activity.! For! example,! when! touched! gently,! wildNtype! or!
heterozygote! littermates! flail! their! limbs! whereas,! GlyT1N/N! KO! mice! did! not! move!
(Gomeza!et)al!2003a).!GlyT1! is!responsible!for!terminating!glycine!neurotransmission!
by! removing! glycine! from! the! synapse,! therefore! explaining! their! constant! muscle!
relaxation!and! lack!of! response!to!touching.!The!phenotype!of!GlyT2!KO!mice!differs!
significantly! from! that! of! GlyT1.! It! is! also! severe! N! they! gain! weight! slowly! and! die!
prematurely!by! the!end!of! the!second!postnatal!week.!These!mice!appear!normal!at!
birth,! but! also! display! a! complex! phenotype! involving! rigid! muscle! tone,! strong!
spontaneous! tremor,! spasticity,! hind! feet! clasping! and! an! impaired! righting! reflex!
(Gomeza! et) al! 2003b).! This! phenotype! closely! resembles! that! of! mutant! mice!








mutations.! A! representation! of! predicted! GlyT2! topology! within! a! membrane! and!
positions!of!known!mutations!in!hyperekplexia!patients.!Transmembrane!domains!are!




GlyT2! defects! also! cause! disorders! similar! to! startle! disease! in! Belgian! Blue! cattle!
(Charlier! et) al! 2008)! and! Irish! Wolfhounds! (Gill! et) al! 2011).! Charlier! et) al! (2008)!
identified! a! missense! mutation! in! SLC6A5! in! Belgian! Blue! cattle! with! congenital!
muscular!dystonia!2!(CMD2),!where!the!calves!exhibit!symptoms!highly!reminiscent!of!
hyperekplexia! in! humans,! but! typically! die! within! a! few! hours! of! birth.! CMD2! was!
discovered!using!innovative!genomeNwide!SNP!scans!that!localised!the!defective!gene!
to! a! 3.61! Mb! segment! of! bovine! chromosome! 29,! harbouring! the! GlyT2! gene.! The!
mutation! T809C! in! exon! 4! of! SLC6A5) results! in! a! L270P! substitution! in! the! third!
membraneNspanning!domain! (TM3)!of!GlyT2.!Further!genotyping!of!cattle! in!Belgium!
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CMD2! cases! were! found! to! be! homozygous! for! this! change,! confirming! that! the!
disorder!showed!recessive! inheritance.!The!affected!residue!was!not!predicted!to!be!
involved! in!glycine!or!Na+!binding,!but! the! leucine!was!highly! conserved!between!all!
vertebrates! suggesting! structural! or! functional! significance.! Mutation! of! the!
corresponding! residue! (L269P)! in! human! GlyT2! abolished! [3H]glycine! uptake! in!
recombinant!assays!(Charlier!et)al!2008).!
!
In! 2011,! Gill! et) al) reported! the! first! genetically! confirmed! cases! of! canine! startle!
disease!in!Irish!Wolfhounds.! In!a! litter!of!seven!puppies,!two!showed!an!exaggerated!
startle! response! with! severe! muscle! stiffness! and! tremor! in! response! to! handling.!
Sequencing!of!SLC6A5!revealed!a!4.2!kb!deletion!containing!exons!2!and!3!resulting!in!
the! loss! of! a! large! part! of! the! end! terminus! as! well! as! all! the! subsequent!
transmembrane!domains!of!the!protein!due!to!a!frameshift!(Gill!et)al!2011).!Both!pups!
were! found! to! be! homozygous! for! this! change,! while! both! parents! and! three! other!
pups! in! the! litter! were! found! to! be! heterozygous,! confirming! recessive! inheritance.!
These! findings! in! cattle! and! companion! animals! are! not! only! significant! for! the!
understanding! of! human! startle! disease,! but! they! are! also! key! in! informing! future!






to! a! greater! understanding! of! the! systems! and! mechanisms! involved! in! locomotor!
network!development!and! function! (Drapeau!et)al! 2002).! Zebrafish!have!become!an!
attractive!model! for! the! study! of!motor! development! for! a! number! of! reasons.! The!
embryos! develop! very! rapidly! and! are! transparent! allowing! the! visualization! of!
dynamic!events! in! live!fish,!such!as!Ca2+!transients!and!axonal!outgrowth.!The!size!of!
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the! brain! or! eye,! for! example! or! length! of! the! body! of! the! fish! can! be! observed! at!
different! time! points! and! are! generally! very! uniform! between! wildNtype! fish.! Also,!
importantly,! the! behaviours! of! zebrafish! embryos! are! easily! assayed! and! well!
characterised.! Embryos! classically! exhibit! three!defined!behaviours!by! 36!hours!post!
fertilization! (hpf).! At! 17! hpf,! embryos! exhibit! a! simple! slow! coiling! behaviour!
independent!of!stimulation,!which!is!seen!as!repetitive!alternating!coiling!of!the!tail.!At!
21! hpf! the! coiling! becomes! stronger! and! occurs! in! response! to! mechanosensory!
stimulation.! Finally! at! 26! hpf,! this! coiling! becomes! swimming,! which! is! initiated! by!
mechanosensory! stimulation,! increasing! from! 7! Hz! to! 30! Hz! at! 36! hpf! (Hirata! et) al!
2004).! In! order! to! understand! the! embryonic! behaviours! of! the! zebrafish,! the!
physiology! of! the! embryonic! neurons! and! muscles! can! be! analysed! using!
electrophysiological!techniques.!
!
Importantly,! forward! genetics! can! be! applied! to! zebrafish,! identifying! genes!
responsible! for! correct! motor! behaviours.! LargeNscale! mutagenesis! using! NNethylNNN
nitrosourea! (ENU)! has! generated! hundreds! of! zebrafish!mutants! that! are! useful! for!
dissecting!synaptic!transmission.!Granato!and!coNworkers!(1996)!performed!a!genetic!
screen! detecting! behavioural! phenotypes! for! motor! functions.! 166! mutants! were!
identified! from! this! screen! exhibiting! embryonic! motility! defects,! which! were! then!
categorised! into! 14!phenotypes,! estimating! to! comprise! defects! in! at! least! 48! genes!
(Granato!et)al!1996).!103!of!these!mutants!displayed!normal!birefringence!of!muscular!
fibres! suggesting! impairments! in! the! nervous! system,! neuromuscular! junction! or!
functional!components!of!muscle!such!as!EC!coupling.!These!mutants!were!categorised!









displays! the! strongest! phenotype! and! harbours! a! G81D!missense!mutation! in! GlyT1!
(Cui!et)al! 2005).!The! te301!allele!displays!a!milder!phenotype!and!harbours!a!C305Y!
missense!mutation!(Mongeon!et)al!2008).!The!mutation! in!the!ta51e! line! is!currently!
unknown.! Curiously,! sho! ta229g! mutants! normally! die! within! two! weeks! of!
development,! but! can! be! maintained! to! adulthood! by! careful! feeding.! By! contrast,!
te301! mutants! recover! by! around! 4N5! dpf.! This! suggests! that! the! G81D! and! C305Y!
substitutions! show! important! differences! in! their! effect! on!GlyT1! function,! and! that!
zebrafish! GlyT1! mutants! are! ideal! for! studying! both! embryonic! and! adult! synaptic!
transmission! and! behaviours.! Despite! these! advances! provided! by! the! study! of! sho!
mutants,!a!similar!ENU!mutant! in!GlyT2!has!remained!elusive.!However,!a! recent!reN
examination! of! zebrafish! motility! mutants! that! had! been! mapped! near! slc6a5! on!
zebrafish!chromosome!7!by!Geisler!and!coNworkers!(2007)!uncovered!a!promising!lead.!















Embryonic! lethal.! d2,! twitch!
only!once,!head!not!straight;!
d5,! head! straight,! in!
response!to!touch!just!jumps!
up! and! falls! down,! then!
vibrates! with! tip! of! tail.!
Resting! position! sideways! or!
upside! down.! Mutations!
G81D! and! C305Y! in! the!
glycine! transporter! 1! gene!
(slc6a9)!on!chromosome!2.!

















reduced! motility,! do! not!





degenerating! in! 50%! of! the!
embryos.!
Granato! et) al! 1996;!
Odenthal!et)al!1996!





Another! interesting! class!of! zebrafish!mutants! is! the! 'accordion'!mutants! N!accordion)
(acc),! zieharmonika) (zim),! diwanka) (diw),! bandoneon) (beo),! quetschkommode) (que),!
bajan)(baj)!and!expander)(exp),!which!are!soNcalled!due!to!the!simultaneous,!bilateral!
contractions!of!the!axial!muscles!in!response!to!tactile!stimuli!(Hirata!et)al)2010).!WildN





mechanism! that,! in! wildNtype! embryos,! prevents! motor! neurons! on! one! side! from!
firing! when! the! muscles! on! the! other! side! are! contracting.! Additionally,! it! was!
demonstrated! that! this! inhibitor!mechanism! is! glycineNmediated! since! application! of!




Inhibitory! GlyRs! belong! to! a! superfamily! of! ligandNgated! ion! channels! that! includes!
nicotinic! acetylcholine! receptors! (nAChRs),! serotonin! (5HT3)! receptors! and! GABAA!
receptors,! and! are! heteromultimers! made! up! of! ligandNbinding! α! subunits! and!
structural!β!subunits.!The!β!subunits!also!bind!gephyrin,!which!is!a!protein!essential!for!
clustering!αβ!GlyRs!at!synapses.!In!mammals,!there!are!four!α!subunit!genes!(GLRA1,!
GLRA2,! GLRA3! and! GLRA4)! and! one! β! subunit! gene! (GLRB).! Zebrafish! have! five! α!
subunit!genes!(glra1,!glra2,!glra3,!glra4a)and!glra4b)!and!two!β!subunit!genes!(glrba)
and! glrbb)! (Hirata! et) al! 2010).! Phylogenetic! analysis! has! shown! high! sequence!
similarities! of! mammalian! GlyR! α1,! GlyR! α2,! GlyR! α3,! and! GlyR! α4! subunits! to!
zebrafish! GlyR!α1,! GlyR!α2,! GlyR!α3,! and! GlyR!α4a/GlyR!α4b! subunits! respectively!
(Imboden!et)al!2001;!Hirata!et)al!2010).!Zebrafish!can!therefore!provide!a!very!useful!
model! for! the! study! of! the! roles! of! the! glycine! receptor! subunits! and! ultimately! aid!
understanding!of!disease!mechanisms!of!mutations!that!affect!these!genes.!Table!1.2!
brings! together! the! current! findings! as! to! which! glycine! receptor! subunit! or! glycine!
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transporter! genes! are! responsible! for! mutants! in! the! ENU! screen! or! the! effects! of!
knockdown.!For!many!genes!the!effect!of!knockdown!is!currently!unknown.!Similarly,!
there!are!accordion)mutants!with!a!currently!unknown!causative!gene.!Expander)(exp))
for! example,! is! an! interesting! mutant! for! which! the! causative! mutation! remains!
unknown.!
!
Gene! Location! Protein! Mutant/Knockdown! Key!references!
Glycine!receptors! !
glra1) Chr!14! GlyR!α1! Knockdown:! no! phenotype!
reported!
DavidNWatine! et) al! 1999;!
Hirata! et) al! 2005;!
McDearmid!et)al)2006!
glra2) Chr!9! GlyR!α2! Unknown) Hirata!et)al!2010!
glra3! Chr!1! GlyR!α3! Unknown! Imboden!et)al!2001b!
glra4a! Chr!14! GlyR!α4a! Knockdown:! Disrupted!
rhythmNgenerating! networks!
and! reduced! number! of!
spinal!interneurons!
Imboden! et) al! 2001a,b;!
McDearmid!et)al!2006!
glra4b! Chr!5! GlyR!α4b! Unknown) Imboden!et)al!2001b!
glrba) Chr!1! GlyR!βa) Unknown! Hirata!et)al!2005!













LargeNscale! genome! sequencing! projects! have! resulted! in!millions! of! known! protein!
sequences! from! various! organisms.! However,! protein! structure! determination! is!
limited! by! cost,! time! and! experimental! challenges! that,! unfortunately,! are! primarily!
inherent! to! XNray! crystallography! and! nuclear! magnetic! resonance! (NMR)!
spectroscopy.! Therefore,! the! rate! of! experimental! structure! determination! for! these!
proteins!is!much!slower,!with!structure!known!for!only!around!one!hundredth!of!those!
that!have!been!characterised!(Eswar!2003).!!However,!with!the!help!of!computational!








sequence! homologues! with! known! structures! that! may! be! used! as! a! template!
structure.!This!is!done!using!fold!recognition!software!and!web!servers!such!as!HHPred!
(Söding! et) al! 2005)! and! GenThreader! (Lobley! et) al! 2009),! which! detect! the! closest!
related!structures! that! should!be!used!as!a! template!structure!on!which! to!base! the!
homology!model.!An!approximate!sequence!alignment!between! the! target! sequence!
and!the!structure!is!created!so!that!a!percentage!sequence!identity!may!be!calculated.!
The!second!stage!of!homology!modelling!is!the!alignment!stage.!The!target!sequence!is!




to! create! these! alignments,! having! different! algorithms! and! different! levels! of!
accuracy.! In! order! to! perform! a! pairwise! alignment! where! just! two! sequences! are!
aligned,! dynamic! programming! is! used! which! is! based! on! an! algorithm! devised! by!
Needleman! and! Wunsch! in! 1970.! A! table! of! scores! for! matches! and! mismatches!
between! amino! acids! (e.g.! the! BLOSUM62! matrix! (Eddy! 2004))! is! given,! along! with!
defined! penalties! for! insertions! and! deletions.! The! NeedlemanNWunsch! algorithm!
(Needleman! &! Wunsch! 1970)! is! generally! used! for! global! alignments! where! the!
program!attempts! to!align!all! of! the! residues/nucleotides! in! the!entire! length!of! the!
sequence,!and! the!SmithNWaterman!algorithm! (Smith!&!Waterman!1981)! is!used! for!
local!alignments,!which!is!more!useful!for!sequences!that!lack!overall!similarity!but!are!
thought!to!have!areas!of!local!similarity!or!shared!motifs.!Heuristic!methods!which!are!
less! accurate! but!more! efficient! are! employed! for! database! searches! such! as! BLAST!
(Basic! Local!Alignment! Search! Tool)! (Altschul!et) al! 1990),!where! short! subsequences!
are! taken! from! the! query! sequence! and! matched! to! a! database! of! candidate!
sequences.!If!multiple!subsequences!are!matched!between!two!sequences!in!the!same!
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locality! then! the!method! will! go! on! to! apply! a!more! sensitive! alignment,! while! the!
sequences! with! no! similarity! are! discarded.! Multiple! sequence! alignments! are! very!
useful! for! identifying! regions! of! conservation! within! a! group! of! related! sequences,!
which! is!of!particular! importance! in!homology!modelling!when! identifying! important!
structural!motifs.!Multiple!sequence!alignments!are!more!computationally!difficult!to!
calculate! in! comparison! to! pairwise! alignments,! but! are! becoming! faster! due! to!










calculated!and!built! computationally!using! the!alignment!and! the! coordinates!of! the!
template! structure! or! structures.! MODELLER! (Sali! &! Blundell! 1993)! is! a! popular!
computer! program! designed! for! this! task! in! particular,! although! is! also! capable! of!
carrying! out! all! four! steps! in! the! process.! This! software! builds! comparative! models!
using! an! alignment! of! the! target! sequence! to! the! template! sequence,! the! atomic!
coordinates!of!the!template!structure!and!a!simple!script!to!instruct!the!program!(Sali!
&!Blundell!1993;!Eswar!et)al!2006).!The!program!executes!the!model!building!by!the!
satisfaction! of! spatial! restraints,! whereby! a! set! of! geometrical! criteria! help! create! a!
















The! fourth! and! final! stage! of! homology! modelling! is! the! model! assessment! stage,!
where! the!accuracy!of! the!models!created! is!assessed.! Identifying! the!most!accurate!
model! from!an! ensemble! of!models! is! a! critical! step! in! protein! structure! prediction.!
The!accuracy!of!a!model!is!usually!directly!correlated!with!the!sequence!identity!of!the!
target! protein! to! the! template! protein! thus! the! sequence! identity! itself! gives! us! the!
most! easily! quantifiable! measure! of! the! accuracy.! However,! this! is! not! adequate,!
particularly! for! models! built! on! templates! with! a! relatively! low! sequence! identity.!
Relative! energy! of! the! model! can! be! calculated! and! compared! to! the! statistical!


















protein! structures! are! found! to! have! the! lowest! energies,! and! can! be! used! as! a!
consistent! benchmark! of! how! “nativeNlike”! a! homology! model! is.! These! structures!
provide! a! great! deal! of! information! about! the! atomic! interactions! that! dictate!what!
makes!a!protein!nativeNlike.!This! information!has!been!utilized!to!generate!many!and!
varied!statistical!potentials! in!order! to!assess! the!accuracy!of!homology!models.!The!
DOPE! (Discrete!Optimised!Potential!Energy)! statistical!potential! (Shen!&!Sali!2006)! is!
an! atomic! distanceNdependent! statistical! potential! that! is! derived! from! a! sample! of!
native!structures!in!the!protein!data!bank!(PDB;!www.pdb.org;!Berman!et)al!2000).!It!is!
widely! used! and! is! incorporated! within! MODELLER! so! that! a! DOPE! score! may! be!
calculated! following! model! building! using! the! same! script! each! time.! These! scores!
allow!us! to!predict! the!most!accurate!model!or!models!out!of!many! that!have!been!
built.! It! also! scores! each! residue! individually,! which! allows! the! determination! of!
problematic!areas!such!as!loop!regions!that!may!require!further!refinement.!Additional!
assessments! can! be! made! on! a! final! model! using! web! servers! such! as! the! QMEAN!
(Qualitative!Model! Energy! Analysis)! server! (Benkert! et) al! 2009),! which! analyses! the!
quality!of! a!model!using!evolutionary! and!physiochemical! criteria,! giving!both!global!
and!individual!residue!quality!estimates.!Simple!servers!such!as!this!one!are!extremely!
useful! to! allow!experts! and! relative!novices! to! realize! the!overall! quality! of! a!model!
and/or!areas!of!the!model!that!are!unreliable!and!may!require!further!refinement.!!
!
1.5.! The! crystal! structure! of! LeuTAA:! a! bacterial! homologue! of! Na+/ClGGdependent!
neurotransmitter!transporters!
Currently,!there!is!no!existing!crystal!structure!for!the!vertebrate!glycine!transporters.!
Membrane! proteins! are! notoriously! difficult! to! purify! due! to! their! high! levels! of!
hydrophobicity,!and!eukaryotic!proteins!can!also!be!very!difficult!to!express.!However,!
in!2005,!Yamashita!and!colleagues!exploited!the! fact! that!prokaryotic!organisms!also!
harbour!amino!acid! transporters!and!crystallised! the! leucine! transporter! (LeuT)! from!
Aquifex)aeolicus.!Although!the!overall!sequence!identity!between!the!prokaryotic!LeuT!
and! eukaryotic! counterparts! is! only! 20N25%,! clusters! of! high! sequence! conservation,!
including! functionally! important! residues,! are! distributed! throughout! the! sequences.!
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This!makes!the!LeuT!structure!a!good!template!for!homology!modelling!of!eukaryotic!
homologues,! such! as! glycine! transporters.! Molecular! cloning! of! a! large! family! of!
neurotransmitter! transporters,! including! those! for! GABA,! glycine,! serotonin! and!
dopamine!(Bröer!2006)!has!already!provided!some!initial!structural!insights.!Analysis!of!
these! sequences! suggested! that! these! transporters! have! 12! transmembrane! regions!
(TMs)!connected!by!a!series!of!intracellular!and!extracellular!loops,!with!the!NN!and!CN
termini! residing! in! the! cytoplasm.! Mutagenesis! and! structure/function! studies! have!









Figure! 1.5.! The! structure! of! the!Aquifex# aeolicus! leucine! transporter.! The!structure!











1.6.! Crystal! structure! of! the! C.# elegans! glutamateGgated! chloride! channel! GluCl:! A!
helpful! insight! into! the! structures! of! the! CysGloop! ligandGgated! ion! channel!
superfamily!
CysNloop! ligandNgated! ion! channels! are! membraneNspanning,! pentameric! receptor!




system! (CNS).! The! CysNloop! receptor! family! includes! the! vertebrate! receptors! for!
serotonin!(5NHT3),!acetylcholine!(nACh),!glycine!(Gly)!and!γNaminobutyric!acid!(GABAA,!
GABAc),!along!with!a!range!of!invertebrate!(GluCl)!and!prokaryotic!(ELIC!and!GLIC)!CysN
loop! receptors! (Thompson! et) al! 2010).! All! CysNloop! receptors! share! a! common!




together! to! form! symmetrical! pentameric! complexes! where! the! second!
transmembrane!(TM2)!helix!of!each!subunit!faces!the!centre!of!the!complex.!Together,!




We! encounter! a! similar! problem! when! understanding! the! molecular! structure! and!
dynamics! of! the! GlyR! as! we! do! for! GlyT2,! since! there! is! currently! no! solved! crystal!
structure! for! this! receptor.! The! structure! for! the! nicotinic! acetylcholine! receptor!
(nAChR)!was,! until! recently,! the! closest! related! structure! available.! The! initial! threeN
dimensional! electron!microscopy! (EM)! image! at! a! 9Å! resolution! was! first! published!
(Unwin!1993),!and!has!been!refined!at!4Å!resolution!(Unwin!2005).!Many!predictions!
about! the!structure!of! the!GlyR!were!made!using!this!structural! information,!despite!
the!relatively!low!sequence!identity!of!the!different!nAChR!subunits!(GlyR!α1!subunit:!




&!Dutzler!2008;!Bocquet!et)al! 2009)!have!also!proved! to!be!very!useful! in!providing!
structural! information! about! the! nAChR! and! other! CysNloop! receptors,! in! particular,!
regarding! the! agonist! binding! site! (Brejc! et) al! 2001),! but! again! these! show! limited!































In!mid! 2011,! the! crystal! structure!of! a!C.) elegans! glutamateNgated! chloride! selective!
ionNchannel! GluCl! resolution! was! determined! at! 3.3Å! resolution! (Hibbs! &! Gouaux!
2011).!The!GluCl!structure!is!an!invaluable!tool!for!predicting!the!structures!of!various!
related! receptors,! shedding! some! more! light! on! the! ligandNbinding! site! (Hibbs! &!
Gouaux!2011)!and!binding!of! ivermectin! (Duterte!et)al! 2012;! Lynagh!&!Lynch!2012),!
since! the! crystallised! structure! includes! these!molecules!bound!within! the! structure.!










Until! recently,! dominant! mutations! in! the! gene! encoding! the! postsynaptic! GlyR!α1!
subunit! (GLRA1)! were! considered! to! be! the! single! major! cause! of! startle! disease.!
However,! a! number! of! novel! mutations! have! recently! been! discovered! in! the!
presynaptic! GlyT2! gene! (SLC6A5)) in! individuals! with! startle! disease,! suggesting! that!
GlyT2!dysfunction!may!represent!a!second!major!cause!of!the!disease.!In!chapter!3,!I!
aimed!to!understand!the!pathogenic!mechanisms!underlying!GlyT2!dysfunction.!Firstly,!




Congenital! muscular! dystonia! (CMD2)! is! an! inherited! disease! found! in! cattle! with! a!
startleNdiseaseNrelated!phenotype.!This!recessive!disorder!can!have!serious!economical!
consequences! for! the! cattle! farming! industry,! as! well! as! animal! welfare! issues,! if! it!
remains!undetected!within!a!herd.!In!chapter!4,!I!investigate!two!new!cases!of!CMD2!
reported! in! Belgian! Blue! calves! from! the! United! Kingdom.! I! aimed! to! develop! rapid!
genotyping!tests!for!the!specific!genetic!mutation!responsible!for!CMD2,!to!be!used!in!
a!preliminary!population!analysis!study!for!CMD2!in!cattle!from!the!United!Kingdom.!
An! additional! aim!was! to! build! a! homology!model! of! bovine! GlyT2,! to! offer! further!
insight! into! the! structural! and! functional! effects! of! the! CMD2! mutation! on! GlyT2!
function.!
!
Whilst!mutations! in! the!GlyR!α1! subunit! and!GlyT2! genes! are! established! causes! of!
startle!disease,!considerably!fewer!mutations!have!been!identified!the!GlyR!β!subunit!
gene! (GLRB).! This! is! unusual,! considering! that! these! GlyR! subunits! are! expressed!
together! to! form! heteromeric! receptors.! In! chapter! 5,! I! aimed! to! determine! the!
pathogenic!mechanisms!of!three!novel!mutations!in!GLRB!that!were!recently!identified!




In! chapter! 6,! I! aimed! to! review! zebrafish! models! of! startle! disease,! identifying! the!
genes! and!mutations! involved! in! known! zebrafish!motility! mutants.! I! also! aimed! to!
identify!new!mutations!in!the!remaining!alleles!of!the!mutants!bandoneon)and!schlaffi,!
exploring!the!possibility!that!the!latter!mutant!harbours!a!mutation!in!slc6a5!encoding!
GlyT2.! I! also! aimed! to! explore! new! approaches! for! disrupting! GlyR! function! in!





























TOPO®! TA! cloning®! kit! for! sequencing! (cat! #:! K4575N02)! containing! pCR®4NTOPO®!
vector,!salt!solution!and!dNTPs:!Invitrogen!Ltd!(Paisley,!UK)!
QuikChange! II! siteNdirected!mutagenesis!kit! (cat!#:!200523)!containing!PfuUltra!HighN
fidelity!DNA!polymerase,!10X!reaction!buffer,!DpnI!restriction!enzyme!and!dNTP!mix:!
Agilent!(Cheshire,!UK)))




















to! the! lysed! tissue! solution!and!mixed!by!vortexing!before! incubating!at!70°C! for!10!
minutes.!200!μl!ethanol!was!added!and!the!solution!was!mixed!by!vortexing.!The!DNA!
was!bound!to!a!QIAamp!Mini!spin!column,!then!washed!by!adding!500!μl!Buffer!AW1!
and! centrifuging! at! 5,900! g! for! 1! min.! Filtrate! was! discarded! and! the! column! was!
washed! again! by! adding! 500! μl! Buffer! AW2! and! centrifuging! at! 16000! g! for! 3!min.!
Filtrate!was!discarded!and!the!column!was!centrifuged!again!at!16000!g!for!2!minutes!
to!ensure!that!all!ethanol!was!removed!from!the!column.!To!elute!the!bound!DNA,!100!





In!many! instances,! existing!plasmid! constructs! containing!DNA!with! the! sequence!of!
interest!could!be!used!as!a!template!for!the!polymerase!chain!reaction.!However,!if!an!
existing!plasmid!was!not!available,!first!strand!cDNA!was!used!which!was!synthesised!
from! poly(A)+! RNA! using! SuperScript®! III! FirstNStrand! Synthesis! SuperMix.! 1N5! µg!
 38!




ice.!10!µl!2×! firstNstrand! reaction!mix!and!2!µl! SuperScript®! III/RNase!OUT™!enzyme!







The! Polymerase! Chain! Reaction! (PCR)! was! used! to! amplify! exons! and! flanking!
sequences! for! selected! genes! of! interest! from! purified! genomic! DNA! or! fullNlength!
cDNAs! from! firstNstrand! cDNA.! Forward! and! reverse! primers! each! of! 20! N! 30! bp! in!
length!were!designed!to!cover! the!start!and!end!of! the!region(s)! to!be!amplified.!All!
primer! stocks!were! diluted! to! 10! pmol/μl! and! sequences! of! all! primers! used! in! this!
project! can! be! found! in! the! Appendix.! Two! PCR! enzymes!were! used! in! this! project:!
Advantage!2!Polymerase,!a!mixture!of!proofreading!enzyme!and!the!hotNstart!enzyme!











Table! 2.1.!PCR! reagents! and! volumes! used.! Reagent!mix!used! in!PCR!amplifications!
from!genomic!DNA!or!cDNA.!
 39!
5! µl! betaine! solution! was! added! in! addition! to! the! reagents! in! table! 2.1! if! GCNrich!
regions!of!DNA!were!being!amplified.!Once!all!reagents!had!been!added,!the!reaction!
tubes!were!centrifuged!briefly!and!loaded!into!a!Thermo!Hybaid!PCR!Express!thermal!





Stage! Temp.! Time! Description!
Denaturation! 94°C! 1!min! The!dsDNA! is!heated!to!a!high!temperature!at!
which! the! strands! melt! apart! or! denature!
allowing! primers! and! deoxyribonucleotides!
(dNTPs)!to!bind!to!complementary!base!pairs.!
Annealing! 55N65°C! 1!min! The! primers! anneal! specifically! to!
complementary! regions! on! the! ssDNA.! The!
temperature! depends! on! the! TM! of! the!
primers.! Temperature! can!be! raised! to! reduce!
nonNspecific!binding.!
Extension! 68N72°C! 1! min!
per!
0.5kb!










Gel! electrophoresis! is! a! method! used! to! separate! a! mixed! population! of! DNA!






distilled! water.! DNA! fragments! were! visualized! and! separated! using! agarose! gels!
containing!SYBR!Safe™!DNA!gel!stain.!SYBR!Safe™!DNA!gel!stain!provides!sensitive!DNA!
and!RNA!detection!with!substantially!reduced!mutagenicity,!making!it!safer!to!use!than!
ethidium! bromide.! 2%! (w/v)! agarose! gels! were! prepared! by! mixing! 2! g! of! agarose!
powder! into! 100! ml! of! 1×! TAE! buffer! and! microwaving! to! dissolve! the! agar.! After!
cooling! the! solution,! 5! µl! of! SYBR! Safe™! DNA! Gel! Stain! was! added! to! enable!
visualisation! of! DNA! fragments! after! electrophoresis.! The! solution! was! poured! in! a!
casting!tray!containing!a!sample!comb!and!allowed!to!solidify!at!room!temperature!for!
30!min.!The!gel!was!placed! in! the!electrophoresis! chamber!and! immersed! in!1×!TAE!
buffer!and!the!comb!was!removed.!Samples!were!mixed!with!3!µl!of!6×!loading!buffer!
then! loaded! into!the!wells.!1!µg!of!1!kb!DNA! ladder!was!used!as!a!molecular!weight!
marker.!Samples!were!loaded!in!the!wells!and!electrophoresed!at!a!constant!voltage!of!













In! order! to! prepare! PCR! inserts! and! plasmid! vectors! for! ligation,! DNA!was! digested!
using!specific!restriction!endonucleases!(Fig!2.1!stage!1).!For!PCR!products,!15!µl!of!gel!
purified!DNA!was!mixed!with!2!μl!10!×!enzyme!buffer,!1!μl!of!each!restriction!enzyme!
and!2!μl!dH2O! to!a! final!volume!of!20!μl.! For!vector!DNAs,!2!μl!plasmid!DNA! (at!0.5!




for! 1N2! hours! for! most! enzymes! used.! Restrictions! enzymes! for! these! digests! were!




This! procedure! was! carried! out! to! inactivate! and! remove! restriction! enzymes! and!
buffer! components! before! proceeding! to! the! ligation! reaction.! The! volume! of! the!





(v/v)! ethanol,! 10! μl! 3!M! sodium! acetate! (pH! 4.8)! and! 1! μl! of! glycogen! (1! μg).! The!
contents!were!mixed!thoroughly!and!the!tube!was!incubated!on!dry!ice!for!15!min.!The!
DNA!was!recovered!by!centrifugation!at!16,000!g!for!15!min!and!the!supernatant!was!





for! subsequent! ligation,! the! pellet!was! resuspended! in! 50!μl! of! buffer! EB! for! a! final!
















digest! the! cDNA! and! the! plasmid! vector! DNA! at! specific! sites! leaving! 'sticky! ends'!





TOPO! cloning! is! a! fast! and! efficient! cloning!method! that! allows! PCR! products! to! be!
cloned!without! the! need! for! restriction! digestion.! TOPO! cloning! utilises! the! enzyme!
topoisomerase!I!which!functions!both!as!a!restriction!enzyme!and!as!a!ligase.!Vaccinia!
virus!topoisomerase!I!specifically!recognises!the!pentameric!sequence!5'NCCCTTN3'!and!


























Mutations! were! introduced! into! GlyT2! and! GlyR! expression! constructs! using! the!
QuikChange! siteNdirected! mutagenesis! kit.! This! rapid! procedure! uses! a! methylated!
supercoiled!doubleNstranded!DNA!template!and!two!synthetic!oligonucleotide!primers!
harbouring! the!desired!mutation.!The! two!primers,!each!complementary! to!opposite!
strands! of! the! vector,! are! extended! during! temperature! cycling! by! PfuUltra) highN




E.) coli,! which! reNcircularises! the! plasmid! (Fig! 2.2).! Mutations! were! introduced! into!
pRcCMVNhGlyT2,!pRK5NhGlyR!β!or!pCS2NzGlyR!α4!plasmids!using!the!QuikChange!siteN
directed! mutagenesis! kit! and! specific! primer! pairs! for! each! mutation.! For! each!
mutagenesis!reaction,!5!µl!of!10X!reaction!buffer,!50ng!dsDNA!template,!1!µl!dNTP!mix!
and! 125! ng! of! each! primer! were! added! to! a! 0.2! ml! microcentrifuge! tube! and! the!
volume!made! up! to! a! total! of! 50! µl! with! ddH2O.! After!mixing,! the! tube!was! briefly!








Figure! 2.2.! The! stages! of! siteGdirected! mutagenesis.! 1.! Parent! DNA! template! is!
denatured.! ! 2.! Mutagenesis! primers! containing! the! desired! mutation! anneal! to! the!
strands! of! the! parent! DNA! and! the! new! DNA! extends.! 3.! Restriction! enzyme! DpnI!
digests! the! methylated! parent! DNA,! leaving! the! new! DNA! containing! the! mutation!





U/μl)! was! added! to! the! 50! μl! mutagenesis! PCR! product,! mixed! thoroughly! and!
incubated!for!1!hour!at!37°C.!Part!of!the!DpnI!digested!PCR!product!(10!μl)!was!then!
loaded!on!a!1%!(w/v)!agarose!gel!and!subjected!to!electrophoresis!at!90!V!for!30!min.!
Detection! of! a! linear! DNA! fragment! with! a! size! consistent! with! vector! plus! insert!
indicated!the!presence!of!mutated!DNA,!since!all!nonNmutated!DNA!was!removed!by!
digestion!with!DpnI.! Finally,! 10! μl! from! each! reaction!were! transformed! into! E.) coli!
competent! cells! and! miniprep! DNAs! were! made! for! analysis! (see! section! 2.2! for!



































Morpholinos! (MOs)! are! short! (25mer)! nucleaseNresistant! oligonucleotides! that! block!
access! of! other!molecules! to! specific! RNA! sequences,!which! can!either! prevent! cells!
from!making!a!target!protein!(translation!blocking!MOs)!or!modify!the!splicing!of!preN
mRNAs! (splice! MOs).! Microinjection! of! MOs! into! zebrafish! embryos! (Nasevicius! &!
Ekker! 2000;! Bill! et) al! 2009)! is! now! an! established! tool! for! studying! gene! function.!
However,! key! controls! are! required,! since! common! nonNspecific! effects! of! MOs! at!
higher! amounts! (>4N10! ng! per! injection)! include! a! general! delay! in! development! or!
widespread! cell! death! (Bill!et)al! 2009).!We! therefore!designed!and! synthesized!both!
translationNblocking!and!spliceNblocking!MOs!specific! for!GlyR!α4a!by!aligning!exon!7!
sequences! for! zebrafish!GlyR!genes! (Fig.!2.3).!The!morpholino!sequences!used!were:!
Glra4aSMO1! 5'NacctagaagagcacaaagagtttcaN3',! Glra4aSMO2! 5'N
acaggaactcattttatgttaccttN3',! Glra4aTBMO! 5'NaaatccttatgacctgagggagcatN3'.! We! also!
determined! the! optimal!MO! amount! required! for! induction! of! a! specific! phenotype!
postNinjection,!without!inducing!toxicity.!RTNPCR!was!also!used!to!assess!the!efficacy!of!








glra1       aaatcacatactctctgtgtttcagGGAAGTTCAC...TCTTCCCAAGgtcagtagtcttcagcacattcatc 
glra2       tttttttttttttattgtcatgcagGGAAGTTCAC...ACTGCCAAAGgtcagaggtcaaccattacaaacaa 
glra3       aactcttttccactttactttttagGCAAGTTCAC...CTTACCTAAGgtcagacaacaaaaagtattcaggc 
glra4a      tatgaaactctttgtgctcttctagGTAAATTCAC...GCTACCCAAGgtaacataaaatgagttcctgtggg 
glra4b      gatggcgctgtgtgcatgtgtacagGTGTCCTATG...CAACAGAGCTgtgagtggcacatataaacacttcc  
glra4a MOs 3'-actttgagaaacacgagaagatcca-5'            3'-ttccattgtattttactcaaggaca-5'  
                      glra4aSBMO1                              glra4aSBMO2 
 























mM#NaOH,# 1%# (w/v)# SDS),# buffer#N3# (neutralisation#buffer# <# 3#M#potassium#acetate#












LightScanner®#Master#Mix# (cat# #:# HRLS<ASY):# BioFire# Diagnostics# Inc# (Salt# Lake# City,#
USA)#














Solutions# required:# 80# mM# CaCl2/50# mM#MgCl2,# 0.1# mM# CaCl2,# 50%# (v/v)# glycerol.#
Competent#E.#coli#cells#were#prepared#using#a#modified#CaCl2#protocol#as#described#by#
Cohen#et#al#(1972).#TOP10#E.#coli#cells#were#used#to#produce#competent#cells.#Aseptic#
technique# was# used# to# streak# TOP10# cells# onto# LB# agar# plates# without# antibiotics,#
which# were# then# incubated# at# 37°C# overnight.# Single# colonies# were# picked# and#
inoculated# into# 3# ml# LB# broth# then# incubated# in# a# shaking# incubator# at# 37°C# with#
shaking#overnight.#The#cultures#were#transferred#into#500#ml#conical#flasks#containing#
200#ml#of#pre<warmed#LB#broth#and#then#incubated#in#a#shaking#incubator#at#37°C.#The#
optical# density# (OD)# of# the# cultures# at# 600# nm# were# measured# using# a# Eppendorf#
Biophotometer#after#2#hours#and#then#regular#intervals#following#this#until#the#OD600#of#





MgCl2#solution,#and#pooled# into#a#single#falcon#tube.#The#cells#were# incubated#on# ice#
for# 10#min# before# centrifuging# again# at# 1,500# g# at# 4°C# for# 3# min.# This# process# was#
repeated#twice,#in#order#to#wash#the#cells#in#the#80#mM#CaCl2/50#mM#MgCl2#solution#a#
total# of# three# times.# The# cells#were# then# resuspended# in# 5.5#ml# of# ice<cold# 0.1#mM#
CaCl2#solution#and#an#equal#volume#of#ice<cold#50%#(v/v)#glycerol#was#added.#The#cells#
were# then# dispensed# into# 550# μl# aliquots# in# pre<chilled# microcentrifuge# tubes# and#










of# room# temperature# LB# broth#was# then# added# and# the# bacteria#were# incubated# at#
37°C#for#1#hr#in#a#shaking#incubator.#During#this#step,#the#cells#were#able#to#express#the#
antibiotic#resistance#gene#encoded#by#the#plasmid.#Finally,#bacteria#were#then#spread#




DNA#minipreps#were#made#using# the#Qiagen# Spin#Miniprep# kit.# This# is# based#on# the#
alkaline# lysis# of# bacteria# followed#by# the# absorption#of#DNA#onto# a# silica#membrane#
and# elution# of# DNA.# Briefly,# single# colonies# from# the# transformed# agar# plates# were#
picked#using#a#pipette#tip#and#used#to#inoculate#2#ml#of#LB#medium#supplemented#with#




250#μl# pre<chilled# buffer# P1# containing# lysozyme# and#RNase.# 250ul# of# Buffer# P2#was#
then#added#and#mixed#by#inversion.#350ul#of#neutralization#buffer#N3#was#finally#added#
and#mixed#by# inversion.#The#microcentrifuge#tubes#were#then#centrifuged#at#16000#g#
for# 10# minutes.# The# supernatant# was# then# transferred# to# a# mini# spin# column# and#
centrifuged#at#16000#g# for#1#minute# in#order# to#bind#the#DNA.#The#column#was#then#
washed#with#750ul#of#wash#buffer#PE# in#order#to#remove#any#cellular#debris#and#two#
centrifugation#steps#were#performed#at#16000g#for#1#minute#each#to#remove#all#wash#
buffer# and# ensure# that# the# column# was# dry.# The# column# was# placed# in# a# fresh#




were#determined# to# contain# correctly# sized#DNA# inserts#by#digestion#with# restriction#
endonucleases,# such# as# EcoRI.# 5# µl# of# purified# plasmid# DNA# was# mixed# with# 0.5# µl#
EcoRI,# 1# µl# 10×# EcoRI# buffer# and# 3.5# µl# water# and# incubated# at# 37°C# for# 1# hour.#




Maxipreps# of# plasmid# DNA# were# carried# out# according# to# the# HiSpeed# Plasmid#
Purification#procedure,#which#is#based#on#a#modified#alkaline#lysis#method#followed#by#
the#binding#of#plasmid#DNA#to#a#resin#in#low#salt#and#pH#conditions.#A#single#bacterial#
colony# was# picked# from# the# agar# plate# and# resuspended# in# 2# ml# of# LB# medium#
supplemented#with# the# appropriate# antibiotic# in# a# 15#ml# falcon# tube.# The# tube#was#
incubated#for#approximately#8#h#at#37°C#in#a#shaking#incubator.#A#200#μl#volume#of#the#
bacteria# culture#was# transferred# into# a# sterile# flask# containing#200#ml#of# LB#medium#
and# the# appropriate# antibiotic.# The# culture#was# grown# for# 12<16# hours# at# 37°C# in# a#
shaking# incubator.# Bacterial# cells#were#harvested#by# centrifugation# at# 4,000# g# for# 15#
min#at#4°C.#After#removing#the#supernatant,#the#pellet#was#resuspended#in#10#ml#pre<
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chilled# buffer# P1.# Then# 10#ml# of# lysis# buffer# P2#was# added# and# the# suspension#was#
mixed#by#inverting#six#times#and#incubated#at#room#temperature#for#5#min.#Finally,#10#
ml#of#pre<chilled#buffer#P3#was#added# to# the# lysate,# the#suspension#was#poured# into#
the#barrel# of# the#Qiafilter# Cartridge# and# incubated#at# room# temperature# for# 10#min.#





collected# in# a# clean# 50# ml# falcon# tube.# DNA# was# precipitated# by# adding# 10.5# ml#
isopropanol#to#the#eluate#and#the#mix#was#incubated#at#room#temperature#for#5#min.#
During#this#incubation,#a#Qiaprecipitator#Maxi#Module#was#attached#to#a#30#ml#syringe.#











For# RFLP# detection,# standard# PCRs# were# performed# using# 50# ng# genomic# DNA,# Pfx#
supermix# and# the# primers# bGlyT2Ex4F1# (5'<ttgggcctctctgagctctc<3')# and# bGlyT2Ex5R1#
(5'<ccccagcatctagtatagagcc<3')#with#35#cycles#of#94°C#for#1#min,#60°C#for#1#min,#68°C#for#
2# min.# PCR# products# were# gel# purified# using# a# QiaQuick# gel# extraction# kit# before#
restriction# digestion# with# FauI# or# HpyCH4V# or# Sanger# DNA# sequencing#
(http://www.dnaseq.co.uk/).#For#standard#HRM#analysis,#PCR#was#performed#using#25#
ng# genomic# DNA,# LightScanner# Master# Mix# and# primers# bGlyT2Ex4F2# (5'<
 52#
gctctcacctcctactctctctttccaa<3')# and# bGlyT2Ex4R1# (5'<gcagggaagggctgaggc<3')# with# 45#
cycles# of# 94°C# for# 30# sec# and# 70°C# for# 30# sec.# For# LunaProbe# analysis,# PCR# was#
performed# using# HotShot#master#mix# in# the# presence# of# LCGreen# Plus# Dye# and# the#
primers# bGlyT2Ex4F1## (5'<ttgggcctctctgagctctc<3')# and# bGlyT2Ex4R2# (5'<
gaacagggtgatgccagagatg<3')# and# unlabelled# 3'# blocked# probe# CMD2P# (5'<
actcaccttgcagggctgggat<3')#with#55#cycles#of#95°C#for#30#sec,#64°C#for#30#sec#and#72°C#







Sequencing# of# DNA# samples# was# carried# out# by# Sequencing# Services,# School# of# Life#
Science,#University#of#Dundee,#Scotland#(http://www.dnaseq.co.uk/).#DNA#sequencing#
was#performed#using#Applied#Biosystems#Big<Dye#Version#3.1#chemistry#on#an#Applied#





5.0# by# alignment# with# reference# sequences# downloaded# from# NCBI#
(http://www.ncbi.nlm.nih.gov/)# or# UCSC# databases# (http://genome.ucsc.edu/).# For#
mutation#identification,#single#nucleotide#variants#(SNVs)#were#noted#and#the#effect#of#
these# changes# on# the# encoded# protein# were# examined# using# bioinformatics#














Penicillin<streptomycin# solution# (cat# #:# P4333):# Sigma<Aldrich# Company# Ltd# (Dorset,#
UK)#









in# MEM#medium# supplemented# with# penicillin<streptomycin# solution# and# plated# on#
poly<L<lysine# coated# 24<well# plates.# When# 40%# confluent,# HEK293# cells# were#
transfected#with# the#pRcCMV<GlyT2#plasmids# at# 1#μg/μl# per#well#with# Lipofectamine#
LTX# reagent# and# incubated# at# 37°C.# 24# hours# after# transfection,# cells# were# washed#
twice#with#1#ml/well#warm#Krebs#buffer#pre<equilibrated#with#5%#CO2<95%#air.#After#2#
min,# cells#were# incubated#with# 1#ml/well# [3H]glycine# at# a# final# concentration# of# 300#
μmol# (0.1# μCi/ml)# for# 5#min.# Cells#were# rinsed# twice#with# ice<cold# Krebs# buffer# pre<
equilibrated#with# 5%# CO2<95%# air,# then# they# were# digested#with# 1#ml/well# of# 0.1M#
NaOH# for# 2# hours.# 750# μl# of# each# sample# was# pipetted# into# tubes# and# 3.5# ml#
scintillation# fluid# was# added# to# each# tube.# The# radioactivity# incorporated# was#
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measured#by#scintillation#counting.#50#μl#of#each#sample#was#used#for#determining#the#
protein# concentration# using# the# Bradford# reagent# (BioRad).# # [3H]glycine# uptake# was#
calculated# as# nmol/min/mg# protein# and# expressed# as# percentage# of# that# in# control#





Homologues# to# the#protein# to#be#modelled#with#known#structures#were# found#using#
HHSearch# and# GenTHREADER.# HHSearch# is# part# of# the# HHPred# online# web# server#






from# the# HHPred# online# server# were# returned# listing# the# top# 10# closest# related#
structures.# Each# structure# was# examined# for# percentage# sequence# identity# and#
biological#function#and#the#best#structure#or#structures#were#selected#as#templates.#
#
Additional# template# detection# was# performed# with# GenTHREADER#
(http://bioinf.cs.ucl.ac.uk/psipred/).# This# server#makes# use# of# a# different#method# for#
predicting#protein#structure,#namely#protein#threading#(Jones#1999;#Lobley#et#al#2009).#
Threading# is#generally#used# for#proteins# for#which#a#structural#homologue#that#could#
be# used# as# a# template# structure# cannot# be# easily# detected# by# sequence# alignment#
methods#(Jones#&#Thornton#1994).#Since#the#number#of#different#known#native#folds#is#
quite# small# (around# 1300# according# to# the# CATH# Protein# Structure# Classification#
database#(http://www.cathdb.info)#(Orengo#et#al#1997),#and#very#few#are#added#each#
year),#there#is#a#high#possibility#that#any#given#protein#with#an#unsolved#structure#can#




template# structure,# while# evaluating# the# fit# using# a# complex# scoring# function# (Jones#
1999,#McGuffin#&#Jones#2003).#The#resulting#sequence#alignment#could#then#be#used#










that#of# the# target#sequence#and#the#template#sequence.#The#50#most#closely# related#
sequences# were# selected# and# the# sequences# downloaded.# Multiple# sequence#
alignments#were#calculated#for#both#the#target#sequence#and#the#template#sequence#
(each# with# the# 50# most# homologous# protein# sequences)# using# the# MUSCLE#





that# of# the# template# more# accurately# and# considering# areas# of# conservation# or#










(actual# structure)# and# of# the# target# structure# (predicted# secondary# structure).#
Secondary# structure# of# the# target# sequence# was# predicted# using# the# TMHMM# web#
server,# a# server# designed# to# predict# transmembrane# helices# in# proteins# using# HMM#
(http://www.cbs.dtu.dk/services/TMHMM/)#(Krogh#et#al#2001).#Residues#that#were#not#
optimally# aligned# based# on# the# actual# and# predicted# secondary# structures# were#
manually# realigned.#Alignment# files#were#edited# in#order# to#allow#the#model<building#
program#to#read#them#correctly.#The#total#number#of#aligned#residues#and#gaps#were#
checked# to# be# the# same# for# each# sequence# and# the# file# was# saved# with# a# '.pir'#
extension# allowing# the#modelling# program# to# read# it.# The# 'pir'# (or# 'ali')# format#must#





Figure# 2.4.# MODELLER# PIR# file# format.# An# example# alignment# in# the# 'pir'# format#
required#for#utilisation#by#MODELLER.#The#first#line#describes#the#sequence#type,#P1#in#
this#case#which#is#the#annotation#for#protein.#This#is#followed#by#a#semicolon#and#the#
sequence# identity.# The# second# line# contains# information# about# sequence# numbering#
and# chain# codes# with# each# element# of# information# separated# by# a# colon.# First,#
'structureX'#for#the#template#or#'sequence'#for#the#target.#'X'#in#'structureX'#is#arbitrary,#
















2.4.5.$ Preparation$ of$ a$ Python$ script$ for$ the$ alignment$ to$ be$ read$ into$ the$model>
building$program$MODELLER$
MODELLER#(Sali#&#Blundell#1993)#is#a#popular#computer#program#designed#for#building#
homology#models.# This# software# builds# homology#models# using# an# alignment# of# the#
target# sequence# to# the# template# structure,# the# atomic# coordinates# of# the# template#
structure#and#a#simple#script#to#instruct#the#program#(Sali#&#Blundell#1993;#Eswar#et#al#
2006).# The# program# executes# the# model# building# by# the# satisfaction# of# spatial#
restraints,# whereby# a# set# of# geometrical# criteria# help# create# a# probability# density#
function#for#each#atom#in#the#structure.#MODELLER#uses#Python#as#a#control#language;#
therefore# all# input# scripts# must# be# Python# scripts.# A# Python# script# was# written# to#
instruct#MODELLER#to#create#a#specified#number#of#models#based#on#the#alignment#of#




Figure# 2.5.#An# example# python# script# used# to# instruct#MODELLER# to# build# models#
based#on#an#alignment.#The#script# instructs#MODELLER#to#build#50#models# for#GlyT2#
based# on# the# alignment# of# the# sequence# with# LeuTAa# (PDB# I.D.:# 2A65).# The# script#
describes# the# location#of# the# input# files# (A),# heteroatom# inclusion# is# 'true'# to# include#
Na+#ions#(B),#the#alignment#file#name#('glyt2_2a65.ali')#and#the#names#of#the#template#
structure# ('2A65')#and# target# sequence# ('GlyT2')#as# specified# in# the#alignment# file# (C),#










In# brief,# this# script# describes# the# location# of# the# input# files# (Fig.# 2.5a),# whether#
heteroatoms# should# be# included# or# not# (Fig.# 2.5b),# the# alignment# file# name# and# the#
names#of#the#template#structure#and#target#sequence#(Fig#2.5d),#the#number#of#models#
that# it# should# calculate# (Fig.# 2.5e),# and# finally# to# calculate# the# discrete# optimised#
potential# energy# (DOPE)# score# for# each#model# (Fig# 2.5f# and# section# 2.4.6).# The# raw#
DOPE# score# is# an# atomic# distance<dependant# statistical# potential# derived# from# a#





(Fig.# 2.5f).# All# the# files# that# MODELLER# required# to# run# the# script,# including# the#
alignment# file# and# the# PDB# atomic# co<ordinate# file# for# the# template# structure,#were#
placed# in# the# same# directory# with# the# script.# MODELLER# was# instructed# to# run# the#





an# atomic# distance<dependent# statistical# potential# that# is# derived# from# a# sample# of#
native#structures#in#the#protein#data#bank#(PDB;#www.pdb.org;#Berman#et#al#2000).#It#is#




for# both# the# new# model# and# the# template# structure# were# plotted# against# residue#
number#using# the#graphical#program#Gnuplot# (http://www.gnuplot.info/).# Plots#were#
then#assessed#to#determine#areas#of#the#model#that#could#be#improved.#Tall#peaks#or#
positive#values#representing#high#energy,# in#general,#correspond#to#problematic#parts#
of# a# model# (Wiederstein# &# Sippl# 2007).# Overlapping# peaks# and# troughs# of# a# model#
 59#
profile#with#the#template#profile#corresponds#to#well#aligned#areas#of#the#sequence.#An#





Figure# 2.6.# Energy# profile# for# the# XIray# crystal# structure# of# the# E.$ coli$
arginine:agmatine#antiporter#(PDB#I.D.#3LRB).#The#DOPE#energy#for#each#atom#in#the#





Computationally# derived# homology# models# typically# contain# significant# errors#
particularly#when# there# is# a# low# sequence# identity#with# the# template# (Eramian#et# al#
2008).# The# overall# accuracy# of# a#model# is# important# to# realise# if# it# is# to# be# used# to#
provide# any# biological# insight.# Methods# by# which# the# accuracy# of# a# model# can# be#
assessed#are#still#somewhat#limited#but#there#are#ways#that#a#model#can#be#scored#and#
assessed#to#determine#its#goodness.#A#normalized#DOPE#Z<score#was#calculated#for#the#
best#model#within#MODELLER# using# a# simple# script.# This# score# is# appropriate# for# an#






















































The# .pdb# file# containing# atomic# coordinates# for# the#model# was# uploaded# on# to# the#
server# and# the# 'QMEAN'# scoring# function# option# was# selected.# A# QMEAN# score#





structures# solved# by# X<ray# crystallography# (Benkert# et# al# 2009,# 2011).# The# sample#
protein# Z<scores# are# plotted# against# protein# size# and# the# Z<score# for# the# model# is#
plotted#on#the#same#graph#(Fig#2.7a).#Other#helpful# results#are#also#reported#such#as#
the# QMEAN# scores# for# specific# terms# that# make# up# the# overall# score# such# as# Cβ#
interaction,# all# atom# interaction# and# torsion# angles.# A# residue# error# plot# is# also#
generated,#similar#to#the#plot#generated#for#the#individual#residue#DOPE#scores,#which#








experimentally# solved#protein#structure#of# the#Dengue#NS3#serine#protease# (PDB# I.D.#
1BEF)#A:# Plot# of# QMEAN# Z<scores# of# native# proteins#with# structures# solved# by# X<ray#






Energy# minimization# was# carried# out# on# the# model# with# the# minimize# structure#
command#in#Chimera,#using#the#Molecular#modelling#toolkit#(MMTK)#method#(Hinsen#
2000)#and#the#AMBER94#force#field#(Cornell#et#al#1995).#Hydrogens#were#added#to#the#
model# before# minimisation# could# be# performed.# Structure# minimization# was#
performed#in#vacuum#with#all#options#set#at#the#default#value#(steepest#descent#steps:#
100,# Steepest# descent# step# size:# 0.02,# conjugate# gradient# steps:# 100,# conjugate#
gradient# step# size:# 0.02,# update# interval:# 10).# Particular# atoms# could# be# fixed# if#
required#so#that#they#would#not#be#adjusted# in#the#minimisation,# for#example# if#only#
atoms#in#a#particular#region#were#intended#to#be#minimised,#the#rest#of#the#atoms#in#













Amino# acids# were# substituted# using# the# 'swapaa'# command# in# Chimera,# then# the#
residue# and# the# surrounding# area# within# the# model# were# thoroughly# explored# by#
examining#all#of#the#possible#rotamers#of#the#residue#in#the#Dunbrack#rotamer#library#
(Dunbrack# 2002),# particularly# focussing# on# clashes# and# hydrogen# bonds# with# other#
surrounding# residues#and# side<chains.#Residues# substituted#as# a# result# of# a#mutation#
can# have# various# structural# or# functional# effects# within# a# protein# that# lead# to# a#
deleterious#phenotype.#The#following#list#of#structural#analyses#was#compiled#based#on#
previous# work# (Martin# et# al# 2002;# Hurst# et# al# 2009)# and# considered# for# each#
substitution.#
− Mutations# affecting# hydrogen# bonding:# Hydrogen# bonds# are# important# for#
stabilizing# the# structure# of# a# protein.# If# a# residue# involved# in# a# hydrogen# bond# is#








acids.# Distortion# will# occur# if# a# glycine# in# such# a# conformation# is# replaced# with#
another#amino#acid.#
− Steric#clashes:#Clashes#of#a#substituted#residue#with#surrounding#residues#will#occur#
















− Disruption# of# buried# charge:# Electrostatic# interactions# are# very# important# in#




− Cation+π# interactions:# A# cation<π# interaction# occurs# between# the# face# of# an#
electron<rich# aromatic# side# chain# (phenylalanine,# tyrosine# or# tryptophan)# and# a#
cationic#side#chain#(lysine#or#arginine)#(Gallivan#et#al#1999).#They#are#comparable#in#
strength# to# a# hydrogen# bond# or# salt# bridge# and# can# play# an# important# role# in#
stabilising#the#3<dimensional#structure.#
− π+π# interactions:# π<π# interactions# (or# π<stacking),# occur# between# the# faces# of# two#
electron<rich#aromatic# side# chains# leading# to#attractive,#non<covalent# interactions.#
Aromatic<aromatic# interactions# are# described# in# the# stacking# of# nucleotides# in# a#
strand# of# DNA# (Hunter# 1993).# They# are# also# important# for# the# self<assembly# of#
proteins#and#are#prevalent#in#protein#crystal#structures#(McGaughey#et#al#1998).#
− Disulphide#bonds:#Disulphide#bonds#are#also#known#as#disulphide#bridges,#ss<bonds#
or# cys<bonds.# They#are# strong# covalent#bonds# that#occur#by#an#oxidation# reaction#
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The# Chimera# option# 'FindHBond'# identifies# possible# hydrogen# bonds# (H<bonds)# using#










π# interactions.# The# web# server# CaPTURE# (http://capture.caltech.edu)# uses# criteria#
described# by# Gallivan# and# Dougherty# in# 1999# to# identify# energetically# significant#
cation<π# interactions# within# protein# structures.# The# criteria,# in# brief,# implement# a#
variant#of#the#OPLS#(optimized#potentials#for#liquid#simulations)#force#field#where#only#
electrostatic# and# van# der#Waals# interactions# are# considered,# and# only# cation<π#with#
binding# energies# above# a# particular# threshold# are# reported# (Gallivan# &# Dougherty#
1999).# If# the#structure#was#available#on#the#PDB,# then#the#PDB# I.D.#was#submitted.# If#
the# structure# was# a# homology# model,# then# the# coordinate# file# in# pdb# format# was#
uploaded.#The#output#was#obtained#within#a#few#seconds#reporting#all#possible#cation<
π#interaction#pairs#and#energetically#significant#pairs.#These#residues#were#checked#to#
determine# whether# they# fell# within# the# region# of# the# substituted# amino# acid# of#









in# the#protein.#Contact# refers# to#all# kinds#of#direct# interactions# that# can#occur:#polar#
and# nonpolar,# favourable# and# unfavourable# (including# clashes),# salt<bridges,# vdW#
forces#(H<bonds#are#not#included).#
#
The# Clash/Contact# parameters# dictate# what# is# considered# a# clash# or# contact.# The#
overlap# between# two# atoms# is# defined# as# the# sum# of# their# vdW# radii# minus# the#























Startle# disease,# also# known# as# hyperekplexia,# is# a# rare# disorder# characterized# by#
evoked# episodes# of# hypertonia.# This# neurological# disorder# can# have# serious#
consequences,# including# sudden# infant# death# from# apnoea# episodes# or# aspiration#
pneumonia# (Nigro# &# Lim# 1992;# Vigevano# et# al# 1989).# Although# symptoms# often#
diminish#during#the#first#year#of#life,#the#exaggerated#startle#response#can#persist#into#
adulthood,# leading# to# unprotected# falls# (Bakker# et# al# 2006;# Thomas# et# al# 2010).#
Fortunately,# hyperekplexia# can# be# treated# using# the# benzodiazepine# clonazepam#
(Harvey#et#al#2008),#which#potentiates# inhibitory#GABAA#receptor#function.#A#physical#
intervention#called# the#Vigevano#manoeuvre,# involving# flexion#of# the#head#and# limbs#
towards#the#trunk,#also#dissipates#and#counteracts#the#effects#of#acute#hypertonia#and#
apnoea# episodes# in# newborns# (Vigevano# et# al# 1989).# Hyperekplexia# is# now# well#
recognized# and# often# detected# within# specialist# neurology# and# paediatric# centres#
worldwide# (Harvey# et# al# 2008;# Davies# et# al# 2010).# Collaborations# between# clinicians#
and# research# scientists# have# revealed# that# the# primary# cause# of# startle# disease# is#
defective# inhibitory# glycinergic# transmission.# Currently,# the# major# genetic# cause# of#
hyperekplexia# is# missense,# nonsense,# frameshift# or# splice<site# mutations# in# the#
postsynaptic#glycine#receptor#(GlyR)#α1#gene#(GLRA1)#(Shiang#et#al#1993,#1995;#Chung#





However,# mutations# in# the# latter# two# genes# are# more# commonly# associated# with#
MOCO# deficiency# (Reiss# &# Hahnewald# 2011)# and# X<linked# intellectual# disability#
(Kalscheuer#et#al#2010;#Holman#et#al#2012).#
Since#many# remaining# cases#do#not#harbour#defects# in# these# genes,# some#years# ago#
researchers# began# to# explore# presynaptic# causes# of# startle# disease.# This# led# to# the#
 67#




transporter# membrane# trafficking,# Na+# or# glycine# binding# sites# (Rees# et# al# 2006).#




I# participated# in# an# international# screening# program# for# GlyT2# mutations# in# startle#
disease,# in# collaboration# with# Prof.# Mark# Rees# at# the# Institute# of# Life# Science,#
University# of# Swansea.# Resequencing# of# SLC6A5# in# 93# unrelated# hyperekplexia#
probands#identified#20#new#recessive#mutations#within#17#index#cases,#of#which#19#are#
novel# variants,# and# nine# were#missense#mutations# (Carta# et# al# 2012).# An# additional#
collaborative#study#was#carried#out#with#Beatriz#López<Corcuera#at#the#Departamento#
de# Biología# Molecular# Centro# de# Biología# Molecular# 'Severo# Ochoa',# Madrid,# Spain.#
Here,#a#novel#dominant#missense#mutation#(Y705C)#was#identified#in#eight#individuals#
from# Spain# and# the# UK# (Giménez# et# al#2012).#My# specific# aims#within# these# studies#
were:#
• To# use# site<directed#mutagenesis# to# introduce#missense#mutations# into# a# human#
GlyT2# expression# construct# in# the# vector# pRcCMV# for# use# in# [3H]glycine# uptake#
assays.#
• To#build#a#homology#model#of#human#GlyT2#based#on# the#crystal# structure#of# the#
Aquifex#aeolicus#leucine#transporter.#
• To# use# this# homology# model# to# predict# how# GlyT2# mutations# specifically# disrupt#
transporter#structure#and#function.!!








DNA# samples# from# individuals# with# a# clinical# diagnosis# of# startle# disease# were#
ascertained# by# referral# from# neurologists,# paediatricians# or# clinical# geneticists# from#
international# centres.# Informed# consent# and# clinical# data# were# obtained# by# the#
referring# clinician# (Local# Research# Ethics# Committee,# the# South# West# Wales# REC).#
Clinical# criteria# included# a# non<habituating# startle# response# (positive# nose<tap# test),#
history# of# neonatal/infantile# hypertonicity# and# negative# results# in# GLRA1# gene#
screening# by# Sanger# sequencing# and# MLPA# (Multiplex# Ligation<Dependent# Probe#
Amplification).# Exons# and# intron<exon# boundaries# of# SLC6A5# were# amplified# by# PCR#
from# genomic# DNA# isolated# from# peripheral# blood# of# patients# using# established#
primers# sets# (Rees# et# al# 2006).# PCR# products# were# directly# sequenced# following# gel#
electrophoresis#and#purification.##
#
Sequence# variants# were# assigned# as# potentially# disease<causing# mutations# after#
exclusion# from# a# panel# of# 400# human# controls# and# cross<referencing# with# common#
SLC6A5# polymorphisms# (Rees# et# al# 2006)# and# those# found# in# dbSNP#
(http://www.ncbi.nlm.nih.gov/projects/SNP/).#This#revealed#20#sequence#variants#that#
were# found# exclusively# in# 17# index# cases,# 14# of# which# showed# homozygous# or#
compound#heterozygous# recessive# inheritance# (Fig.# 3.1;# Table# 3.1;# Carta#et# al# 2012).#
These# included# four# nonsense# mutations# (W151X,# R191X,# Y297X,# R439X),# four#
frameshift# mutations# (P108L+fs25X,# L198R+fs123X,# S489F+fs39X,# I665K+fs1X)# and#
three# splice# site# mutations# (IVS14+1∆G,# IVS13+1# G>T,# IVS8+1# G>A).# Nine# novel#
missense#mutations#affected#residues#in#TM2#(L237P,#P243T#and#E248K),#TM3#(A275T),#
TM7#(S513I),#the#extracellular#TM7<TM8#loop#(F547S)#and#the#intracellular#TM10<TM11#
loop# (Y656H,# G657A).# These# missense# mutations# were# assessed# using# the#
bioinformatics# programmes# SIFT# (http://sift.jcvi.org/),# which# uses# sequence#
conservation# (Ng# 2003),# and# Polyphen<2# (http://genetics.bwh.harvard.edu/pph2),#





Case# Inheritance# Exon# Genotype## Consequences# Class#
1# AR# 14# IVS14+1∆G#(H)# Impact#on#splicing# Splice#site#
2*# AR# 4# C727A#(H)# P243T# Missense#
3*# AR# 5# C891A#(H)# Y297X# Nonsense#
4# AR# 8# C1315T#(H)# R439X# Nonsense#
5# AR# 8# C1315T#(H)# R439X# Nonsense#











































#12# NC# 2# G452A#(P)# W151X# Nonsense#
13# NC# 8# C1315T#(P)# R439X# Nonsense#

















17# AR# 10## G1538T#(H)# S513I# Missense#
#
Table#3.1.#Details#of#SLC6A5$hyperekplexia#mutations.#
Key:#*Indicates#an#affected# sibling#with# the# same#mutation(s),# †indicates#where#only#
one#parent#was#available#to#assess#compound#heterozygote#status#since#the#maternal#
allele# did# not# carry# the# Y656H# mutation.# ‡Indicates# parental# samples# were# lost# to#
contact# and# long<range# PCR# attempts# were# unsuccessful# (22# kb# target).# Mode# of#
Inheritance:# NC# <# not# confirmed;# CH# <# compound# heterozygosity;# AR# <# autosomal#






of# putative# transmembrane# (TM)#domains# (coloured#boxes)# and#amino#acid# residues#
affected#by#hyperekplexia#mutations#(Eulenburg#et#al#2006;#Rees#et#al#2006;#Carta#et#al#
2012).#Blue#and#red#triangles# indicate#residues# in#GlyT2#that#are# likely# to#co<ordinate#
Na+# and# Cl<# ions,# respectively,# based# on# structure/function# studies# of# the# bacterial#
leucine#transporter#LeuT#and#other#mammalian#neurotransmitter#transporters#such#as#
GAT<1#and#SERT.#However,#GlyT2#binds#three#Na+#ions#(Supplisson#&#Roux#2002),#while#









































L198R+fs123 R191X W151X 
Y705C 
exon 1 | exon 2 
exon 2 | exon 3 
exon 3 | exon 4 
exon 4 | exon 5 
exon 5 | exon 6 
exon 6 | exon 7 
exon 7 | exon 8 exon 8 | exon 9 
exon 9 | exon 10 
exon 10 | exon 11 
exon 11 | exon 12 
exon 12 | exon 13 exon 13 | exon 14 




























   




Position' Exon' Protein' Type' SIFT'' PolyPhen42' Overall'Prediction'
c.T710C# 4# L237P# Missense## Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.C727A# 4# #P243T# #Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.G742A# 4# E248K# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.G823A# 5# A275T# Missense# Tolerated#(0.3)# Possibly#damaging#(0.774)# Pathogenic#(Carta!et!al#2012)#
c.C916G# 5# L306V# Missense# Damaging#(0.02)# Probably#damaging#(1.0)# Pathogenic#(Rees#et!al!2006)#
c.C1274T# 8# T425M# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Rees#et!al!2006)#
c.T1444C# 9# W482R# Missense## Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Rees#et!al!2006)#
c.A1526G# 10# N509S# Missense# Damaging#(0)# Possibly#damaging#(0.998)# Pathogenic#(Rees#et!al!2006)#
c.T1530G# 10# S510R# Missense# Damaging#(0.01)# Possibly#damaging#(0.935)# Pathogenic#(Rees#et!al!2006)#
c.G1538T# 10# S513I# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.T1640C# 11# F547S# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.T1966C# 13# Y656H# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Carta!et!al#2012)#
c.G1970C# 14# G657A# Missense# Damaging#(0)# Possibly#damaging#(0.931)# Pathogenic#(Carta!et!al#2012)#
c.A2114G# 15# Y705C# Missense# Damaging#(0)# Probably#damaging#(1.0)# Pathogenic#(Giménez#et!al#2012)#
#
Table' 3.2.' Single' nucleotide' variants' in' SLC6A5' causing' hyperekplexia.' Prediction# of# pathogenicity# of# the# likelihood# of# missense#
mutations# leading# to# amino# acid# substitutions# found# in# individuals# with# hyperekplexia# using# the# SIFT#








Type! SIFT! PolyPhen92! Overall!Prediction!














InsGA# 9# p.L307R#/#p.L285R# Missense# Damaging#(0)# Probably#damaging#(0.997)# Pathogenic#(James#et#al#2012)#
c.G996T# 9# p.W332C#/#p.W310C# Missense# Damaging#(0)# Probably#damaging#(0.999)# Pathogenic#(James#et#al#2012)#






3.4.$ [3H]glycine$ uptake$ assays$ demonstrate$ that$ the$ majority$ of$ GlyT2$ mutations$
impair$glycine$uptake$
Mutations# were# introduced# into# an# expression# construct# encoding# human# GlyT2#
(pRcCMV>hGlyT2;#Rees#et#al#2006)#using#the#QuikChange#site>directed#mutagenesis#kit#
(Stratagene)# and# the# complete# coding# region#was# sequenced# to# verify# that# only# the#
desired#mutation#had#been#introduced.#To#examine#the#effects#of#GlyT2#mutations#on#
glycine# uptake,# HEK293# cells# were# transfected# with# wild>type# and# mutant# GlyT2#
constructs#and#used#for#[3H]glycine#uptake#assays#(Rees#et#al#2006;#Carta#et#al#2012).#




of# [3H]glycine# uptake,# although# at# a# lower# level# than# wild>type# GlyT2.# Further#
characterization# of# the# A275T# mutation# in# Xenopus# laevis# oocytes# by# Stéphane#
Supplisson#(Ecole#Normale#Supérieure,#Paris,#France)#demonstrated#that#this#mutation#




[3H]glycine#uptake# assays# for# the#dominant# Y705C#mutation#were# carried#out#by# the#
López>Corcuera# group# using# COS7# cells.# The# Vmax# of# glycine# transport# by# the# Y705C#
mutant#was#around#60%#of#the#wild>type#GlyT2#Vmax#(23#±#2.5#for#GlyT2Y705C#versus#38#±#
3.2# nmol# gly/mg# protein/5# min# for# wild>type).# The# co>expression# of# wild>type# and#












(Rees#et#al#2006),# [3H]glycine#uptake#was# calculated#as#nmoles/min/mg#protein# then#
expressed# as# a# percentage#of# the# empty# expression# vector# transfected# control.#Only#




Fold# recognition# of# human# GlyT2# was# performed# with# GenTHREADER# (Lobley# et# al#
2009)# and# HHPred# (Söding# et# al# 2005).# The# structure# of# the# bacterial# leucine#
transporter# (LeuT;# PDB:# 2A65;# Yamashita# et# al# 2005)# was# identified# as# the# best#
template# using# both# approaches# (GenTHREADER# p>value:# 2e>21;# HHPred# e>value:# 0).#
Profile>profile# alignments# were# generated# between# the# human# GlyT2# sequence# and#
the# LeuT# structure# using# MUSCLE# (http://www.ebi.ac.uk/Tools/muscle/index.html;#
Edgar# 2004)# and# T>coffee# ('Combine'# option)# web# servers#
(http://www.ebi.ac.uk/Tools/t>coffee/)# (Notredame# et# al# 2000).# The# final# alignment#
between# GlyT2# and# LeuT# was# visually# checked# in# the# molecular# graphics# program#
Chimera# (Petterson# et# al# 2004)# comparing# the# actual# secondary# structure# of# the#











































































































structure# for# the# GlyT2# sequence# was# predicted# using# TMHMM# server,# a# server#
designed#to#predict#transmembrane#helices# in#proteins#using#a#hidden#Markov#model#
(http://www.cbs.dtu.dk/services/TMHMM/;# Krogh# et# al# 2001).# The# alignment# was#
visually#assessed#in#Chimera#and#changes#were#made#manually#by#moving#residues#that#
were# not# optimally# aligned#based#on# the# actual# and# predicted# secondary# structures.#
The# final#alignment#was#prepared# in# the# 'pir'# format#so#that#MODELLER#could#read# it#
and#is#shown#in#Fig.#3.3.##
#
A# large#part#of# the#extracellular# loop#between#TM3#and#TM4# (residues#312>354)#was#
removed# since# it# has# little# or# no# sequence# identity# with# the# template# or# any# other#
known# structure# and# therefore# was# not# possible# to# model# this# region# with# any#
accuracy.# Full# stops# indicate# heteroatoms,# which# in# this# case# are# the# two# Na+# ions.#
GlyT2#is#known#to#bind#three#Na+#ions#(Roux#&#Supplisson#2000),#but#the#binding#site#of#
one# of# these# Na+# ions# remains# elusive# since# there# are# currently# no# structural#
homologues#available#that#bind#more#than#two#Na+#ions.#The#'L'#and#the#'G'#at#the#end#

















LeuT REHWATRLGLILAMAGNAVGLGNFLRFPVQAAENGGGAFMIPYIIAFLLVGIPLMWIEWA 64 
GlyT2 RGNWSSKLDFILSMVGYAVGLGNVWRFPYLAFQNGGGAFLIPYLMMLALAGLPIFFLEVS 151 
 * :*:::*.:**:*.* ******. ***  * :******:***:: : *.*:*::::* : 
 
LeuT MGRYGGAQGHGTTPAIFYLLWRNRFAKILGVFGLWIPLVVAIYYVYIESWTLGFAIKFLV 124 
GlyT2 LGQFAS-QGPVSVWKAI------PALQGCGIAMLIISVLIAIYYNVIICYTLFYLFASFV 211 
 :*::.. **  :.   :         :  *:  * *.:::****  * .:** : :  :* 
 
LeuT GLVPEPPP/TDPDSILRPFKEFLYSYIGVP-----KGDEPILKPSLFAYIVFLITMFINV 180 
GlyT2 SVLPWGSC/TMVNFTSQANKTFVSGSEEYFKYFVLKISAGIEYPGE-IRWPLALCLFLAW 271 
 .::*  .  *  :   :. * *: .          * .  *  *.      : : :*: 
 
LeuT SILIRGISKGIERFAKIAMPTLFILAVFLVIRVFLLETPNGTAADGLNFLWTPDFEKLKD 240 
GlyT2 VIVYASLAKGIKTSGKVVYFTATFPYVVLVILLIRGVTLPG-AGAGIWYFITPKWEKLTD 331 
  *:  .::***:  .*:.  *     *.*** ::   *  * *. *: :: **.:***.* 
 
LeuT PGVWIAAVGQIFFTLSLGFGAIITYASYVRKDQDIVLSGLTAATLNEKAEVILGGSISIP 300 
GlyT2 ATVWKDAATQIFFSLSAAWGGLITLSSYNKFHNNCYRDTLIVTCTNSATSIFAGFVIFSV 391 
 . **  *. ****:**  .*.:** :** : .::   . * .:  *. :.:: *  *    
 
LeuT AAVAFFGVANAVAIAKAGAFNLGFITLPAIFSQTAGGTFLGFLWFFLLFFAGLTSSIAIM 360 
GlyT2 IGFMANERKVNIENVADQGPGIAFVVYPEALTRLPLSPFWAIIFFLMLLTLGLDTMFATI 451 
  ..        :  .   . .:.*:. *  ::: . ..* .:::*::*:  ** : :* : 
 
LeuT QPMIAFLEDEL-KL--SRKHAVLWTAAIVFFSAHLVMFLN---KSLDEMDFWAGTIGVVF 414 
GlyT2 ETIVTSISDEFPKYLRTHKPVFTLGCCICFFIMGFPMITQGGIYMFQLVDTYAASYALVI 511 
 :.::: :.**: *   ::* ..   ..* **   : *: :     :: :* :*.: .:*: 
 
LeuT FGLTELIIFFWIFGADKAWEEINRGGIIKVPRIYYYVMRYITPAFLAVLLVVWAREYIPK 474 
GlyT2 IAIFELVGISYVYGLQRFCEDIEMMIGFQPNIFWKVCWAFVTPTILTFILCFSFYQWEPM 571 
 :.: **: : :::* ::  *:*:    ::   ::     ::**::*:.:* .   :: *  
 
LeuT IMEETHWTVWITRFYIIGLFLFLTFLVFLAERRRNHESAGT/L..                515     
GlyT2 TYG-SYRYPNWSMVLGWLMLACSVIWIPIMFVIKMHL----/G..                612 






Pro).#Hydrophilic# and# charged# residues#are# coloured# in#blue# (Asp,#Glu,#Asn,#Gln,#Arg,#
His,# Lys).# Residues# highlighted# in# grey# are# conserved# between# LeuT# and# GlyT2# (also#
denoted#by#a#*)#and#residues#that#are#partially#conserved#(grouped#by#similar#residue#








The# GlyT2# homology#model# was# calculated# to# have# a# normalized# DOPE# Z>score# of# >
 76#




0,# are# considered# unfavourable.# Areas# in# the# plot# where# the# energies# overlap# are#
usually#correlated#with#regions#of#high#conservation#between#target#and#template.#This#
step# was# useful# for# highlighting# specific# regions# of# a# model# with# high# energies# and#
therefore# likely# inaccuracies.# Generally,# regions# of# particularly# high# energies#were# in#



























































on# a# sample# of# proteins# taken# from# PDB,# of# which# most# are# globular# proteins.#
Membrane#proteins#are#significantly#more#difficult#to#crystal#and#therefore#there#are#a#
much#smaller#number#of#membrane#proteins#in#the#PDB#relative#to#soluble#ones.#There#
are# around# 83,000# proteins# in# the# PDB,# of# which# only# around# 600# of# them# are#










the# cluster# but# on# the# border.# This# indicates# that# the# GlyT2# homology#model# has# a#










































































































locally# in# vacuum# on# the# model# with# the#minimize# structure# command# in# Chimera,#
using# the# Molecular# Modelling# ToolKit# (MMTK)# method# (Hinsen# 2000)# and# the#






Alignment# of# the# Aquifex# aeolicus# LeuT# with# GlyT2# allowed# residues# potentially#
involved#in#coordinating#glycine#or#Na+#and#Cl>#binding#to#be#identified.#Substitution#of#
Na+# and# glycine# binding# residues# in# GlyT2# has# previously# been# shown# to# underlie#
pathogenicity# in#startle#disease# (Rees#et#al#2006).#However,#many#of# the#novel#GlyT2#
mutations# discovered# in# this# study# did# not# lead# to# substitutions# of# residues# that#
directly# bind# Na+# or# glycine.# To# gain# further# insight# into# the# precise# molecular#
mechanisms# underlying# these# new# missense# mutations,# I# examined# each# mutation#
individually# in# the# context# of# the# homology# model# of# GlyT2.# Amino# acids# were#
substituted#using#the# 'swapaa'#command# in#Chimera#(Pettersen#et#al#2004),# then#the#
residue# and# the# surrounding# area# within# the# model# was# thoroughly# explored# by#
examining# all# possible# rotamers# of# the# residue# side# chain# in# the# Dunbrack# rotamer#
library#(Dunbrack#2002),#taking#into#account#the#lowest#clash#score,#highest#number#of#
H>bonds# and# highest# rotamer# probability.# A# pragmatic# approach# was# taken# into#




Three# of# the# missense# mutations# result# in# substitution# of# residues# in# TM2# (L237P,#
P243T#and#E248K).# Introduction# (L237P)#or#elimination# (P243T)#of#proline# residues# in#
 79#
transmembrane# helices# is# predicted# to# destabilize# the# native# fold# of# the# helix,# thus#
resulting# in#accelerated#degradation#or#aggregation#of#the#mutant#protein#(Bajaj#et#al#
2007).# By# contrast,# substitution# E248K# in# TM2# results# in# the# replacement# of# a#
negatively#charged#glutamate#residue#for#a#positively#charged#lysine,#with#a#longer#side#
chain#that#introduces#potential#clashes#with#A480#and#A481#in#TM6#(Fig.#3.6b,c).#These#















of# residues# involved# in# Cl># binding# in# GAT>1# and# SERT# suggests# that# residues# Y233#
(TM2),#Q473#and#S477#(TM6)#together#with#N509#and#S513#(TM7)#are#likely#to#perform#
equivalent#roles#in#GlyT2#(Fig.#3.7a)#(Forrest#et#al#2007;#Zomot#et#al#2007;#Ben>Yona#et#










monomer# showing# coloured# transmembrane# helices# as# ribbons.# Glycine# and# two# (of#
three)# Na+# ions# (purple# spheres)# are# depicted.# Note# that# the# TM3>TM4# extracellular#
loop#(EL2;#indicated#on#Fig#3.8a)#was#not#modelled#due#to#an#insertion#of#residues#312>
354#in#GlyT2#relative#to#LeuT.#B#and#C:#Substitution#E248K#in#TM2#replaces#a#negatively>
charged# glutamate# for# a# positively>charged# lysine,# with# a# longer# side# chain# that#



















































































the# orientation# of# the# potential# glycine>binding# residue# Y287# and# destabilize# the#
unwound# region# of# TM1,# which# contains# several# determinants# of# glycine# and# Na+#
binding.# F# and# G:# Substitution# S513I# in# TM7# introduces# a# larger# side# chain# at# this#
position,# resulting# in# predicted# clashes# with# N213# (TM1)# and# N509# (TM7),# both# of#
which#are#involved#in#the#binding#of#Na+.#Note#that#N509#and#S513#are#also#predicted#
to#be#involved#in#coordinating#Cl>#binding#to#GlyT2#(see#figure#3.7).#H$and$I:$Substitution#







coordination# by# Y233# in# TM2,# Q473# and# S477# in# TM6,# N509# and# S513# in# TM7.$ B:#
Substitution# S513I# in# TM7# introduces# a# larger# side# chain,# which# lacks# the# essential#
hydroxyl#necessary#for#the#coordination#of#Cl>#and#may#occlude#the#binding#site.#Since#a#
hydroxyl#at# this#position# is#highly#conserved# in#SLC6# transporters# (Forrest#et#al#2007;#





acute#bend#and#participates# in# conformational#mobility# during# the# transport# cycle# in#
DAT (Norregaard#et#al#1998),#GAT>1#(Zomot#et#al#2003),#GlyT1#(Ju#et#al#2004)#and#SERT#
(Mitchell# et# al# 2004).# Substitution# Y656H# in# the# intracellular# TM10>TM11# loop# is#
predicted# to#abolish#a# cation>π# interaction#between#Y656#and#R660# (Fig.#3.6h,i).# This#
























protein# in# this# unwound# region.# The# substitution#may# also# interfere# with# important#
intracellular# GlyT2# accessory# protein# interactions.# The# neighbouring# residue# was#
substituted# (G657A)# in# another# individual# with# hyperekplexia,# which# is# predicted# to#




side# chain# of# E701# (Fig# 3.9).# Y705# is# a# highly# conserved# residue# between# GlyT2# in#






Figure$ 3.8.$ Phylogenetic$ and$ familial$ alignments$ of$ TM11$ in$ GlyT2.$ Upper# panel:#
Phylogenetic# comparison# of# TM11# of# GlyT2# containing# Y705# (boxed).# Lower# panel:#
Sequence# alignment# of# GlyT2# TM11# with# other# proteins# from# the# human# SLC6#
superfamily.# Sequences# were# obtained# from#NCBI# (www.ncbi.nlm.nih.gov)# and#were#









Gallus$gallus ! ! !VCWAFVTPTILTFILCFSFYQWEPMTYGAYHYPGWS!












hCRTR ' 'SLC6A8! !WCWSFFTPLVCMGIFIFNVVYYEPLVYNNTYVYPWWG!
hNET ' 'SLC6A2! !LCWKFVSPAFLLFVVVVSIINFKPLTYDDYIFPPWAN!
hDAT ' 'SLC6A3$ !LCWKLVSPCFLLFVVVVSIVTFRPPHYGAYIFPDWAN!






Gallus$gallus ! ! !VCWAFVTPTILTFILCFSFYQWEPMTYGAYHYPGWS!









hGAT2' 'SLC6A13 C LFLTPAVCTATFLFSLIKYTPLTYNK YTYPWWG!
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hBGT1' 'SLC6A12 !ISWLFLTPGLCLATFLFSLSKYTPLKYNNVYVYPPWG!
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hNET ' ' 2! LC K VSPAFLLFVVVVSIINFKPLTYDDYIFPPWAN!
hDAT ' ' 3$ L KLVSPCFLLFVVVVSI TFRP HYGAYIFPDWAN!




Figure$3.9.$Molecular$model$of$GlyT2$ showing$ the$ localization$of$Y705$ in$TM11.$A:#
Homology#model#of#the#GlyT2#monomer#showing#the#predicted#position#of#Y705#at#the#
membrane# interface.# B:# Y705# is# predicted# to# interact# with# E701# by# a# H>bond.# C:#
Substitution# Y705C# is# predicted# to# abolish# the# hydrogen# bond,#which#may# lead# to# a#
disruption#of#the#fold#of#the#protein#in#this#region.$
#
Molecular# modelling# of# GlyT2# predicted# that# Y705# was# located# at# the# membrane#
interface# with# the# extracellular# space,# with# the# side# chain# orientated# inside# the#
membrane#towards#E701,#forming#a#hydrogen#bond#(Fig.#3.9).#Substitution#of#the#polar#
residue#tyrosine#with#non>polar#cysteine#is#likely#to#abolish#this#hydrogen#bond,#which#
may# in# turn# disrupt# the# fold# of# the# helix# in# this# area.# Furthermore,# the# Y705C#
substitution#introduces#a#reactive#thiol#group#in#the#place#of#a#hydroxyl>containing#side#
chain.#Cysteines#are#frequently#involved#in#disulphide#bonding#with#other#cysteines#via#



















Figure$ 3.10.$Molecular$model$ of$ GlyT2$ showing$ the$ location$ of$ cysteines.$Cysteine#
residues# of# human# GlyT2# are# coloured# in# red,# and# C705# in# yellow.# C311# and# C320#




plasma# membrane# by# thiol# labelling# with# impermeant# cysteine#
methanethiosulphonate# (MTSEA)# reagents.# They# also# demonstrated# that# membrane#
expression#of#Y705C#was#impaired,#but#could#be#restored#to#wild>type#levels#with#the#
permeable# thiol# reagent#DTT,#suggesting# that#C705# is# involved# in#aberrant#disulphide#
bond#formation#(Giménez#et#al#2012).#In#cell>surface#labelling#experiments,#where#free#
thiols# of# exposed# cysteines# were# labelled# with# MTSEA>biotin,# they# showed# that#
sulfhydryl#(SH)>labelled#GlyT2#Y705#membrane#expression#was#around#2>3#fold#higher#
than# that# of#wild>type#GlyT2,# suggesting# that# the# Y705C#mutation# increases# cysteine#
availability#at#the#cell#surface.#They#showed#that#the#Y705#mutant#formed#an#additional#
disulphide# bond# compared# to# wild>type# GlyT2.# By# using# a# pretreatment# of# N>
ethylmaleimide#(NEM),#which#modifies#free#thiols#preventing#SH>labelling,#then#adding#












binding# partner# of# Y705C,# selected# cysteine# residues# based# on# location# whereby# an#
intra>#or#intermolecular#disulphide#bond#with#C705#would#be#possible#(Fig.#3.10),#were#
individually# substituted# to# serine# to# form# double# mutants.# They# found# that#







Chen# et# al# 2007).# Therefore,# it# is# likely# that# the# Y705C# mutant# disrupts# GlyT2# cell#




The# studies# described# here# have# revealed# the# existence# of# several# new# pathogenic#
mechanisms# that# result# in#defective#glycine# transport.#Previously#known#mechanisms#
included# truncation# of# the# GlyT2# polypeptide# due# to# nonsense# and# frameshift#
mutations#(Eulenburg#et#al#2006;#Rees#et#al#2006),#to#which#splice>site#mutations#can#
now#be# added.# Truncating# nonsense# or# frameshift#mutations# distributed# throughout#
the#GlyT2#coding#region#were#found# in#11/20#patients.#As#well#as# loss#of# function#via#
protein# truncation,# these# mutations# also# have# the# potential# to# lead# to# nonsense>
mediated# RNA# decay.# One# nonsense# mutation# (R439X)# was# detected# in# several#
apparently# unrelated# cases# from# different# ethnic# backgrounds.# Splice>site#mutations#
were# identified# in# cases# 1# (IVS14+1∆G),# 7# (IVS13+1# G>T)# and# 9# (IVS8+1# G>A),# all#
affecting#the#+1#position#(in#different# introns).#This#means#that#the#first#nucleotide# in#
the#corresponding#intron#(i.e.#part#of#the#splice#donor#site#consensus,#'gt')#is#deleted#or#
substituted.# These# changes# are# predicted# to# result# in# either# mis>splicing# or# intron#
retention.#
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Previous# pathogenic#mechanisms# reported# for#missense#mutations# (Rees#et# al#2006)#
that# resulted# in# apparently# normal#membrane# trafficking# included# defects# in# glycine#
(W482R#in#TM6)#or#Na+#binding#(N509S#in#TM7).#With#the#exception#of#S513I#in#TM7,#
the#new#missense#substitutions#described# in#this#study#(L237P,#P243T,#E248K,#A275T,#
F547S,# Y656H,#G657A,#Y705C)#do#not#directly# affect#predicted#Na+#or# glycine#binding#
residues# (Fig.# 3.5).# However,# homology# modelling# of# human# GlyT2# based# on# the#
structure#of#the#bacterial#leucine#transporter#LeuT#(Yamashita#et#al#2005)#and#analysis#
of# key# structure>function# studies# of# related# transporters# has# allowed# us# to# suggest#
several# hypothetical# pathogenic# mechanisms# for# hyperekplexia# mutations.# These#
include# mutations# that# are# predicted# to:# i)# affect# the# conformation# of# TM2# (L237P,#
P243T);# ii)# indirectly# affect# glycine# (A275T,# E248K)# or#Na+# (A275T,# S513I)# binding;# iii)#
directly# affect# Cl># binding# (S513I);# iv)# affect# the# conformational# mobility# of# EL4B#
(F547S);# v)#affect#a# cation>π# interaction#within#or#accessory#protein# interactions#with#
the# intracellular# TM10>TM11# loop# (Y656H,# G657A);# and# vi)# affect# disulphide# bonds#
within#or#between#GlyT2#molecules#(Y705C).##I#have#also#confirmed#that#the#Cl>#binding#
residue# S513# in# GlyT2# (equivalent# to# S372# in# SERT# and# S331# in# GAT>1)# has# a# key#
functional#role#in#glycine#uptake.#Replacement#of#S372#in#SERT#with#glutamate#(S372E)#
or# aspartate# (S372D)# results# in# Cl># insensitive# transporters# with# low# uptake# activity.#




The# identification# of# these# new# GlyT2# mutations# effectively# triples# the# number# of#
known#individuals#with#presynaptic#defects,#firmly#establishing#mutations#in#the#GlyT2#
gene#as#a#second#major#cause#of#startle#disease#(Carta#et#al#2012;#Giménez#et#al#2012).#
Taken# together# with# the# recent# study# of# mutations# in# the# GlyR# α1# subunit# gene#
(GLRA1)#(Chung#et#al#2010),#it#is#now#apparent#that#recessive#hyperekplexia#is#far#more#
common# on# a# population# basis# than# dominant# hyperekplexia,# which# received# initial#
attention# due# to# the# characterization# of# extended# families# (Shiang#et# al# 1993;# 1995)#






function# of# multiple# GlyR# subtypes,# i.e.# α2β,# α3β# as# well# as# the# predominant# α1β#








Livestock# farming# has# changed# dramatically# over# the# last# 50# years,# due# to# the#
implementation# of# efficient# breeding# programs# aimed# at# increasing# 'performance#
indicators'#such#as#feed#conversion#efficiency#(a#measure#of#the#efficiency#of#converting#
feed#mass#into#increased#body#mass),#milk#production#and#fertility.#Whilst#selection#for#
these# desirable# traits# increases# profitability,# it# can# also# result# in# reduced# effective#
population# sizes# due# to# inbreeding,# especially# in# those# species# where# artificial#
insemination# is# common.# As# a# result# of# the# practice# of# utilising# so>called# 'elite# sires'#
with# desirable# traits,# recessive# genetic# defects# are# beginning# to# emerge# and# cause#
significant#economic#and#animal#welfare#issues.#A#classical#example#is#bovine#leukocyte#
adhesion# deficiency# (BLAD),# a# lethal# immunodeficiency# disorder# affecting# 14%# of#















high>density# single# nucleotide# polymorphism# (SNP)# panels# (Charlier# et# al# 2008).# This#
study# reported# the# genetic# basis# of# three# inherited# recessive# disorders:# congenital#
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muscular#dystonia#(CMD)#types#1#and#2#in#Belgian#Blue#cattle#and#ichthyosis#foetalis#in#
Italian# Chianina# cattle.# Ichthyosis# foetalis# (IF)# is# a# severe# form# of# ichthyosis#
characterized#by#a#thickening#of#the#keratin# layer# in#the#foetal#skin,#which#appears#as#
large#horny#plates#that#are#separated#by#deep#cracks.#Affected#calves#abort#or#die#soon#
after#birth# (Molteni#et#al# 2006).#The#genetic# cause#of# IF#was# found# to#be#a#missense#
mutation# (H1935)# in#ABCA12# on# bovine# chromosome# 2.# This# gene# encodes# an# ATP>
binding# cassette# (ABC)# transporter# found# in# the# lamellar# granules# of# keratinocytes,#
where# it# is# thought# to# have# an# important# role# in# the# regulation# of# lipid# trafficking#
(Akiyama#et#al# 2006).#Missense#mutations# in# the# first#ATP>binding#domain#of#human#
ABCA12# cause# lamellar# ichthyosis# type# 2# (Lefévre# et# al# 2003)# whilst# nonsense,#
frameshift# and# missense# mutations# underlie# the# more# severe# harlequin# ichthyosis#
(Kelsell#et#al#2005;#Thomas#et#al#2006).#
#
Careful# examination# of# CMD# suggested# two# distinct# phenotypes,# classified# as# CMD1#
and# CMD2# (Vandeputte# et# al# 2006).# Calves# affected# by# CMD1# have# impaired#
swallowing,#fatigue#upon#stimulation#or#exercise#and#muscle#myotonia#resulting#in#an#
inability# to# flex# limbs#and# falling# that#could#cause#serious# injury# (Charlier#et#al#2008).#
CMD1#calves#do#not#survive#into#adulthood#but#die#within#a#few#weeks#of#birth#due#to#
respiratory# complications.# By# contrast,# calves# with# CMD2# suffer# severe# episodes# of#
muscle#hypertonia#upon#acoustic#or# tactile# stimulation#and# typically#die#within#a# few#
hours#of#birth.#The#gene# for#CMD1#was#mapped#to#bovine#chromosome#25#and#DNA#
sequencing#of#candidate#genes#revealed#a#R559C#missense#mutation#in#the#ATP#binding#
site# of# the# fast>twitch# skeletal>muscle# Ca2+# ATPase# SERCA1,# encoded# by# ATP2A1#
(Charlier#et#al#2008).#SERCA1#is#responsible#for#pumping#Ca2+#from#the#cytosol#back#into#
the# sarcoplasmic# reticulum,# thereby# inducing# muscle# relaxation# after# contraction.#
Interestingly,# a# second# ATP2A1# missense# mutation# (R164H)# was# subsequently#
identified# in# congenital# pseudomyotonia#of#Chianina# cattle# (Drögemüller#et#al# 2008).#
Mutations# in#human#ATP2A1#cause#Brody#myopathy,#a#rare#recessive#disorder#where#
affected# individuals# have# exercise>induced# muscle# cramps# and# impaired# muscle#
relaxation# (Odermatt#et#al# 1996;#Vattemi#et#al# 2010).#By# contrast,# CMD2#mapped# to#
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bovine# chromosome#29#and#was# found# to#be#a# L270P#missense#mutation# in#SLC6A5,#




episodes.# Introduction#of# the# corresponding#mutation# (L269P)# into# the#human#GlyT2#




This# pioneering# study# opened# the# way# for# the# characterization# of# further# cattle#
disorders# and# a# recent# notable# success# was# the# characterisation# of# crooked# tail#
syndrome#(CTS)#in#Belgian#Blue#cattle#(Fasquelle#et#al#2009).#In#this#disorder,#affected#
animals# have# a# crooked# tail# and# shortened# head,# growth# retardation,# extreme#
muscularity# and# spastic# paresia# ># progressive# stiffness# and# contraction# (spasticity)# in#
the#lower#limbs.#Whilst#CTS#is#not#necessarily#lethal,#it#does#cause#animal#suffering#and#
economic# losses# due# to# treatment# of# affected# animals.# CTS# maps# to# bovine#
chromosome# 19# and# was# recently# found# to# be# caused# by# different# loss>of>function#
mutations# in# the# bovine#MRC2# gene,# encoding# the#mannose# receptor# C# type# 2,# also#
known#as#180#kDa#Endocytic#Transmembrane#Glycoprotein# (Endo180;#Fasquelle#et#al#
2009;#Sartelet#et#al#2012).#MRC2#plays#a# role# in#extracellular#matrix#degradation#and#
remodelling,# showing# strong# expression# in# developing# bone.# Whilst# the# link# to#
muscular#symptoms#is#less#clear,#a#related#mannose#receptor#is#known#to#play#a#role#in#
myoblast#motility#and#muscle#growth.#In#an#initial#study,#a#2#bp#deletion#in#MRC2#was#
discovered# in# affected# animals.# The# resulting# frameshift# reveals# a# premature# stop#
codon#that#causes#nonsense>mediated#decay#of#the#mutant#messenger#RNA.#A#second#
loss>of>function#mutation# ># C636R,# which# causes# defects# in# receptor# oligomerization#
was# also# recently# reported# (Sartelet# et# al# 2012).# CTS# is# also# peculiar# in# that# the#
incidence#of#this#disorder#has#risen#very#suddenly#in#the#Belgian#blue#breed,#with#25%#
of# animals# now# estimated# to# be# CTS# carriers# (Fasquelle# et# al# 2009).# One# potential#
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explanation#for#this# is#that#Belgian#Blues#are#notorious#for#their#exceptional#muscular#
development# known# as# ‘double>muscling’# (Figure# 4.1).# This# extreme# phenotype# is#
related# at# least# in# part# to# an# 11# bp# loss>of>function# deletion# in# the#myostatin# gene#
(MSTN)# that# has# become# fixed# in# the# breed.# Myostatin# is# a# secreted# growth#
differentiation# factor# that# is# a# member# of# the# TGF# beta# protein# family# that# inhibits#






Figure$ 4.1.$ Images$ of$ Belgian$ blue$ sires$ showing$ characteristic$ 'doubleQmuscling'.$
Double>muscling# phenotype# is# an# inherited# condition,#which# results# in# the# increased#






Health# and# Veterinary# Laboratories# Agency.# Both# calves# exhibited# what# were# to# be#
recognized#as#classic#clinical#signs#of#congenital#muscular#dystonia#2#(CMD2).#The#aims#
of#our#study#were:#
# To# investigate# these# two#cases#using#molecular#genetics#approaches# to#determine#




British# Blue# Cattle# Society# and# to# conduct# a# preliminary# population# analysis# for#
CMD1,#CMD2#and#CTS#in#cattle#from#the#United#Kingdom.#







on# consecutive# days# to# different# dams# by# caesarean# section# and# were# the# first#
offspring# of# a# Belgian# Blue# bull.# This# bull# and# the# two# dams# showed# no# clinical#
abnormality.#By#contrast,#both#affected#calves#exhibited#persistent#lateral#recumbency#




second# was# euthanized# 48# hours# after# birth.# Clinical# examination# of# the# live# calf#
revealed#abdominal#breathing#and#slight#hyperpnoea (increased#depth#of#breathing).#
Withdrawal# and# patellar# reflexes# were# also# present,# but# difficult# to# assess# since#
performing#such#tests#induced#spasms.#There#was#obvious#neck#stiffness#and#the#carpal#
joints#could#not#be#flexed#more#than#30°.#Performing#these#manipulations#stimulated#
spasms# and# caused# distress# to# the# calf.# Both# calves# were# of# the# expected# size# and#
weight.# Bacteriological# cultures# were# unremarkable# and# there# was# no# evidence# of#
congenital# Bovine# Viral# Diarrhoea# (BVD)# infection.# Macroscopic# examination# of# the#
brain# revealed# a# persistent# cavum# septum# pellucidum# and# brain# swelling# (tentorial#
notch# on# occipital# cortices)# in# both# calves.# No# abnormality#was# detected# on# routine#
histological# examination# of# brain# (calf# 1# and# 2)# or# spinal# cord# (calf# 1).# These# clinical#
signs# suggested# an# inherited# defect,# since# the# observed# muscle# stiffness# was# not#









the# sire,# both# dams# and# nine# additional# animals# from# the# affected# farm# (Table# 4.1).#
Both# calves# were# homozygous# for# the# causative# c.T809C# mutation,# providing#
confirmation#of#the#diagnosis#of#CMD2#(Figure#4.2b).#As#expected,#the#sire#and#dams#of#
the#affected#calves#were#heterozygous#carriers#of#the#c.T809C#mutation#(Figure#4.2b),#
as#were#three#of#seven#animals# in#calf# to# the#carrier#sire# (Table#4.1).#This#genotyping#
was# confirmed# by# developing# simple# restriction# fragment# length# polymorphisms#
(RFLPs;# Figure# 4.2c,d)# using# the# enzymes# FauI# and#HpyCH4V# that# detect# the#mutant#





$ Status$ Genotype$ Outcome$
1# In#calf#to#bull#X# Normal## Calf#normal#
2# In#calf#to#bull#X# Heterozygous$(C/T)$ Calf#normal#
3# In#calf#to#bull#X## Heterozygous$(C/T)$ Calf#normal#
4# In#calf#to#bull#X# Normal#(T/T)# Calf#normal#
5# In#calf#to#bull#X# Heterozygous$(C/T)$ Calf#normal#
6# In#calf#to#bull#X# Normal#(T/T)# Calf#normal#






























Figure$ 4.2.$ Genotyping$ confirms$ the$ identification$ of$ CMD2$ cases$ in$ Belgian$ Blue$





mutant# alleles# showing# the# positions# of# the# FauI# and# HpyCH4V# restriction# enzyme#
recognition# sites# used# in# RFLP# analysis.# D:# RFLP# analysis# of# duplicate# samples#












Since# approximately# 55,000#Belgian#Blue# cattle# are# registered#with# the#British# Cattle#
Movement#Service#(www.bcms.gov.uk),#screening#for#genetic#mutations#requires#high>
throughput#methods.#Since#DNA#sequencing#of#PCR#amplicons#is#a#relatively#expensive#
method# of# genotyping,# I# decided# to# explore# an# alternative#method# of# detecting# the#
CMD2#mutation#>#LightScanner#high#resolution#melting#(HRM)#analysis#(Wittwer#2009).#
This#method#relies#upon#differential#PCR#amplicon#melting#in#the#presence#of#LCGreen#
Plus# Dye# (Figure# 4.3).# A# variant# of# this# method# was# also# employed# that# used# a#
LunaProbe# (Montgomery# et# al# 2007)# a# single# 3'>blocked,# unlabelled# oligonucleotide#




cases# (Figure#4.4d)#and# carried#out# further#genotyping#of# fourteen#unrelated#Belgian#
Blue# sire# DNAs# that# were# kindly# provided# by# Pam# Weiner# (Roslin# Institute).#
Surprisingly,# two#out#of# fourteen#of# these#sires#were#carriers#of# the#CMD2#mutation.#
From#the#British#Blue#Society#database#(http://www.britishbluecattle.org/database),#it#
was#estimated#that#the#three#carrier#sires# identified#to#date#had#generated#a#total#of#
1017# offspring# and# 1432# second>generation# offspring.# The# decision# was# therefore#







Figure$ 4.3.$ A$ schematic$ representation$ of$ high$ resolution$ melting$ (HRM).$ A:# An#
illustration#to#show#how#a#DNA#double#helix#separates#or#“melts”#apart#as#temperature#
increases.# The# temperature# at# which# an# amplicon# melts# is# directly# related# to# its#
sequence,# and# even# a# single# base# difference# between# two# sequences# will# lead# to#
different#melting# temperatures.#HRM# involves# the#addition#of# intercalating#dyes# that#
bind#dsDNA#and#fluoresce,#and#then#as#the#stands#melt#apart#they#become#unbound.#
This# process# is# monitored# in# real# time# by# recording# the# amount# of# fluorescence# as#
temperature# increases# then# plotting# to# generate# a# melt# curve.# B,$ C:# # DNA# that# is#
homozygous# for# a#mutation# (red# curves)#will#melt# at# a# different# temperature# to# the#
wild>type#(black#curves).#DNA#that#is#heterozygous#for#the#same#mutation#will#also#have#






























curves# and#difference# curves# showing#HRM#analysis# of# a# selection#of#SLC6A5# exon#4#
amplicons.# Note# that# PCR# products# from# heterozygous# carriers# (red# curves)# melt# at#
lower#temperatures#than#wild>type#amplicons#(grey#curves)#because#of#the#mismatch#
caused# by# heterozygosity.# C:# Genotyping# using# asymmetric# PCR# and# an# unlabelled#
LunaProbe# that# spans# the# SNP# of# interest# is# complementary# to# the# overproduced#
strand# and# has# been# blocked# at# the# 3'# end# to# prevent# extension.# As# the# product# is#
melted,#the#LunaProbe#melt#allows#detection#of#the#mutant#c.809C#allele#(blue#curves),#
the#heterozygous#state#(red#curves)#and#the#wild>type#c.809T#allele#(grey#curves).#D,E:#
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Blue# Cattle# Society# (BBCS)# of# which# almost# all# were# being# used# for# artificial#
insemination.#Of# the#49#bulls,#DNA#was#obtained# from#semen# for#46#bulls,# and# from#
nasal# swabs# (DNA#Genotek# Inc.,#Kanata,#Canada)# for#3#bulls.#The#sampling#design# for#
cows#was#intended#to#span#at#least#four#age#groups#in#order#to#obtain#a#clear#picture#
across# cohorts# within# a# generation.# All# were# sampled# using# nasal# swabs.# The# BBCS#
requested#samples#from#100#cows#and#distributed#swabs#accordingly,#however#only#59#
samples#were# returned# to# Roslin.#One# semen# straw#was# duplicated# (sexed/unsexed)#
making#a#total#of#109#DNA#samples#processed.#DNA#was#extracted#at#Ark#Genomics#at#
the#Roslin# Institute.#The#quality#of# the#extracted#DNA#was#assessed# for#suitability# for#
Illumina#SNP#genotyping#at#KBioscience# (Hoddesden,#UK;#www.kbioscience.co.uk).#All#
109# samples# were# genotyped# for# three# loci:# ATPA2A1,# SLC6A5# and# MRC2# which#
underlie#the#diseases#CMD1,#CMD2#and#CTS#respectively.#Of#the#63#samples#obtained#
with#nasal#swabs,#10/63#(16%)#failed.#Note,#again#that#failures#cannot#be#assumed#to#
be# due# to# the# capacity# of# the# swab# if# used# correctly,# but# are# likely# to# reflect# the#
adequacy#of#the#sampling#by#the#farmers.#Our#contribution#to#this#research#effort#was#
to# re>test# all# genotyping# failures,# mutation# carriers# and# a# sample# of# non>carriers# at#
these#loci.#Confirmatory#genotyping#was#performed#using#standard#Sanger#sequencing#
of#PCR#products#and#in#addition#an#RFLP#was#developed#for#CMD1,#based#on#digestion#
with# DraIII,# which# recognises# the# sequence# CACNNNGTG.# There# is# a# gain# of# DraIII#
recognition#site#in#the#CMD1#mutant#allele.#The#wild>type#DNA#would#only#be#digested#
in# one# position# leading# to# two# fragments# of# 39bp# and# 353bp.# DNA# of# an# affected#
animal#would#be#digested#in#two#positions#leading#to#three#fragments#of#39bp,#176bp#
and# 177bp.# Digestion# of# DNA# from# a# carrier#would# therefore# lead# to# a# total# of# four#
fragments# (39bp,#176bp,#177bp#and#353bp)# since#50%#of# the#DNA#present#would#be#




CMD1$ Bulls$ Cows$ Total$
Non>Carrier# 51# 54# 105#
Carrier# 0# 3$ 3$
Total## 51# 57# 108#
#
CMD2$ Bulls$$ Cows$ Total$$
Non>Carrier# 48# 53# 101#
Carrier# 3$ 1$ 4$
Total## 51# 54# 105#
#
CTS$ Bulls$$ Cows$ Total$$
Non>Carrier# 47# 49# 96#
Carrier# 4$ 0# 4$





Collectively# 6/51#bulls# (12%)# and#4/57# (7%)#of# cows#were# identified# as# carriers# of# at#
least# one# deleterious# variant# ># one# bull# carried# two# variants.# Thus,# the# carrier#








4.7.$ Molecular$ modelling$ of$ bovine$ GlyT2$ suggests$ a$ mechanism$ for$ the$ CMD2$
mutation$
In# this#aspect#of# the#project,# I# aimed# to#determine#how#the#L270P#mutation#disrupts#
GlyT2#function.#The#L270#residue#is#not#predicted#to#be#directly#involved#in#glycine#or#
Na+#binding#(Charlier#et#al#2008;#Figure#4.5#upper#panel),#however,#a#leucine#residue#is#










of# bovine# GlyT2# protein# highlighting# the# 12#membrane# spanning# domains# (TM1>12),#
the#predicted#Na+# (blue#triangles)#and#glycine#binding#residues# (black#circles)#and#the#




The# introduction# of# a# proline# at# residue# 270# can# provide# significant# local# structural#





Fold# recognition# of# bovine# GlyT2# was# performed# with# GenTHREADER# (Lobley# et# al#
2009)# and# HHPRED# (Söding# et# al# 2005)# in# order# to# identify# the# closest# homologue#
available#in#the#PDB.#The#bacterial#leucine#transporter#(LeuT)#(PDB:#2A65;#Yamashita#et#
al#2005)#was#identified#as#the#best#template#structure#(GenTHREADER#p>value:#2e>21;#
HHPred# e>value:# 0).# A# profile>profile# alignment# between# the# bovine# GlyT2# sequence#
and#the#LeuT#structure#was#generated#using#the#MUSCLE#(Edgar#2004)#and#T>COFFEE#
(Notredame# et# al# 2000)# web# servers,# ultimately# resulting# in# 26%# sequence# identity.#
Based# on# this# alignment# (Fig.# 4.6),# 50# homology# models# of# bovine# GlyT2# were#
calculated#using#MODELLER>9v7# (Eswar#et#al#2008),# including#heteroatoms# (two#Na2+#
ions# in# the# glycine#binding# site)# and# aligning# the#bound# leucine#with# glycine.#A# large#
part#of#the#extracellular#loop#between#TM3#and#TM4#(residues#313>355)#was#removed#






















partially# conserved# (grouped# by# similar# residue# characteristics,# such# as# charge,#




and# the# best# model# based# on# the# lowest# score# was# selected.# The# GlyT2# homology#




LeuT REHWATRLGLILAMAGNAVGLGNFLRFPVQAAENGGGAFMIPYIIAFLLVGIPLMWIEWA 64 
GlyT2 RGNWSSKLDFILSMVGYAVGLGNVWRFPYLAFQNGGGAFLIPYLMMLALAGLPIFFLEVS 251 
 * :*:::*.:**:*.* ******. ***  * :******:***:: : *.*:*::::* : 
 
LeuT MGRYGGAQGHGTTPAIFYLLWRNRFAKILGVFGLWIPLVVAIYYVYIESWTLGFAIKFLV 124 
GlyT2 LGQFAS-QGPVSVWKAI------PALQGCGIAMLIISVLIAIYYNVIICYTLFYLFASFV 304 
 :*::.. **  :.   :         :  *:  * *.:::****  * .:** : :  :* 
 
LeuT GLVPEPPP/TDPDSILRPFKEFLYSYIGVP-----KGDEPILKPSLFAYIVFLITMFINV 180 
GlyT2 SVLPWGSC/TMVNFTSQANKTFVSGSEEYFKYFVLKISAGIEYPGE-IRWPLAFCLFLAW 405 
 .::*  .  *  :   :. * *: .          * .  *  *.      : : :*: 
 
LeuT SILIRGISKGIERFAKIAMPTLFILAVFLVIRVFLLETPNGTAADGLNFLWTPDFEKLKD 240 
GlyT2 VIVYASLAKGIKTSGKVVYFTATFPYVVLVILLIRGVTLPG-AGAGIWYFITPKWEKLTD 464 
  *:  .::***:  .*:.  *     *.*** ::   *  * *. *: :: **.:***.* 
 
LeuT PGVWIAAVGQIFFTLSLGFGAIITYASYVRKDQDIVLSGLTAATLNEKAEVILGGSISIP 300 
GlyT2 ATVWKDAATQIFFSLSAAWGGLITLSSYNKFHNNCYRDTLIVTCTNSATSIFAGFVIFSV 524 
 . **  *. ****:**  .*.:** :** : .::   . * .:  *. :.:: *  *    
 
LeuT AAVAFFGVANAVAIAKAGAFNLGFITLPAIFSQTAGGTFLGFLWFFLLFFAGLTSSIAIM 360 
GlyT2 IGFMANERKVNIENVADQGPGIAFVVYPEALTRLPLSPFWAIIFFLMLLTLGLDTMFATI 584 
  ..        :  .   . .:.*:. *  ::: . ..* .:::*::*:  ** : :* : 
 
LeuT QPMIAFLEDEL-KL--SRKHAVLWTAAIVFFSAHLVMFLN---KSLDEMDFWAGTIGVVF 414 
GlyT2 ETIVTSISDEFPKYLRTHKPVFTLGCCVCFFIMGFPMITQGGIYMFQLVDTYAASYALVI 644 
 :.::: :.**: *   ::* ..   ..* **   : *: :     :: :* :*.: .:*: 
 
LeuT FGLTELIIFFWIFGADKAWEEINRGGIIKVPRIYYYVMRYITPAFLAVLLVVWAREYIPK 474 
GlyT2 IAIFELVGISYVYGLQRFCEDIEMMIGFQPNIFWKVCWAFVTPTILTFILCFSFYQWEPM 704 
 :.: **: : :::* ::  *:*:    ::   ::     ::**::*:.:* .   :: *  
 
LeuT IMEETHWTVWITRFYIIGLFLFLTFLVFLAERRRNHESAGT/L..                515 
GlyT2 TYG-SYRYPNWSMVLGWLMLACSVIWIPIMFVIKMH-----/G..                739 
     ::     : .    ::   .: : :    : *       ** 
 
!
Figure! 3.3.! Alignment! of! LeuT! and! bovine! GlyT2! sequences.! Residues' are' coloured'
according' to' their' hydrophobicity' using' the' Kyte5Doolittle' hydrophobicity' scale' (Kyte' &'
Doolitte' 1982),' where' the'most' hydrophobic' residues' are' coloured' in' bright' red' (I,' V,' L),'
then' less'hydrophobic' in'dark'red'(F,'C,'A,'M)'and'black' (G,'T,'W,'S,'Y,'P).'Hydrophilic'and'
charged'residues'are'coloured'in'blue'(D,'E,'N,'Q,'R,'H,'K).'Residues'highlighted'in'grey'are'
conserved' between' LeuT' and' GlyT2' (also' denoted' by' a' *)' and' residues' that' are' partially'
conserved' (grouped'by'similar' residue'characteristics,' such'as'charge,'aromaticity,'polarity'











high# energy,# particularly# DOPE# scores# that# are# more# than# 0,# are# considered#
unfavourable.#Areas#in#the#plot#where#the#energies#overlap#are#usually#correlated#with#










Evaluating# this#model#using# the#QMEAN#web# server# (Benkert#et#al#2009)# indicated#a#
reasonable#model# considering# that# it# is#a#membrane#protein# (QMEAN#Z>score#=# >3.8,#


















































Figure$ 4.8.$ QMEAN$ scores$ of$ bovine$ GlyT2$ homology$ model$ and$ LeuT$ structure$
plotted$ against$ scores$ for$ other$ native$ proteins.$ Normalised# QMEAN6# scores# for#
bovine#GlyT2#homology#model#(A)#and#LeuT#structure#(B)#plotted#alongside#a#sample#of#
other# scores# for# crystal# structures# of# other# native# proteins.# The# score# for# the# GlyT2#
model# lies# just#outside#of# the#cluster#of# scores# for#proteins#of#a# similar# size,#and# the#




Leu270# is#predicted# to#be# found#on# the#protein#exterior,# and#positioned#at# a# turn# in#










































































































TM1# and# TM6# (Yamashita#et# al#2005).# A# tyrosine# at# residue# 108# (Tyr108)# located# in#
















































































signs# consistent# with# congenital# muscular# dystonia# type# 2# (CMD2).# DNA# sequencing#
and# RFLP# analysis# indicated# that# both# calves# were# homozygous# for# the# mutation#
c.T809C# in# SLC6A5,# causing# a# L270P# substitution# in# TM3# on# bovine# GlyT2.# Further#
testing#of#animals#from#the#index#farm#and#a#sample#of#Belgian#Blue#sires#revealed#an#
unexpectedly# high# frequency# of# CMD2# carriers.# Fortunately,# a# second# bull# that# was#
clear# of# the# c.T809C# mutation# was# identified# (Table# 4.1),# ensuring# a# clear# future#
breeding# strategy.# New# inexpensive# genotyping# tests# for# the# CMD2# allele# were# also#
developed# that# can# be# used# to# confirm# diagnosis,# identify# carriers# and# guide# future#





CTS# allele# recently# discovered# by# Sartelet# et# al# (2012).# Since# the# Belgian# Blue# is# of#








Using# homology# modelling# of# bovine# GlyT2,# based# on# the# crystal# structure# of# a#
bacterial# leucine# transporter,# I# also# predicted# that# the# L270P# mutation# is# likely# to#








spinal# cord,# brainstem# and# retina,# consisting# of# heteropentameric# combinations# of#
ligand>binding#GlyR#α#subunits#(α1>α4)#together#with#the#GlyR#β#subunit#(Lynch#2009).#





GlyR#β#subunit#was,#until# recently,#widely#assumed#to#play#a#purely#structural# role# in#
heteromeric# GlyRs.# In# part,# this# was# due# to# the# key# role# of# the# GlyR# β# subunit# in#
mediating# high>affinity# interactions# with# the# synaptic# clustering# molecule# gephyrin#
(Meyer#et#al#1995),#which#in#turn#controls#the#dynamic#localisation#of#GlyRs#at#synaptic#
sites#(Feng#et#al#1998)#More#recently,#the#GlyR#β#subunit#was#also#reported#to#interact#








three# innovative# studies#have# revealed# that# the#GlyR#β# subunit# represents# the#major#
component# of# heteromeric# GlyRs,# which# are# more# likely# to# exist# in# a# 2α1:3β#
stoichiometry# with# the# subunit# arrangement# β>α>β>α>β.# Grudzinska# and# colleagues#
(2005)#compared#the#effects#of#mutations#affecting#predicted#glycine#binding#residues#
in# GlyR# α1# and# β# subunits.# Co>expression# of# mutant# α1# with# wild>type# β# subunits#
resulted#in#a#full#rescue#of#the#GlyR#EC50#value#for#glycine,#whilst#co>expression#of#wild>
 109#
type# α1#with#mutant# β# subunits# resulted# in# a# decrease# in# EC50.# A# subsequent# study#
(Dutertre# et# al# 2012)# revealed# that# the# GlyR# β# subunit# contributes#more# to# agonist#
binding#site#formation#than#had#been#previously#realised.#Experiments#with#GlyR#α1β#
concatemers#also# revealed# that# functional#heteromeric#GlyRs#can#be#produced#when#
co>expressed#with#GlyR#β#monomers#but#not#when#expressed#alone,#or#with#GlyR#α1#
monomers#(Grudzinska#et#al#2005).#This#result#was#consistent#with#either#a#2α:3β#or#a#
1α:4β# stoichiometry.# However,# quantification# of# radiolabeled# methionine#
incorporation#into#recombinant#α1β#versus#α1#GlyRs#suggested#a#2α1:3β#stoichiometry#




Defects# in# the# adult# GlyR# isoform# (α1β)# also# have# an# important# a# role# in# disease.#
Mutations# in#GLRA1,# encoding# the# GlyR# α1# subunit,# are# the#major# genetic# cause# of#





mutations# are# less# frequent,# but# recessive#mutations# have# also# been# found# in# three#
families#with#hyperekplexia# (Rees#et#al#2002;#Al>Owain#et#al#2012;#Lee#et#al#2012),# in#








and#W310C# substitutions# in# the# second# (TM2)# and# third# (TM3)#membrane>spanning#
 110#
domains,#respectively.#An#additional#missense#mutation#in#GLRB#was#recently#reported#









• To# correlate# the# results# of# fluorescence>based# imaging# and# electrophysiological#












USA).# Primers# recognizing# the# ten#GLRB# coding# exons# and# flanking# splice# sites#were#
designed# using# the# LightScanner# Primer# Design# Software# package,# version# 1# (Idaho#
Technology#Inc,#Salt#Lake#City,#Utah).#To#avoid#allelic#dropout,#all#primers#were#placed#
in# intronic# regions# that# were# devoid# of# single>nucleotide# polymorphisms# (SNPs)# as#
revealed# by# National# Center# for# Biotechnology# Information# databases.# Single#
nucleotide#variants#(SNVs)#were#assessed#against#those#found#in#NCBI#dbSNP#Build#136#






Figure$ 5.1.#Human$ GlyR$ β $ subunit$ mutations$ identified$ in$ individuals$ with$ startle$
disease.$A:#Amino#acid#sequence#of#human#GlyR#β#subunit#(Uniprot:#P48167)#indicating#
the# positions# of# putative# transmembrane# (TM)# domains# (grey# shaded# boxes)# and#
amino#acid#residues#affected#by#hyperekplexia#mutations#(Rees#et#al#2002;#Al>Owain#et#
al# 2012;# Lee#et#al# 2012).#Red# text#denotes# the#gephyrin>binding#motif#between#TM3#




L285R# substitution# in# the# second# membrane>spanning# domain# (TM2)# of# the# GlyR# β#
subunit.#Since#this#change#was#found#in#the#heterozygous#state#(Fig.#5.1b)#and#neither#
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        I  F  S  V  L  S  L  A  S  
Normal ATCTTCTCAGTCCTCAGCTTGGCCTCT 
        I  F  S  V  R  S  L  A  S  
Mutant ATCTTCTCAGTCCGAAGCTTGGCCTCT 
        A  L  D  V  W  L  I  A  C  
Normal GCTCTTGATGTTTGGCTTATTGCTTGC 











et# al# 2012)# in# nine# individuals# in# a# large# family# of# Saudi# Arabian# origin# with#





of# Turkish# origin# (homozygous# for# W310C),# exhibited# exaggerated# startle# and#
hypertonia# in# the# neonatal# period,# requiring# respiratory# support.# Neither# was#
dysmorphic,# but# both# were# and# remain# small# for# their# age.# The#male# had# transient#
dystonic# posturing# in# infancy# but# then# motor# development# largely# normalized# and#
startling# became# less# prominent.# Now# nine# years# old,# he# plays# football# well# and# is#
making# good# progress# in# school# and# socially.# Strabismus# (eye# misalignment)# was#
observed# at# 14#months,# but# is# no# longer# present.# In# this# case,# there# was# no# family#
history# of# startle# disease.# The# female# developed# hypsarrhythmia# (abnormal# EEG)# in#
early# childhood,# which# settled,# but# she# is# still# treated# with# clonazepam,# the# typical#
pharmacological# treatment# for# hyperekplexia.# She# does# not# have# apparent# visual# or#







M177R,$ L285R# and#W310C# substitutions#were# predicted# (Table# 5.1)# to# be# damaging#
using# SIFT# (http://sift.jcvi.org/;# Ng# 2003).# Using# Polyphen>2#






makes# a# significantly# better# template# for# homology# modelling# of# the# human# GlyR#
compared#to#other# ligandNgated#ion#channel#structures#such#as#Gloeobacter#violaceus#
GLIC# (Bocquet#et# al# 2009),#Erwinia# chrysanthemi# ELIC# (Hilf#&#Dutzler# 2008)# or# the#T.#





44.4%# (α1)# and# 38.9%# (β)# identity# (Fig# 5.2).# By# contrast,# GlyR# subunits# share# lower#
sequence# identity#with#GLIC# (α1:# 21.8%#and#β:# 24.6%)# and#different# nAChR# subunits#
(α1:# 19.7# to# 20%#and#β:# 23.9# to# 24.6%).# A# short# part# of# the# sequence#was# removed#
from# the#β# subunit# at# the#NNterminus# (residues#1N30),# and# the#extended# loop# region#




subunit# (for#GlyR#α1:# residues#C138NC152#and#C198NC209,# for#GlyR#β:#C161NC175#and#
C221NC233).#Each#model#was#assessed#with#the#DOPE#statistical#potential#score#(Shen#
&#Sali#2006)#and# the#best#model#based#on# the# lowest# score#was# selected.#The#GlyT2#
homology# model# was# calculated# to# have# a# normalized# DOPE# ZNscore# of# N0.222,#










are# conserved#between#GlyR#α1#or#βb#and#GluCl# (also#denoted#by#a#*)# and# residues#
that#are#partially#conserved#(grouped#by#similar#residue#characteristics,#such#as#charge,#




GlyR α1 SPSDFLDKLMGRTSGYDARIRPNF-KGPPVNVSCNIFINSFGSIAETTMDYRVNIFLRQQ 67 
GluClα  SDSKILAHLF--TSGYDFRVRPPTDNGGPVVVSVNMLLRTISKIDVVNMEYSAQLTLRES 58 
      α * *.:* :*:  ***** *:**   :* ** ** *:::.::..*  ..*:* .:: **:. 
 
GlyR α1 WNDPRLAYNEYPDDSLDLD-PSMLDSIWKPDLFFANEKGAHFHEITTDNKLLRISRNGNV 126 
GluClα  WIDKRLSYGVKGDGQPDFVILTVGHQIWMPDTFFPNEKQAYKHTIDKPNVLIRIHNDGTV 118 
      α * * **:*.   *.. *:   :: ..** ** **.*** *  * * . * *:** .:*.* 
 
GlyR α1 LYSIRITLTLACPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQEQGAVQVADGL--TL 184 
GluClα  LYSVRISLVLSCPMYLQYYPMDVQQCSIDLASYAYTTKDIEYLWKEHSPLQLKVGLSSSL 178 
      α ***:**:*.*:*** *: :***** * ::*   .** :*: : *:*:..:*:  **  :* 
 
GlyR α1 PQFILKEEKDLRYCTKHYNTGKFTCIEARFHLERQMGYYLIQMYIPSLLIVILSWISFWI 244 
GluClα  PSFQLTNTST-TYCTSVTNTGIYSCLRTTIQLKREFSFYLLQLYIPSCMLVIVSWVSFWF 237 
α *.* *.: .   ***.  *** ::*:.: ::*:*::.:**:*:**** ::**:**:***: 
 
GlyR α1 NMDAAPARVGLGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAV 304 
GluClα  DRTAIPARVTLGVTTLLTMTAQSAGINSQLPPVSYIKAIDVWIGACMTFIFCALLEFALV 297 
α :  * **** **:**:****:**:* .:.** ***:****:*:..*: *:*.****:* * 
 
GlyR α1 NFVS------------RQHKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNQ 344 
GluClα  NHIANAGTTEWNDISKRVDLISRALFPVLFFVFNILYW--SRFGH------- 340 




GlyR β  STSNILNRLLVS-YDPRIRPNF-KGIPVDVVVNIFINSFGSIQETTMDYRVNIFLRQKWN 93 
GluCl β SDSKILAHLFTSGYDFRVRPPTDNGGPVVVSVNMLLRTISKIDVVNMEYSAQLTLRESWI 60 
        * *:** :*:.* ** *:**   :* ** * **:::.::..*: ..*:* .:: **:.* 
 
GlyR β  DPRLKLPSDFRGSDALTVDPTMYKCLWKPDLFFANEKSANFHDVTQENILLFIFRDGDVL 153 
GluCl β DKRLSYGVKGDGQPDFVI-LTVGHQIWMPDTFFPNEKQAYKHTIDKPNVLIRIHNDGTVL 119 
        * **.   .  *.  :.:  *: : :* ** **.***.*  * : : *:*: *..** ** 
 
GlyR β  VSMRLSITLSCPLDLTLFPMDTQRCKMQLESFGYTTDDLRFIWQSGDPVQLE---KIALP 210 
GluCl β YSVRISLVLSCPMYLQYYPMDVQQCSIDLASYAYTTKDIEYLWKEHSPLQLKVGLSSSLP 179 
         *:*:*:.****: *  :***.*:*.::* *:.***.*:.::*:. .*:**:   . :** 
 
GlyR β  QFDIKKEDIEYGNCTKYYKGTGYYTCVEVIFTLRRQVGFYMMGVYAPTLLIVVLSWLSFW 270 
GluCl β SFQLTNTSTTY--CTS-VTNTGIYSCLRTTIQLKREFSFYLLQLYIPSCMLVIVSWVSFW 236 
  .*::.: .  *  **.  ..** *:*:.. : *:*:..**:: :* *: ::*::**:*** 
 
GlyR β  INPDASAARVPLGIFSVLSLASECTTLAAELPKVSYVKALDVWLIACLLFGFASLVEYAV 330 
GluCl β FDRTAIPARVTLGVTTLLTMTAQSAGINSQLPPVSYIKAIDVWIGACMTFIFCALLEFAL 296 
  ::  * .***.**: ::*:::::.: : ::** ***:**:***: **: * *.:*:*:*: 
 
GlyR β  VQVMLNNPK-----------/YARALFPFCFLFFNVIYWSIYL- 361 
GluCl β VNHIANAGTTEWNDISKRVDLISRALFPVLFFVFNILYWSRFGH 340 







was#plotted# alongside# the# corresponding# residues# in# a# single# subunit# from# the#GluCl#
template# structure# (Fig.# 5.3a).# The# same#was# done# for# a# single# GlyR# β# subunit# (Fig.#
5.3b).# Peaks# of# high# energy,# particularly# DOPE# scores# that# are# more# than# 0,# are#












Evaluating# the#model# using# the#QMEAN#web# server# (Benkert#et# al#2009)# indicated# a#
reasonable#model#considering#that#it#is#a#membrane#protein#(QMEAN#ZNscore#=#N3.24),#

























































































































Figure!5.4.!QMEAN! scores!of! human!GlyR!α1β ! homology!model! and!GluCl! plotted!
against!scores!for!other!native!proteins.!Normalised#QMEAN6#scores#for#human#GlyR#
homology#model#(A)#and#GluCl#(B)#plotted#beside#a#sample#of#other#scores#for#crystal#




with# the# 'swapaa'# command# in# Chimera# (Pettersen# et# al# 2004)# using# the# Dunbrack#
backboneNdependent# rotamer# library# (Dunbrack# 2002)# and# taking# into# account# the#
lowest#clash#score,#highest#number#of#HNbonds#and#highest#rotamer#probability.#
#
My# GlyR#model# (Fig.# 5.5a)# predicts# that# L285# in# the# GlyR# β# subunit# is# a# poreNlining#
residue,# projecting# a# small,# uncharged,# hydrophobic# side# chain# into# the# ionNchannel#
lumen# (Fig.# 5.5b).# The# L285R# mutation# introduces# a# significantly# larger,# positivelyN
charged#side#chain#that#projects#further#into#the#chloride#channel#(Fig.#5.5c).#Because#







































































































AspN271# at# the# N5'# position# at# the# cytoplasmic# end# of# TM2# (Fig.# 5.6a,b).# This# is#
consistent# with# different# models# of# anionNchannel# function# which# suggest# that# the#
































of# residues# that# line# the# ClN# channel# are# indicated# with# black# circles# and# residue#
numbers# indicated# for# GluCl# and# the# GlyR# β# subunit.# B,! C:# Schematic# diagrams#
depicting#two#GlyR#β#subunit#TM2#αNhelices#and#residues#lining#the#ClN#channel#for#wildN
type#L285#(B)#and#the#R285#mutant#(C).#Blue#spheres#represent#the#predicted#internal#








































By#contrast,# the# sideNchain#of#W310# in#TM3# is#part#of#an# intramembrane#network#of#
aromatic# residues# (phenylalanine,# tyrosine,# histidine# and# tryptophan)# contributed# by#
TM1,#TM3#and#TM4#(Fig.#5.7a,b).#Substitution#W310C#introduces#a#significantly#smaller#
and# shorter# side# chain# into# this#position# (Fig.# 5.7d),#with#a# reactive# sulfhydryl# group.#
Although#I#considered#that#C310#might#form#a#disulphide#bond#with#C314#in#TM3,#one#
turn#down#the#helix#in#our#model,#the#distance#between#the#two#sulphur#atoms#(4.6Å)#





M177# is# a# hydrophobic# amino# acid# located# in# the#GlyR# extracellular# domain# on# a# βN
sheet#(β7).#The#sideNchain#of#this#residue#forms#part#of#a#hydrophobic#pocket#(Fig.#5.8a)#
that# is# conserved# within# the# GluCl# structure# (Hibbs# &# Gouaux# 2011),# which# has# an#
isoleucine# at# the# equivalent# position.# The# M177R# substitution# results# in# the#
introduction#of#a#positivelyNcharged,#hydrophilic#side#chain#into#this#pocket#(Fig.#5.8b),#
which# is# predicted# to# have# a# significant# effect# on# the# folding# of# the# extracellular#
domain.#Although#M177/R177#are#not#predicted# to#directly# influence#glycine#binding#








Figure! 5.7.!Mutation!W310C! disrupts! hydrophobic! stacking! of!membranePspanning!
domains!TM1PTM3.!A:#Cutaway#view#from#the#extracellular#side#of#the#GlyR#β#subunit#
showing# how# the# sideNchain# of# residue#W310# in# TM3# contributes# to# a# hydrophobic#
stack#of#aromatic#residues#contributed#by#membraneNspanning#domains#TM1,#TM3#and#




C,D:# Side# view# showing# the# hydrophobicity# of# individual# residues# in# the# stack# by#
colouring#the#atom#surfaces.#Hydrophobic#surfaces#are#depicted#in#orange,#hydrophilic#
in# blue# and#white# indicates# neutral# polarity.# The#W310C# substitution# is# predicted# to#
disrupt# the# hydrophobic# stack,# altering# the# tertiary# fold# of# the# membraneNspanning#
domains.#Disulphide#bond#formation#is#unlikely,#since#this#is#rare#within#the#membrane#





















To# test# these# predictions,# I# used# siteNdirected#mutagenesis# (QuikChange,# Agilent)# to#
introduce#each#mutation#into#a#human#GlyR#β#subunit#cDNA#cloned#into#the#expression#
vector# pRK5.# These# constructs# were# verified# by# sequencing# and# analysed# by# Anna#
Bode,#Angelo#Keramidas#and#Joseph#Lynch#at#the#Queensland#Brain#Institute,#Brisbane,#
Australia.#HEK293# cells#were# coNtransfected#with# expression# constructs# encoding# the#
GlyR#α1#subunit#together#with#either#wildNtype#or#mutant#GlyR#β#subunit.#PatchNclamp#
electrophysiology#was# used# to# analyse# the# effects# of# the# L285R,#W310C# and#M177R#
mutations# on#GlyR# function.# DoseNresponse# relationships# confirmed# that# the# agonist#
sensitivity# for# GlyRs# containing# either# L285R# or# W310C# mutant# did# not# change#




(Fig.# 5.9d).# However,# due# to# the# resistance# of# heteromeric# α1β# GlyRs# to# picrotoxin#
(Pribilla# et# al# 1992),# this# inhibition# was# typically# only# about# 100# pA.# SingleNchannel#
recordings# in# the# absence# of# glycine# confirmed# the# spontaneous# activity# of# α1βL285R#
GlyRs#(Fig.#5.9e).#For#α1βW310C#GlyRs,#the#maximal#current#amplitude#was#significantly#








Side#view#of#part#of# the#GlyR#β# subunit#extracellular#domain#showing# the# location#of#
M177#within# a#βNsheet# structure.# The#polarity# of# the# surface# residues# is# shown#with#
hydrophobic# residues# depicted# in# orange,# hydrophilic# in# blue# and# white# indicating#
neutral# polarity.# B:!M177# is# located# close# to# F182,# which# is# involved# in# a# cationNπ#
interaction#with#the#amide#group#of#glycine.#C:!#Mutation#M177R#is#predicted#to#result#
in# the# loss# of# a# hydrophobic# sideNchain# and# replacement# with# a# hydrophilic# residue#







































Figure! 5.9.! Functional! characterization! of!GlyRs! containing! βL285R,! βW310C! and!βM177R!
using! patchPclamp! electrophysiology.#A! P! C:# Sample# glycine# doseNresponse# traces# in#
α1β,# α1βL285R,# α1βW310C# and# α1βM177R# GlyRs.# D:# Inhibition# of# leak# currents# in# hGlyR#
α1βL285R# by# 100# µM# picrotoxin# (PTX).# The# inward# current# transient# was# always#
observed# in# 5# cells.#E:# Spontaneous# singleNchannel# currents# for# α1βL285R# GlyRs.#Most#
openings# were# of# 2# N# 10# ms# duration# as# illustrated# in# Patch# 1.# Occasionally,# with#
multiple#channels#in#the#patch,#longer#activations#were#also#observed,#as#in#Patch#2.#F:#
Mean#currents#activated#by#100#µM#glycine#in#cells#expressing#α1β#GlyRs#in#a#1:1#ratio#







EC50!(µM)! nH! Imax!(nA)! n!
α1β! 39#±#4# 2.4#±#0.2# 14#±#3# 5#
α1βL285R! 49#±#7# 1.2#±#0.1**# 9#±#4# 3#
α1βW310C! 28,#58# 1.7,#4.0# 0.22,#0.15# 2#


















































































In# this# chapter,# I# describe# the# identification# and# functional# characterization# of# novel#
mutations# in# the# GlyR# β# subunit# gene# (GLRB)# that# have# revealed# new# pathogenic#
mechanisms# underlying# startle# disease/hyperekplexia.# We# identified# two# new#
missense# variants# in# GLRB# causing# L285R# and# W310C# substitutions# in# membrane#
spanning#domains#TM2#and#TM3,#respectively.#Using#molecular#modelling,# I#was#able#
to#establish#the#likely#pathogenic#mechanisms#for#L285R#and#W310C,#as#well#as#a#third#
mutation# N# M177R# N# recently# reported# in# a# large# Saudi# Arabian# family# with#
hyperekplexia.# L285R# is# a# de# novo# mutation,# i.e.# not# found# in# either# parent,# which#
disrupts# the# integrity# of# the# 9'# leucine# hydrophobic# girdle.# # α1βL285R# GlyRs# were#








On# first# impressions,# W310C# appeared# to# be# a# classical# recessive# hyperekplexia#
mutation,# appearing# to# interfere# with# GlyR# trafficking# rather# than# affecting# glycine#
sensitivity.# However,# detailed# analysis# revealed# both# novel# pathogenic# mechanisms#
and# mode# of# inheritance# for# this# missense# mutation.# Molecular# modelling# revealed#
that# W310# is# a# key# residue# involved# in# a# hydrophobic# stack# formed# by# aromatic#
residues# in# TM1,# TM3# and# TM4# that# determines# GlyR# subunit# stoichiometry.# The#
W310C#substitution#in#TM3#is#predicted#to#act#by#destabilizing#intramembrane#packing#
of# αNhelices,# a# result# that# is# in# accord# with# our# functional# studies,# which# suggested#
compromised# cellNsurface# expression# of# α1βW310C.# However,# we# cannot# rule# out# the#
possibility# that# reductions# in#channel#open#probability#or# singleNchannel#conductance#




case# of# incomplete# dominance,# i.e.# a# mutation# that# has# an# intermediate# effect# in#
heterozygous#carriers.##
#
The# remaining# GLRB# substitution# we# studied# in# detail# was# M177R,# which# both#
molecular#modelling# and# functional# studies# suggest# interferes# indirectly#with# agonist#
binding,#by#disrupting#a# local#βNsheet# fold# in# the# large#extracellular#domain.#M177# is#
located#just#five#residues#away#from#F182,#which#participates#in#a#cationNπ#interaction#




Based# on# our# recent# experience# with#GLRA1# and# SLC6A5,# I# consider# it# likely# that# a#
number#of#recessive#SNVs#remain#to#be#discovered#in#GLRB.#In#this#regard,#I#found#that#
eleven# additional# potentially# pathogenic# variants# in# GLRB# have# recently# been#
deposited#in#dbSNP#and#1000#genomes#project#databases.#Many#of#these#variants#are#
associated# with# nextNgeneration# sequencing# studies# such# as# the# NHLBI# Exome#
Sequencing#Project#(Tennessen#et#al#2012),#(Appendix#tables#2#and#3).#It#is#notable#that#
Sanger# DNA# sequencing#may# not# have# validated# these# variants,# and# the# pathogenic#
relevance# to# startle# disease# remains# unproven.# However,# based# on# the# discovery# of#
four#new#GLRB#variants#associated#with#hyperekplexia#in#this#year#alone,#I#recommend#






In# 1996,# Granato# and# coNworkers# performed# a# genetic# screen# detecting# behavioural#
phenotypes#for#motor#functions#in#mutant#zebrafish.#166#mutants#were#identified#from#
this#screen#exhibiting#embryonic#motility#(Granato#et#al#1996).#They#were#categorised#
into#14#phenotypes,# according# to# their# responses# to# touch:#no# response,#normal#but#
reduced# response,# vigorous# but# abnormal# response,# or# simultaneous,# bilateral#
contractions.# 103# of# these# mutants# displayed# abnormal# birefringence# of# muscular#
fibres# suggesting# impairments# in# the# nervous# system,# neuromuscular# junction# or#
functional#components#of#muscle#such#as#excitationNcontraction#coupling.#A#subset#of#
these# mutants# have# proven# to# be# useful# models# for# defective# glycinergic#
neurotransmission.# For#example,# the# zebrafish#shocked# (sho)#mutant# is# characterised#
by# an# abnormal# response# to# tactile# stimulation.# Typically,# a# wildNtype# fish# would#














slc6a9,# encoding# GlyT1,# although# the# mutation# in# the# ta51e# allele# remains#
uncharacterised.#The#sho#mutant#has#proven#to#be#extremely#useful#in#understanding#
homeostatic#mechanisms#that#operate#at#glycinergic#synapses#–#e.g.#GlyRs#were#downN
regulated# in# the# sho# mutant# (Mongeon# et# al# 2008),# perhaps# in# an# attempt# to#
compensate# for# the# excessive# levels# of# glycine# that# would# result# when# GlyT1# is#
inactivated.# Despite# these# advances,# a# similar# mutant# affecting# GlyT2# has# remained#
elusive.#However,#a# recent# reNexamination#of#zebrafish#motility#mutants#uncovered#a#
promising# lead.# The#macho# class#mutant# schlaffi# (sla)#maps# between#markers# z1206#
and#z4999,#a# region# that#harbours#slc6a5.#However,#whether# this#mutant#harbours#a#
mutation#in#slc6a5#remained#to#be#determined.#Since#no#photographs#or#videos#existed#
for# these# mutants,# I# was# also# unable# to# verify# the# accuracy# of# the# sla# phenotype#
described#to#date#(see#table#1.1).#
#
Another# useful# class# of# zebrafish# mutants# was# the# soNcalled# 'accordion'# class# (Table#
6.1),# which# includes# accordion# (acc),# zieharmonika# (zim),# diwanka# (diw),# bandoneon#
(beo),#quetschkommode# (que),#bajan# (baj)# and#expander# (exp).#WildNtype#embryos#at#
24N28# hpf# show# characteristic# coiling# movements# in# response# to# tactile# stimuli# (Fig.#





side# from# firing#when# the#muscles# on# the# other# side# are# contracting.# At# first,# it#was#
demonstrated# that# most# accordion# mutants# would# represent# defects# in# glycinergic#
transmission,#since#application#of#strychnine#N#a#GlyR#antagonist,#to#wildNtype#embryos#
phenocopied# the# abnormal# 'accordion'# behaviour# (Granato# et# al# 1996;# Hirata# et# al#
2004).#However,#it#has#since#become#apparent#that#there#are#a#number#of#mechanisms#
that#can#result#in#an#accordionNlike#phenotype#and#mutations#have#been#discovered#in#
genes# involving# cholinergic# neurotransmission# (e.g.# acetylcholinesterase# encoded# by#
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ache,#choline#acetyltransferase,#encoded#by$chat)#or#muscle#function#(e.g.#the#SERCA1#
Ca2+# ATPase# encoded# by# atp2a1).# Other# mutants,# such# as# expander# (exp)# or#
quetschkommode# (que)# remained#uncharacterised# for#many#years.#However,# the#que#
mutation#was#characterised# recently#and#shown# to#be#a#model#of#maple# syrup#urine#
disease# (MSUD).# This# disorder# is# also# known# as# branchedNchain# ketoaciduria,# an#
autosomal# recessive# metabolic# disorder# affecting# branchedNchain# amino# acids.#
Curiously,#the#condition#is#named#after#the#distinctive#sweet#odour#of#affected#infants'#
urine.# In# humans,#MSUD# is# caused# by#mutations# in#BCKDHA,#BCKDHB,#DBT# and#DLD#
which#encode#branchedNchain#keto#acid#dehydrogenase#E1α,#branchedNchain#keto#acid#
dehydrogenase# E1β,# dihydrolipoamide# branched# chain# transacylase# E2# and#
dihydrolipoamide#dehydrogenase,#respectively.##
#
Together,# these# proteins# make# up# the# mitochondrial# branchedNchain# αNketo# acid#
dehydrogenase# enzyme# complex# (BCKD)# that# is# responsible# for# catalysing# the#
branchedNchain# amino# acids# (BCAAs),# isoleucine,# leucine,# and# valine.#Defective# BCKD#
prevents#normal#breakdown,#leading#to#a#build#up#of#these#amino#acids#and#their#byN
products#in#the#body,#which#at#high#levels#are#toxic#to#the#brain#and#other#organs.#This#
disease# can# be# manageable# by# following# a# strict# diet,# but# without# control# the#
accumulation#of#these#substances#ultimately# leads#to#serious#medical#conditions#such#
as#brain#damage#and#coma.#In#a#recent#study#by#Friedrich#et#al#(2012)#it#was#found#that#
que# mutant# fish# harbour# a# recessive# mutation# at# the# intronNexon# boundary# in# dbt,#
resulting#in#a#failure#to#remove#the#intron#between#exons#6#and#7.#The#intron#contains#
multiple# stop# codons,#which# results# in# a# prematurely# terminated# protein# that# is# not#
functional.# Elevated# levels# of# BCAAs# were# also# detected# in# the# que# zebrafish,#




BCAA# toxicity# (Friedrich# et# al# 2012).# This# example# illustrates# quite# nicely# how#
characterisation# of# zebrafish# ENU# mutants# can# lead# to# useful# models# of# human#
 130#





the# body# of# a# 22# hpf# wildNtype# zebrafish# embryo,# which# exhibits# the# classic# coiling#








































uncoordinated# contraction# of# trunk#
muscles# resulting# in# a# contracted# wavy#
notochord,# 10N20%# shorter# than# wild#
type.#Mutations! I97N,! S766F,! T848I! in!
the! skeletal! muscle! sarcoplasmic!
reticulum! Ca2+PATPase! SERCA1! gene!
(atp2a1)!on!chromosome!3.!
Granato# et# al# 1996;#
Odenthal#et#al#1996;#
Hirata#et#al#2004; 





tf247! IVS2P2A>C! Embryonic# lethal.# Uncoordinated#
contraction#of#trunk#muscles,#eventually#
completely# immotile.# Intron! 2! splice!
acceptor! site! mutation! in! the! choline!
acetyltransferase! gene! (chat)! on!
chromosome!13.!






















uncoordinated# contraction# of# trunk#
muscles# resulting# in# a# contracted# wavy#




Granato# et# al# 1996;#
Odenthal#et#al#1996;#













uncoordinated# contraction# of# trunk#
muscles# resulting# in# a# contracted# wavy#
notochord,# slightly# bent# up,# 10# to# 20%#
shorter# than# wild# type,# small# eyes# and#
enlarged# hindbrain# ventricle.# Intron! 4!
splice! acceptor! site! and! nonsense!
mutations! W447X! and! Q608X! in! the!
procollagen! lysine! 2Poxoglutarate! 5P
dioxygenase! 3! gene! (plod3)! on!
chromosome!23.#










tu12# Unknown# Embryonic# lethal.# Uncoordinated#
contraction#of#trunk#muscles#resulting#in#
a# contracted# wavy# notochord,# 10N# 20%#
shorter# than#wild# type.#Unknown! gene!
on!chromosome!11.#






ti274# IVS6+1G>A# Embryonic# lethal.# Uncoordinated#
contraction#of#trunk#muscles#resulting#in#
a# contracted# wavy# notochord,# 10N20%#
shorter# than# wild# type.# Splice! site!
mutations!dihydrolipoamide!branchedP
chain!transacylase!E2!(dbt)!on!chr!22. 



















a# contracted# wavy# notochord,# 10N20%#





Granato# et# al# 1996;#
Odenthal#et#al#1996;#
Behra# et# al# 2002;#
Downes# &# Granato#
2004#




Although# there# are# clearly# many# routes# to# the# 'accordion'# phenotype# (Fig# 6.3),#
bandoneon# mutants# are# defective# in# glycinergic# synaptic# transmission.#Mutations# in#
glrbb#were#identified#as#the#basis#for#the#beo#mutant#phenotype,#leading#to#defective#
GlyR#β# subunit# function.# The# underlying#mutations# for# some,# but# not# all#beo# alleles#
were#identified#(Hirata#et#al#2005;#Masino#&#Fetcho#2005)#(Table#6.2).#These#resulted#in#
either#missense#changes#(L255R#in#TM1,#L275R#in#TM2)#or#a#nonsense#mutation#(Y79X).#



































Table! 6.2.# beo$ mutant! alleles! and! known! causative! mutations.! ‡# Mutant# lost.#
§Strongest#allele.!†Viable#allele.!
#
Since# the# advent# of# the# zebrafish# genome# sequencing# project# in# 2001#
(http://www.sanger.ac.uk/modelorgs/zebrafish.shtml),# the# identification# of# the#
chemically# induced#mutations# responsible# for# abnormal# phenotypes# has# been#much#
improved.# In#addition,#new#techniques#for#gene#disruption#have#been#developed.#For#
example,# the# knockdown# of# genes# using# specifically# designed# antisense# morpholino#




be# injected# directly# into# embryos# and# the# transgenic# fish# will# exhibit# cellN# or# tissue#
specific# induced# expression# of# the# injected# genes.# For# increased# efficacy,# virusN# or#





There# is#much# that# remains# to# be# discovered# and# understood# about# the# glycinergic#
transmission# in# zebrafish.# Four# bandoneon# alleles# remain# uncharacterized,# and# it#
remained# to# be# determined#whether# schlaffi# represents# an# authentic# GlyT2#mutant.#
Identification# of# the# mutations# in# these# zebrafish# could# uncover# some# interesting#
mutations# in# GlyR/GlyT2,# and# shed# light# on# the# structure# and# function# of# these#
proteins.#I#was#also#intrigued#by#a#genetrap#line#recently#reported#for#the#glra4a#gene,#
which# indicated# expression# in# neurones# in# the# spinal# cord# and# hindbrain.# Since# the#
corresponding#gene#(GLRA4)#is#a#pseudogene#in#humans#(Simon#et#al#2004),#I#decided#
that#it#would#be#interesting#to#knock#down#this#gene#in#zebrafish,#to#learn#more#about#
the# biological# role# of# the# α4# subunit.# In# addition# to# morpholino# knockdown,# I# also#
wished# to# find# out# whether# it# was# possible# to# interfere# with# receptor# function# by#
expressing#an#α4a#subunit#in#zebrafish#containing#a#dominant#hyperekplexia#mutation#
–#equivalent#to#R271Q#in#the#GlyR#α1#subunit.#The#aims#of#this#study#were:#
• To# identify# the# causative# mutations# of# the# uncharacterised# zebrafish# bandoneon#
alleles#by#PCR#and#sequencing#of#glrbb#from#mutant#and#homozygote#DNA.#























sequences# using# Sequencher# 5.0.# Nucleotides# that# differed# from# the# reference#
sequence#in#one#or#more#of#the#clones#were#noted.#Nucleotide#changes#that#resulted#in#
missense# or# nonsense# mutations# that# were# specific# to# the# line# under# examination#
could#represent#the#causative#mutation.#Unique#point#mutations#were#found#in#all#four#
beo# alleles,# with# three# resulting# in# nonsense# mutations# and# one# in# a# missense#
mutation.# Mutations# in# beo# alleles# tm115,# ta86d# and# ta92# are# nonsense# mutations#






ta86d# T303A# Y79X# 297  AGACTACTATGGACTAT→ACGTGTCAACATCTTCC 
74    E  T  T  M  D    *  R  V  N  I  F    
ta92# A1093T# K343X# 1078 GAGGCGGAGAGAGCAA→TAGATCGCCACCAAGGAG 
265   E  A  E  R  A     *  I  A  T  K  E     
tm115# C325T# Q87X# 311  AACATCTTCCTGAGAC→TAACGCTGGAATGACCCC 
82    N  I  F  L  R     *  R  W  N  D  P    
tf242# T301G# Y79D# 286  GAGACTACTATGGACT→GATCGTGTCAACATCTTC 
74    E  T  T  M  D     D  R  V  N  I  F    
!
Table! 6.3.!Mutations# identified# in# remaining#beo#alleles#and# the# resulting#changes# in#
the#GlyR#βb#subunit#sequence.#
 
These# truncated# proteins# are# predicted# to# be# nonNfunctional,# since# significant#
functional# domains# of# the# protein# will# be# lost.# Q87# and# Y79# both# lie# in# the# large#
extracellular# domain# of# the# receptor.# They# both# occur# close# to# the# NNterminus# and#
therefore#only#a#short#part#of#the#extracellular#domain#would#be#translated,#with#loss#
 135#
of# the# entire# TM1NTM4# region.# K343X# occurs# within# the# large# intracellular# loop#
between#TM3#and#TM4.#A#truncation#here#would#result#in#the#loss#of#TM4#and#a#large#
majority# of# the# intracellular# loop,# which# is# likely# to# have# a# dramatic# effect# on# the#
tertiary#fold#of#the#subunit#and#a#concomitant#loss#of#the#gephyrin#binding#site#located#
between#TM3#and#TM4.#The#missense#mutation#identified#in#the#tf242#allele#results#in#
Y79D#substitution# in# the#extracellular#domain# (Table#6.3;#Fig.#6.4),#which#could#affect#
ligand# binding# by# neighbouring# α# subunits,# or# assembly# of# αβb# heteromers.# Taken#
together,# these# data# indicate# that#mutations# resulting# in# protein# truncation# are# the#
predominant# mechanism# disrupting# GlyR# βb# function# in# the# beo# allele# series# (4/7#





Figure!6.4.#Zebrafish!GlyR!βb!sequence! indicating!mutations! found! in!different!beo!
alleles.#Sequence#of#the#zebrafish#GlyR#βb#(Uniprot#I.D.:#F1Q5M0)#protein#showing#the#
residues# affected# by# beo# mutations.# Predicted# membraneNspanning# domains# (TM1N
TM4)#are# indicated#by#coloured#boxes,# the#extracellular#domain# is#boxed# in#grey#and#
the#conserved#gephyrinNbinding#motif#is#underlined.#




























encodes# a# yeast# transcription# factor# activator# protein,# flanked# by# internal# ribosome#
entry# site# (IRES)# and# a# polyadenylation# signal# (Fig.# 6.5)# was# integrated# into# glra4a#
between#exon#1# and# exon#2.#GAL4# is# a# yeast# protein# and# is# not# naturally# present# in#
other# organisms,# and# has# no# effect,# since# it# normally# has# no# appropriate# activating#
sequences#to#bind#in#the#zebrafish.#However,#GAL4#works#efficiently#as#a#transcription#
factor#when#expressed#in#close#proximity#to#an#upstream#activator#sequence#(UAS)#that#
will# usually# be# a# fluorescent# protein# such# as# enhanced# green# fluorescent# protein#
(EGFP).# The# zebrafish# glra4a:GAL4# geneNtrap# line# was# therefore# crossed# with# a#
UAS:EGFP#line.#The#offspring#express#GAL4,#which#binds#to#the#UAS#and#subsequently#





Figure! 6.5.! A! schematic! representation! of! creating! a! glra4a! gene! trap! by! gene!
transfer.###The#gene#transfer#vector#Tol2#at#either#end#of#the#DNA#allows#insertion#into#
the#zebrafish#genome#–#in#this#case#between#exons#1#and#exon#2#of#glra4a.#The#splice#
acceptor# (SA)# interrupts# normal# splicing# and# ensures# that# the# inserted# sequence# is#
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Expression# of# glra4a:GAL4# was# determined# by# visualisation# of# EGFP.# Expression# is#




Figure! 6.7.! glra4a:GAL4! is! expressed! in! commissural! primary! and! secondary!
ascending!neurons.!The#images#show#a#portion#of#the#zebrafish#spinal#cord#at#48#hpf#



















The# very# first# hyperekplexiaNcausing#mutations# to#be#discovered#were# two#dominant#
missense#mutations#in#GLRA1#leading#to#substitutions#in#the#same#residue,#R271Q#and#
R271L# (Shiang# et# al# 1993).# These# mutations# remain# the# most# frequently# reported#
dominant#mutations#and#have#been#identified#in#a#number#of#unrelated#hyperekplexia#
patients#(Schorderet#et#al#1994;#Tijssen#et#al#1994;#Elmslie#et#al#1996;#Rees#et#al#2001;#
Kimura#et#al# 2006;#Chung#et#al# 2010).# Interestingly,#mutations# leading# to#R271X#and#
R271P#have#also#been#reported# (Gregory#et#al#2008;#Lee#et#al#2012).# In#order# to#test#











cDNA# for# a# particular# GlyR# subunit# and# expressing# the# corresponding# protein# in#
zebrafish#could#yield#a#specific#phenotype,#comparing# this# to#morpholino#knockdown#
for# the#same#gene.#A# fullNlength#zebrafish#glra4a# (Uniprot# I.D.#Q5CZW5)#cDNA# in# the#
pDNRNLIB# vector# (GeneService,# Source#Bioscience#UK# Ltd)#was#used# as# a# template# in#
PCR# reactions# with# specifically# designed# primers# to# generate# a# glra4a# cDNA# with#
compatible# restriction# sites# to# allow# their# insertion# into# pCS2+# (Glra4aNEcoRI# 5'N
agagaattcgccaccatgctccctcaggtcataagN3'# and# glra4aNSalI# 5'N
atggtcgacttaagggttggcgtggatatcctcgtN3').# Following# PCR,# the# cDNA# was# digested# with#
appropriate# restriction# enzymes# and# ligated# into# pCS2+.# The# constructs# were# then#
verified# by# Sanger# DNA# sequencing.# I# then# used# siteNdirected# mutagenesis#
 139#
(QuikChange,# Agilent)# to# introduce# the# R278Q#mutation# involving# two# base# changes#
(Fig.# 6.8)# into# the# zebrafish# GlyR# α4a# subunit# cDNA# using# specifically# designed#
mutagenesis#primers#that#contain#the#base#changes#highlighted#in#Fig.#6.8#(R278Q1#5'N
ccacccagagctccggttcacaagcctcgctacN3'# and# R278Q2# 5'N




             T  Q  S  S  G  S  R  A  S  L  P  K  V  S  Y  V  293 
R278Q1 5'-ccacccagagctccggttcacaagcctcgctac-3' 
            ACCCAGAGCTCCGGTTCAAGAGCCTCGCTACCCAAGGTGTCCTACGTG 960 
#





6.6.! Morpholino! knockdown! and! overexpression! of! an! artificial! GlyR! α4a! R278Q!
mutation!reveals!aberrant!swimming!behaviour!
Splice# site# (SMO)#and# translation#blocking# (TMO)#morpholinos#α4aNSMO1,#α4aNSMO2#
and# α4aNTMO# (see# Materials# and# Methods# 2.1.12)# were# injected# into# zebrafish#





the# lack# of# a# specific# GlyR# α4a# subunit# antibody,# RTNPCR# was# used# to# monitor# the#
effects# of# α4aNSMO1# and# α4aNSMO2.# mRNA# was# extracted# from# zebrafish# that# had#
been# injected# with# α4aNSMO1# and# α4aNSMO2# plus# nonNinjected# zebrafish# embryos#
(wildNtype# control).# RTNPCR# was# performed# using# primers# targeted# within# exon# 6#
(forward)#and#exon#8#(reverse)#of#zebrafish#glra4a#and#the#PCR#products#corresponding#





site#was#used#within#exon#7.#Both#outcomes# result# in# a# frameshift# and# loss#of# intact#
GlyR#α4a#subunits.#RTNPCR#with#similar#primers#targeted#against#zebrafish#glra1#did#not#







the#deletion#of#exon#7# for#α4aNSMO1# (lane#3)#and# the#deletion#of#part#of#exon#7# for#
α4aN#SMO2#(lane#4).#Intact#GlyR#α4a#exon#7N9#PCR#products#are#seen#in#the#control#(393#
bp,# lane# 2)# and# smaller# amounts# are# also# observed# in# lanes# 3# and# 4.# A# fragment# of#
around#178#bp#is#seen#in#sMO1,#which#is#made#up#of#exon#6#and#8#only.#A#fragment#of#
321#bp#in#SMO2#contains#exons#6#and#8#and#part#of#exon#7,#which#excludes#the#region#
that# codes# for# TM2.#GlyR#α1# exon# 7# is# present# in# control# and# both# SMO# fish# (lower#
panel).#Photographic#images#provided#by#Max#Suster.#
#




























Although# the# zebrafish# appeared# to# eventually# recover# and# swim# away# from# the#
stimulus,# this# took#significantly# longer.#Thus,#knockdown#with#α4aNSMO1#significantly#
impairs#escape#behaviour.#The#same#behaviour#was#observed#in#embryos#injected#with#








behaviour.! The# wildNtype# (control)# fish# responds# to# touch# by# with# a# CNbend,# a# turn#
away# from# the# stimulus# and# rapid# swimming.# However,# embryos# injected#with# α4aN










to! exhibit! correct! escape! behaviour.!Embryos# injected#with#mRNA# for# the#GlyR#α4a#
subunit#R278Q#mutant#escape#more#slowly,#and#have#a#pronounced#head#retraction#N#




To# gain# further# insights# into# the# potential# pathogenic# mechanisms# of# the# R278Q#
mutation,# I#constructed#a#homology#model#of#the#zebrafish#α4aβb#GlyR#based#on#the#
crystal#structure#of#the#GluCl#from#C.#elegans#(PDB:#3RHW)#(Hibbs#&#Gouaux#2011).#A#
profileNprofile# alignment# between# the# zebrafish# GlyR# α4a# and# βb# subunits# and# the#
GluCl#α#subunit#was#generated#using#the#MUSCLE#and#TNCOFFEE#web#servers#resulted#
in# 37.7%# (α4a)# and# 44.7%# (βb)# identity.# A# short# part# of# the# sequence#was# removed#
from# both# the#α4a# and# the#βb# subunits# at# the# NNterminus# (residues# 1N15# and# 1N33,#
respectively),#and#the#extended# loop#region#between#TM3#and#TM4#of#both#α4a#and#
βb#subunits#were#removed# (residues#319N396#and#335N450,# respectively)# since# it#was#
not# possible# to#model# these# regions# reliably# due# to# very# low# sequence# identity. The#
final# alignments# are# shown# in# Fig.# 6.12.# The# models# were# built# with# additional#
restraints#enforcing#disulphide#bonds#between#cysteine#residues#involved#in#the#cysNcys#
loops#within#each#subunit#(for#GlyR#α4a:#residues#C145NC159#and#C205NC216,#for#GlyR#
βb:# C160NC174# and# C220NC232).# Each# model# was# assessed# by# MODELLER# with# the#
Discrete#Optimized#Protein#Energy#(DOPE)#statistical#potential#score#(Shen#&#Sali#2006)#
and# the# optimal# model# was# selected# based# on# the# lowest# score.# The# GlyR# α4aβb#
homology# model# was# calculated# to# have# a# normalized# DOPE# ZNscore# of# N0.298,#












βb# (B)# (also# denoted# by# a# *)# and# residues# that# are# partially# conserved# (grouped# by#
similar# residue# characteristics,# such# as# charge,# aromaticity,# polarity# and# size)# are#






GlyR α4a SPSDFLDKLMGRTSGYDARIRPNF-KGPPVNVTCNIFINSFGSITETTMDYRLNVFLRQQWNDPR 79 
GluCl    SDSKILAHLF--TSGYDFRVRPPTDNGGPVVVSVNMLLRTISKIDVVNMEYSAQLTLRESWIDKR 63 
    * *.:* :*:  ***** *:**   :* ** *: *:::.::..*  ..*:*  :: **:.* * * 
 
GlyR α4a LAYSEYPDASLDLD-PSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFQNGNVLYSIRITLIL 143 
GluCl    LSYGVKGDGQPDFVILTVGHQIWMPDTFFPNEKQAYKHTIDKPNVLIRIHNDGTVLYSVRISLVL 99 
    *:*.   *.. *:   :: ..** ** **.*** *  * : . * *:**.::*.****:*::*:* 
 
GlyR α4a SCPMDLKNFPMDIQTCTMQLESFGYTMNDLIFEWLSDNPVQVADDL--TLPQFVLKEEKDLGYCT 206 
GluCl    SCPMYLQYYPMDVQQCSIDLASYAYTTKDIEYLWKEHSPLQLKVGLSSSLPSFQLTNTST-TYCT 193 
    **** *: :***:* *:::* *:.** :*: : * ...*:*:  .*  :**.* *.: .   *** 
 
GlyR α4a KHYNTGKFTCIEVKFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVGLGITTVLTMT 271 
GluCl    SVTNTGIYSCLRTTIQLKREFSFYLLQLYIPSCMLVIVSWVSFWFDRTAIPARVTLGVTTLLTMT 252 
    .  *** ::*:...::*:*::.:**:*:**** ::**:******::  * **** **:**:**** 
 
GlyR α4a TQSSGSRASLPKVSYVKAIDIWMAVCLLFVFAALLEYAAVNFVS------------RQHTISRAV 324 
GluCl    AQSAGINSQLPPVSYIKAIDVWIGACMTFIFCALLEFALVNHIANAGTTEWNDISKRVDLISRAL 303 
   :**:* .:.** ***:****:*:..*: *:*.****:* **.::            * . ****: 
 
GlyR α4a FPLSFLIFNVFYWITYKVLR 348 
GluCl    FPVLFFVFNILYW--SRFGH 340 




GlyR β   STSNILNRLLMT-YDSRIRPNF-KGIPVEVSVNIFINSFGSIQETTMDYRVNIFLRQRWNDPRLR 62 
GluCl    SDSKILAHLFTSGYDFRVRPPTDNGGPVVVSVNMLLRTISKIDVVNMEYSAQLTLRESWIDKRLS 65 
           *:** :*: : ** *:**   :* **  .**:::.::..*: ..*:* .:: **: * * ** 
 
GlyR β   LPTDFKGSDALTVDPTMFQCLWKPDLFFANEKNANFHDVTQENILLFIFRNGDVLVSMRLSVTLS 126 
GluCl    YGVKGDGQPDFVI-LTVGHQIWMPDTFFPNEKQAYKHTIDKPNVLIRIHNDGTVLYSVRISLVLS 129 
           .. . .  :.:  .: : :* ** **.***:*  * : : *:*: *..:* ** *:*:*:.** 
 
GlyR β   CPLALQLFPMDTQYCKMQLESFGYTTKDLVFIWQSGDPVQMD---EIALPQFDVKKEDIKYANCT 188 
GluCl    CPMYLQYYPMDVQQCSIDLASYAYTTKDIEYLWKEHSPLQLKVGLSSSLPSFQLTNTSTTY--CT 192 
         **: ** :***.* *.::* *:.*****: ::*:. .*:*:.   . :**.*::.: . .*  ** 
 
GlyR β   KYYPGTGYYTCVEVIFTLRRQVGFYMMGVYAPTLLIVVLSWLSFWINPDASAARVPLGILSVLSL 253 
GluCl    S-VTNTGIYSCLRTTIQLKREFSFYLLQLYIPSCMLVIVSWVSFWFDRTAIPARVTLGVTTLLTM 208 
         .  ..** *:*:.. : *:*:..**:: :* *: ::*::**:***::  * .***.**: ::*:: 
 
GlyR β   SSECTSLASELPKVSYVKAIDIWMIACLLYGFASLVEYAVVQVMLNSPK-----------/YARA 302 
GluCl    TAQSAGINSQLPPVSYIKAIDVWIGACMTFIFCALLEFALVNHIANAGTTEWNDISKRVDLISRA 314 
   :::.:.: *:** ***:****:*: **: * *.:*:*:*:*: : *: .             :** 
 
GlyR β   LFPFTFLFFNVIYWSVYL- 324 
GluCl    LFPVLFFVFNILYWSRFGH 340 




of#each# residue# for#a# single#GlyR#α4a# subunit#and#a# single#GlyR#βb#subunit# from# the#
best#model#were#plotted#alongside# the# corresponding# residues# in#a# single# subunit#of#
the#GluCl#template#structure#(Fig.#6.13).#Peaks#of#high#energy,#particularly#DOPE#scores#
that# are# more# than# 0,# are# considered# unfavourable.# Areas# in# the# plot# where# the#
energies# overlap# are# usually# correlated# with# regions# of# high# conservation# between#
target#and#template.#This#step#was#useful# for#highlighting#specific# regions#of#a#model#













using# the# QMEAN# web# server# (http://swissmodel.expasy.org/qmean/cgi/index.cgi)#
(Benkert#et#al#2008,#2009).#The#QMEAN6#score#of#the#model#(ZNscore#=#N2.8)#fell#within#
a#range#typically#found#for#native#proteins#of#similar#size#(Fig.#6.14)#(Benkert#et#al#2009,#
































































































































and# the# GluCl# structure# (B)# plotted# alongside# other# scores# for# a# sample# of# crystal#
structures#of#other#native#proteins.#The#scores#for#both#the#GlyR#α4aβb#model#and#the#
GluCl#structure#lie#on#the#border#of#the#cluster#of#scores#for#native#protein#structures#of#




The# R278Q# substitution# was# modelled# into# the# GlyR# homology# model# with# the#
'swapaa'# command# in#Chimera# (Pettersen#et#al# 2004)#using# the#Dunbrack#backboneN
dependent#rotamer# library# (Dunbrack#2002)#and#taking# into#account#the# lowest#clash#
score,#highest#number#of#HNbonds#and#highest#rotamer#probability#(Fig.#6.15).#R278#is#
predicted#to#be# located#on#the#second#transmembrane#domain#helix# (TM2),#adjacent#
to# the# TM2NTM3# loop# and# close# to# the# membrane# in# the# extracellular# space# (Fig.#
6.15a).# The# native,# positivelyNcharged# arginine# residue# is# substituted# to# a# glutamine,#
which# has# an# uncharged# sideNchain.# A# study# by# Lynch# (2004)# showed# that# the# same#




































































































βb# subunits# in# blue.# Grey# spheres# depict# the# predicted# location# of# the# membrane#
boundaries.#B:#R278#is#predicted#to#be#located#on#TM2#at#the#extracellular#end#of#the#
helix,# but# close# to# the#membrane.#C:# The# residue# is# substituted# to# a# glutamine# that#
lacks#the#positive#charge#found#in#the#arginine#side#chain.#This#may#have#some#impact#
on#the#gating#of#the#channel#or#interactions#with#adjacent#subunits.!D:#An#alternative#





2007;# Shan# et# al# 2012).# Although# there# are# no# obvious# interactions# or# clashes# that#










To# ascertain#whether# a#mutation# in# zebrafish# slc6a5#was# responsible# for# the# schlaffi#
(sla)# phenotype,# genomic# DNA# was# extracted# from# homozygous# sla# mutants# (allele#
th239)# and# siblings,# kindly# provided# by# Robert# Giesler# (Institute# of# Toxicology# and#
Genetics,# Karlsruhe# Institute# of# Technology,# Germany).# Zebrafish# slc6a5# amplicons#
were#generated#from#homozygous#mutants#by#standard#PCRs#using#the#primers#listed#
in#the#appendix#(Table#4).#SNVs#were#identified#by#aligning#the#sequences#with#native#




slc6a5$ Amplicon!size! SNV! Resulting!codon!
Exon#1# 151#bp# None# N#
Exon#2# 537#bp# None# N#
Exon#3# 264#bp# None# N#
Exon#4# 218#bp# G753A# A253A#(synonymous)#
Exon#5# 283#bp# T819A# Y273X#(nonsense)#
Exon#6# 232bp# None# N#
Exon#7# 226bp# None# N#




Exon#10# 198bp# None# N#
Exon#11# 150bp# C1985T# D565D#(synonymous)#
Exon#12# 230bp# C1755T# Y585Y#(synonymous)#
Exon#13# 195bp# C1896T# I632I#(synonymous)#
Exon#14# 199bp# C1974G# G658G#(synonymous)#
Exon#15# 248bp# G2097A# P699P#(synonymous)#
Exon#16# 264bp# None# N#
!
Table!6.4.!SNVs!found!in!slc6a5!in!sla$th239!fish.!





All# SNPs# result# in# synonymous# changes# (i.e.# do#not# change# the#encoded#amino# acid)#
with# the# exception# of# T819A# which# represents# a# nonsense# mutation# in# exon# 5,#





For# further# proof# that# the# mutation# Y273X# could# underlie# the# sla# phenotype,# we#
designed# a# translationNblocking# morpholino# against# the# zebrafish# GlyT2# mRNA# and#
revived# the# sla# mutant# with# the# help# of# the# Zebrafish# Stock# Center# in# Tübingen,#
Germany.# In#collaboration#with#Hiromi#Hirata# (Center# for#Frontier#Research,#National#
Institute#of#Genetics,#Japan)#I#demonstrated#that#the#sla#mutant#and#microinjection#of#
the#GlyT2NTMO#resulted#in#an#'accordion'#phenotype,#similar#to#the#beo#mutant.#At#72#
hpf,# instead#of# exhibiting# a# classical# escape# response,# they# respond#by# simultaneous#
contraction#of# the#muscles#of# the# trunk# leading# to#a#shortening#of# the#body,#without#
swimming# (Fig.# 6.13).# This# phenotype#mimics# that# of# the# beo# mutants# that# harbour#




Resequencing# of# the# remaining# beo#mutant# alleles# resulted# in# the# identification# of#
missense# and#nonsense#mutations# in#glrbb.#Mutations# Y79X,# Y79D,#Q87X# and#K343X#
were# identified# in# alleles# ta86d,# tf242,# tm115# and# ta92,# respectively# (Table# 6.5).#
Characterisation#of# these# variants# and# their# functional# consequences# is# of# significant#
biological# interest,# since# the# different#beo# alleles# have# different# apparent# strengths.#
For#example,#beo#larvae#typically#die#7#dpf,#either#due#to#the#inability#to#swim#and#feed#
effectively,# or# due# to# cumulative# notochord# damage# from#muscle# contractions.# It# is#
interesting# to# note# that# a# K343X# nonsense# mutation# that# was# found# in# beota92# is#
















































the# gephyrin# binding# motif)# and# TM4.# Complementation# of# a# truncated# GlyR# α1#
subunit# by# an# independentlyNexpressed# CNterminal# domain# containing# TM4# was#
recently# reported# for# in# the# mouse# oscillator# mutant# (Villmann# et# al# 2009).# It# is#
therefore#possible# that# the# truncated#GlyR#βb#protein# is# somehow# incorporated# into#





site# morpholinos# revealed# that# knockdown# of# the# GlyR# α4# subunit# gave# rise# to#








into# specific# GlyR# subtypes# and# transported# to# appropriate# synapses.# The# head#
retraction# observed# could# also# be# thought# of# as# a# partial,# localised# 'accordion'Nlike#




(resulting# in# a# Y273X# truncation)# strongly# suggests# that# a# defect# in# the# GlyT2# gene#
underlies#the#sla#phenotype.#However,#the#reported#phenotype#of#the#sla#mutant#did#
not#match#with#the#expected#phenotype,#i.e.#that#a#GlyT2#mutant#should#resemble#the#
beo# phenotype.# Since#no#photographs#or# videos#of#sla#mutants#exist,# the#sla#mutant#
was#revived#and#used#to#establish#that#the#sla#mutant#and#slc6a5#knockdown#did#result#
in#an# 'accordion'Nlike#phenotype# (Fig.#6.16).#Future#work#should#seek#to#establish# the#
causative#mutation# in# the# second#sla# allele,# ty112,#as#well# as#attempting# recovery#of#
the#sla#phenotype#by#recombinant#expression#of#zebrafish#or#human#GlyT2.#Certainly,#
the# discovery# of# a# new#GlyT2#mutant#will# allow# zebrafish# researchers# to# investigate#







wildNtype# fish# swim# away# from# the# tactile# stimulus# applied# to# the# tail.# In# both# sla#
mutants#and#GlyT2#TMO#fish,# the#stimulus#results# in#bilateral#contractions#within# the#
trunk#of#the#fish#leading#to#shortening#of#the#body.#Dotted#lines#have#been#added#as#a#
guide# to# highlight# shortening# in# sla#mutants# and#GlyT2#MO# fish.# Single# images#were#









The# majority# of# published# studies# on# startle# disease# assume# that# the# disorder# is#
predominantly# caused# by# dominant# mutations# affecting# residues# in# the# TM2NTM3#
domains#of# the#GlyR#α1# subunit.#However,# it# is#now#becoming# increasingly#apparent#
that#recessive#mutations#in#GLRA1#are#more#common#on#a#population#basis#(Chung#et#
al#2010).#Moreover,#both#recessive#and#dominant#mutations# in#SLC6A5,#encoding#the#




et#al#1994;# Schorderet#et#al# 1994;#Tijssen#et#al# 1994;#Elmslie#et#al# 1996;#Milani#et#al#
1996;#Seri#et#al#1997;#Saul#et#al#1999;#Miraglia#Del#Giudice#et#al#2003;#Lapunzina#et#al#
2003;#Kimura#et#al#2006;#Poon#et#al#2006;#Becker#et#al#2008;#Gregory#et#al#2008;#Kang#
et# al# 2008;# Chung# et# al# 2010;# Lee# et# al# 2012).# By# contrast,# mutations# in#GLRB# and#
SLC6A5#were#first#reported#in#2002#and#2006,#respectively#(Rees#et#al#2002,#2006).#This#
'head# start'# for# GLRA1# is# also# reflected# in# the# NCBI# geneNtesting# registry#
(http://www.ncbi.nlm.nih.gov/gtr/).# Of# the# clinical# laboratories# worldwide# offering#
screening# for# startle# disease,# seven# screen# for#GLRA1#mutations#whereas# only# three#
offer#screening#for#GLRB#and#two#for#SLC6A5#mutations.#However,#this#testing#does#not#
reflect# the# true#prevalence#of#disease#alleles.# In# chapter#3,# I# described# the#discovery#
and#analysis#of#twenty#new#pathogenic#sequence#variants#for#GlyT2#in#17#index#cases,#a#
finding#that#firmly#establishes#SLC6A5#as#a#second#major#startle#disease#gene#(Carta#et#
al# 2012).#GlyT2#mutations#were# found# in# individuals# from# the#UK,#Australia,# Canada,#
France,# Italy,# Jordan,# the#Netherlands,#Portugal,# Spain#and# the#USA,#also#establishing#
that#startle#disease# is#a#global#phenomenon.# In#addition,#a#recurrent#dominant#GlyT2#
mutation# N# Y705C# N#was# also# described# in# several# individuals# from# the#UK# and# Spain#
(Giménez# et# al# 2012).# My# molecular# modelling# studies# were# particularly# useful# in#
understanding#how#these#new#GlyT2#mutations#could#cause#startle#disease,#since#the#
vast# majority# of# the# mutations# were# nonNfunctional# in# [3H]glycine# uptake# assays.##
 153#
Although# many# loss# of# function# mutations# resulted# in# protein# truncation,# missense#
mutations# were# predicted# to:# i)# affect# the# conformation# of# TM2# (L237P,# P243T);# ii)#
indirectly#affect#glycine#(A275T,#E248K)#or#Na+#(A275T,#S513I)#binding;#iii)#directly#affect#
ClN#binding#(S513I);# iv)#affect#the#conformational#mobility#of#EL4#(F547S)#and#v)#affect#





economics# of# the# livestock# farming# industry.# Efficient# breeding# programs# are#
implemented#to#increase#profitability#by#selection#of#animals#with#desirable#traits#with#





the# inbreeding# can# lead# to# the# emergence# of# recessive# genetic# defects,# which# can#
ultimately# result# in# reduced# effective# population# sizes# leading# to# economic# issues# as#
well# as# concerns# with# animal# welfare.# In# chapter# 4,# I# described# novel# methods# for#
detecting# a# mutation# in# SLC6A5# in# congenital# muscular# dystonia# type# 2# (CMD2)# in#
Belgian#Blue#cattle.#Since#this# is#a#recessive#defect,# it# is#possible#to#screen#unaffected#
animals# to# determine# whether# they# are# carriers# of# the# mutation.# Animals# that# are#
found# to# carry# the# CMD2# could# be# excluded# from# future# breeding,# resulting# in#
elimination#of#the#mutation#in#future#generations.#However,#since#elite#sires#may#have#
other# valuable# traits,# another# possibility# is# to# use# diagnostic# tests# to# guide# breeding#









of# startle# disease# and# were# only# reported# in# a# single# family# (Rees# et# al# 2002).# This#
situation#was#also# reflected# in#mouse#models#of# startle#disease,#with# four#models#of#




due# to#methodological# considerations.#Early#attempts#at# screening#GLRB#used#singleN




for#mutation#detection# N# although# this# is# likely# to#be# superseded# in# time#by# targeted#
nextNgeneration#sequencing#panels#(Lemke#et#al#2012).##
#
It# is# also# clear# that# there# are# key# differences# in# the# relative# damage# caused# by#
equivalent#missense#changes#in#GlyR#α1#versus#GlyR#β#subunits.#For#example,#dominant#
startle#disease#mutations#in#GLRA1#predominantly#affect#key#amino#acid#residues#in#the#
TM2# domain# and# TM2NTM3# linker# region# of# the#GlyR# α1# subunit,#where# they# act# to#
uncouple# ligand# binding# from# channel# gating.# Shan# and# colleagues# (2011)# recently#
demonstrated# that# GlyR# function# is# less# sensitive# to# hyperekplexiaNmimicking#
mutations#introduced#into#the#TM2NTM3#loop#of#the#GlyR#β#subunit#than#that#of#the#α1#
subunit.# This# suggests# that# the# GlyR# α1# TM2NTM3# loop# dominates# the# β# subunit# in#
gating# heteromeric# α1β# GlyRs# and# in# turn# that# it# is# perhaps# unlikely# that# a# set# of#
equivalent#dominant#mutations#in#the#TM2NTM3#linker#will#be#found#in#GLRB.#Rather,#
my#molecular#modelling#studies#suggest#that#GLRB#mutations#found#to#date#appear#to:#
i)# cluster# near# key# glycine# binding# residues# (M177R,# G229D)# or# ii)# are# found# in#
membraneNspanning# domains# TM1NTM3,# where# they# affect# ionNchannel# function#
(L285R)# or# disrupt# hydrophobic# sideNchain# stacking# (W310C).# Other# potential#
 155#
pathogenic#mechanisms#for#GLRB# include#protein#truncation#(via#deletion,#frameshift,#
splice# site# or# nonsense#mutations)# or#mutations# in# the# gephyrinNbinding# site# located#
between#TM3#and#TM4.#At#least# in#vitro,#artificial#missense#mutations#affecting#single#
amino#acids,#such#as#F398A#in#the#GlyR#β#subunit#gephyrinNbinding#motif#are#capable#of#




I# also# studied# GlyRs# and# GlyTs# in# zebrafish,# an# organism# that# is# amenable# to#
developmental#and#genetic#analysis#using#mutagenesis,#geneNtraps#and#rapid#targeted#





and# functional# roles.# For# example,# the# zebrafish# mutant# bandoneon# (beo)# harbours#
mutations# in# one# of# the# paired# GlyR# β# subunit# genes# (glrbb),# resulting# in# bilateral#
muscle# contractions# due# to# loss# of# reciprocal# glycinergic# inhibition# of#motor# circuits#
(Hirata# et# al# 2005).# However,# the# other# GlyR# β# subunit# gene# (glrba)# is# unable# to#




that# mimic# beo# had# been# discovered# in# zebrafish.# This# suggested# that# the# beo#
phenotype# might# result# from# the# loss# of# multiple# GlyR# subtypes,# or# that# GlyR# βb#
participates# in# embryonic# GlyRs# that# do# not# contain# GlyR# α1.# Some# supporting#
evidence#for#the#former#possibility#has#been#provided#by#my#studies#on#the#zebrafish#
GlyR# α4a# subunit# gene.# My# initial# interest# in# this# subunit# was# stimulated# by# the#
discovery# of# a# glra4a# geneNtrap,# which# demonstrated# the# expression# of# glra4a# in#
brainstem# and# spinal# cord# neurons.# Morpholino# knockdown# of# glra4a# or#
 156#






I#was# able# to# demonstrate# that# the#mutant# schlaffi# (sla)# represents# a#GlyT2#mutant,#
caused# by# a# nonsense# mutation# in# slc6a5.# Curiously,# the# phenotype# originally#
described# for# this# mutant# is# likely# to# be# incorrect,# since# analysis# of# the# mutant#




Based# on# the# results# presented# in# this# thesis,# I# recommend# that# GLRA1,# GLRB# and#
SLC6A5#should#have#equal#status#in#the#molecular#genetic#diagnosis#of#startle#disease.#
Mutations#in#GLRB#and#SLC6A5#were#associated#with#additional#clinical#symptoms,#such#
as# severe#neonatal# apnoea#episodes# (Rees#et#al# 2006;#Carta#et#al# 2012),#which#have#
additional#implications#for#patient#care.#Fortunately,#in#most#cases,#a#positive#response#
was#seen#to#treatment#with#clonazepam#(Rees#et#al#2006;#Carta#et#al#2012),#meaning#
that# startle# disease# responds#well# to# pharmacotherapy.# Although# sequential# genetic#
analysis# of# hyperekplexia# cases# has# revealed# many# additional# mutations# in# GLRA1,#






possibility# is# that# mutations# exist# in# genes# unrelated# to# GlyT2s# or# GlyTs.# There# are#
certainly# precedents# for# extensive# genetic# heterogeneity# in# other# neurological#
disorders.# For# example,# mutations# in# both# inhibitory# GABAA# receptor# (Baulac# et# al#
 157#
2001;# Harkin# et# al# 2002)# and# voltageNgated# Na+# channel# genes# (Wallace# et# al# 1998;#
Escayg#et#al#2000)#are#associated#with#generalized#epilepsy#with# febrile# seizures#plus#
(GEFS+).# In# my# view,# the# future# challenges# are# to:# i)# understand# the# regulatory#
elements#controlling#transcription#of#GLRA1,#GLRB#and#SLC6A5#and# ii)#use#alternative#
disease# geneNdiscovery# techniques,# such# as# array# comparative# genomic#hybridization#








dynamics# studies#may# also# be# very# useful# for# understanding# the# flexibility# in# certain#
regions# of# the# glycine# transporters# and# receptors# that# contribute# to# their# correct#
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Type) dbSNP)ID) SIFT) Polyphen?2) Overall)
Prediction)
c.A54G$ 2$ p.E18E$/$p.E/5E$ Synonymous$ rs11552656$ /$ /$ Benign$
c.T121C$ 2$ p.S41P/p.S19P$ Missense$ rs139168167$ Tolerated$(0.14)$ Possibly$damaging$(0.940)$ Benign$
c.G417T$ 5$ p.W139C/p.W117C$ Missense$ rs62636642$ Damaging$(0)$ Probably$damaging$(1.000)$ Benign*$
c.T423C$ 5$ p.P141P$/$p.P119P$ Synonymous$ /$ /$ /$ Benign$
c.C822T$ 8$ p.Y274Y$/$p.Y252Y$ Synonymous$ /$ /$ /$ Benign$





rs34766493$ /$ /$ Likely$
pathogenic$
c.T948C$ 9$ p.L316L$/$p.L294L$ Synonymous$ rs1801154$ /$ /$ Benign*$
c.A1044G$ 9$ p.A348A$/$p.A326A$ Synonymous$ /$ /$ /$ Benign$























c.G22C$ 1$ p.A8P$/$p.A/15P$ Missense$ rs139961228$ Tolerated$(0.22)$ Benign$(0.000)$ Benign$
c.G92A$ 2$ p.K31R$/$p.K9R$ Missense$ rs149863285$ Tolerated$(0.22)$ Possibly$damaging$(0.956)$ Benign$
c.T121C$ 2$ p.S41P$/$p.S19P$ Missense$ rs139168167$ Tolerated$(0.14)$ Possibly$damaging$(0.940)$ Benign$
c.C146G$ 3$ p.A49G$/$p.A27G$ Missense$ rs141963848$ Damaging$(0.02)$ Benign$(0.071)$ Benign$
c.G185A$ 3$ p.R62K$/$p.R40K$ Missense$ rs144279427$ Tolerated$(1)$ Benign$(0.001)$ Benign$
c.A404G$ 5$ p.Y135C$/$p.Y113C$ Missense$ rs141265285$ Damaging$(0)$ Benign$(0.331)$ Pathogenic?$
c.T415C$ 5$ p.W139R$/$p.W177R$ Missense$ rs143539995$ Damaging$(0)$ Probably$damaging$(0.999)$ Pathogenic?$
c.G417T$ 5$ p.W139C$/$p.W117C$ Missense$ rs62636642$ Damaging$(0)$ Probably$damaging$(1.000)$ Benign*$
c.A446G$ 5$ p.K149R$/$p.K127R$ Missense$ rs140878124$ Damaging$(0)$ Probably$damaging$(0.997)$ Pathogenic?$
c.C499T$ 5$ p.R167C$/$p.R145C$ Missense$ rs145671356$ Damaging$(0.01)$ Probably$damaging$(1.000)$ Pathogenic?$
c.G511A$ 5$ p.V171I$/$p.V149I$ Missense$ rs138787100$ Tolerated$(0.22)$ Benign$(0.049)$ Benign$
c.G587A$ 7$ p.R196H$/$p.R174H$ Missense$ rs141976916$ Damaging$(0.05)$ Possibly$damaging$(0.910)$ Pathogenic?$
c.G653A$ 7$ p.G218E$/$p.G196E$ Missense$ rs146321769$ Tolerated$(0.15)$ Benign$(0.049)$ Benign$
c.A676G$ 7$ p.I226V$/$p.I204V$ Missense$ rs138300557$ Tolerated$(0.47)$ Benign$(0.004)$ Benign$
c.C688T$ 7$ p.Q230X$/$p.Q208X$ Nonsense$ rs151023274$ /$ /$ Pathogenic?$
c.G752A$ 7$ p.G251D$/$p.G229D$ Missense$ rs121909749$ Damaging$(0)$ Probably$damaging$(1.0)$ Pathogenic?$
c.G766A$ 8$ p.V256M$/$p.V234M$ Missense$ rs144334540$ Damaging$(0)$ Probably$damaging$(0.999)$ Pathogenic?$
c.G799A$ 8$ p.G267S$/$p.G245S$ Missense$ rs142433300$ Damaging$(0.02)$ Probably$damaging$(1.0)$ Pathogenic?$
c.G967C$ 9$ p.V323L$/$p.V301L$ Missense$ rs147779008$ Damaging$(0)$ Possibly$damaging$(0.920)$ Pathogenic?$
c.DA1072$ 9$ p.R359GfsX26$/$p.R347GfsX26$
Deletion$/$
Frameshift$ rs34766493$ /$ /) Pathogenic?$
c.G1133A$ 10$ p.G378E$/$p.G356E$ Missense$ rs149915285$ Tolerated$(0.85)$ Benign$(0.010)$ Benign$
c.C1385G$ 10$ p.A462G$/$p.A440G$ Missense$ rs148031091$ Tolerated$(0.22)$ Benign$(0.051)$ Benign$
$
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AD# # Autosomal#dominant#
Amp# # Ampicillin#
AR# # Autosomal#recessive#
ARHGEF9# Cdc42#guanine#nucleotide#exchange#factor#9#gene#
BCAA# # Branched8chain#amino#acids#
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beo% % Bandoneon%mutant%
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CNS# # Central#nervous#system#
DAT# # Dopamine#transporter#
dNTPs# # Deoxyribonucleotides#
DNA# # Deoxyribonucleic#acid#
DOPE# # Discrete#Optimised#Potential#Energy#
EB# # Elution#buffer#
ECD# # Extracellular#domain#
EDTA# # Ethylenediaminetetraacetic#acid#
EGFP# # Enhanced#green#fluorescent#protein#
EL# # Extracellular#loop#
ELIC# # Erwinia%chrysanthemi#ligand8gated#ion#channel#
ENU# # Ethylnitrosourea#
GABA# # γ8aminobutyric#acid#
GAT# # GABA#transporter#
GCS# # Glycine#cleavage#system#
GEF# # Guanine#nucleotide#exchange#factor#
GFP# # Green#fluorescent#protein#
GLIC# # Gloeobacter#violaceus#ligand8gated#ion#channel#
GLRA1# # Glycine#receptor#α1#subunit#gene#
GLRB# # Glycine#receptor#β#subunit#gene#
GluCl# # Glutamate8gated#chloride#channel#
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GPHN# # Gephyrin#gene#
HEK293# Human#Embryonic#Kidney#293#
hpf# # Hours#post#fertilisation#
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IRES# # Internal#ribosome#entry#site#
LB# # Luria8Bertani#
Leu# # Leucine#
LeuT# # Leucine#transporter#
MO# # Morpholino#
MSUD# # Maple#syrup#urine#disease#
nAChR## Nicotinic#acetylcholine#receptor#
NET# # Noradrenaline#transporter#
NMDA## N8methyl8D8aspartate#
NMDAR# NMDA#receptor#
OMIM# # Online#Mendelian#Inheritance#in#Man#
pA# # Polyadenylation#
PCR# # Polymerase#chain#reaction#
PSD# # Postsynaptic#density#
QMEAN# Qualitative#Model#Energy#Analysis#
que% % quetschkommode%mutant#
RNA# # Ribonucleic#acid#
RT8PCR# Reverse#transcription#polymerase#chain#reaction#
SA# # Splice#acceptor#
SCOP# # Structural#Classification#of#Proteins#database#
SDS# # Sodium#dodecyl#sulphate#
SERT# # Serotonin#transporter#
sla% % schlaffi%mutant%
SLC6A5# Solute#carrier#family#6#member#5#gene#
SMO# # Splice8site#morpholino#
SNVs# # Single#nucleotide#variants#
TAE# # Tris8acetate#EDTA#
Tris8EDTA# Tris(hydroxymethyl)methylamine8ethylendiamine8tetraacetic#acid#
TM# # Transmembrane#domain#
TMO# # Translation8blocking#morpholino#
UAS# # Upstream#activation#sequence#
UCSC# # University#of#California#Santa#Cruz##
VIAAT# # Vesicular#inhibitory#amino#acid#transporter#
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